id	sid	tid	token	lemma	pos
iajs-3546	1	1	60	60	NUM
iajs-3546	1	2	©	©	PROPN
iajs-3546	1	3	2025	2025	NUM
iajs-3546	1	4	the	the	DET
iajs-3546	1	5	author(s	author(s	NOUN
iajs-3546	1	6	)	)	PUNCT
iajs-3546	1	7	.	.	PUNCT
iajs-3546	2	1	published	publish	VERB
iajs-3546	2	2	by	by	ADP
iajs-3546	2	3	college	college	NOUN
iajs-3546	2	4	of	of	ADP
iajs-3546	2	5	education	education	NOUN
iajs-3546	2	6	for	for	ADP
iajs-3546	2	7	pure	pure	ADJ
iajs-3546	2	8	science	science	NOUN
iajs-3546	2	9	(	(	PUNCT
iajs-3546	2	10	ibn	ibn	PROPN
iajs-3546	2	11	al	al	PROPN
iajs-3546	2	12	-	-	PUNCT
iajs-3546	2	13	haitham	haitham	PROPN
iajs-3546	2	14	)	)	PUNCT
iajs-3546	2	15	,	,	PUNCT
iajs-3546	2	16	university	university	NOUN
iajs-3546	2	17	of	of	ADP
iajs-3546	2	18	baghdad	baghdad	PROPN
iajs-3546	2	19	.	.	PUNCT
iajs-3546	3	1	this	this	PRON
iajs-3546	3	2	is	be	AUX
iajs-3546	3	3	an	an	DET
iajs-3546	3	4	open	open	ADJ
iajs-3546	3	5	-	-	PUNCT
iajs-3546	3	6	access	access	NOUN
iajs-3546	3	7	article	article	NOUN
iajs-3546	3	8	distributed	distribute	VERB
iajs-3546	3	9	under	under	ADP
iajs-3546	3	10	the	the	DET
iajs-3546	3	11	terms	term	NOUN
iajs-3546	3	12	of	of	ADP
iajs-3546	3	13	the	the	DET
iajs-3546	3	14	creative	creative	ADJ
iajs-3546	3	15	commons	common	NOUN
iajs-3546	3	16	attribution	attribution	NOUN
iajs-3546	3	17	4.0	4.0	NUM
iajs-3546	3	18	international	international	ADJ
iajs-3546	3	19	license	license	NOUN
iajs-3546	3	20	measurement	measurement	NOUN
iajs-3546	3	21	of	of	ADP
iajs-3546	3	22	several	several	ADJ
iajs-3546	3	23	hematological	hematological	ADJ
iajs-3546	3	24	and	and	CCONJ
iajs-3546	3	25	serological	serological	ADJ
iajs-3546	3	26	parameters	parameter	NOUN
iajs-3546	3	27	in	in	ADP
iajs-3546	3	28	patients	patient	NOUN
iajs-3546	3	29	with	with	ADP
iajs-3546	3	30	scabies	scabie	NOUN
iajs-3546	3	31	mariam	mariam	PROPN
iajs-3546	3	32	y.	y.	PROPN
iajs-3546	3	33	al	al	PROPN
iajs-3546	3	34	-	-	PUNCT
iajs-3546	3	35	fadhly1	fadhly1	PROPN
iajs-3546	3	36	*	*	PROPN
iajs-3546	3	37	,	,	PUNCT
iajs-3546	3	38	wasan	wasan	PROPN
iajs-3546	3	39	a.	a.	PROPN
iajs-3546	3	40	al	al	PROPN
iajs-3546	3	41	-	-	PUNCT
iajs-3546	3	42	marsomy2	marsomy2	PROPN
iajs-3546	3	43	,	,	PUNCT
iajs-3546	3	44	and	and	CCONJ
iajs-3546	3	45	hiba	hiba	PROPN
iajs-3546	3	46	h.	h.	PROPN
iajs-3546	3	47	maqdasi	maqdasi	PROPN
iajs-3546	3	48	3	3	NUM
iajs-3546	3	49	1	1	NUM
iajs-3546	3	50	,	,	PUNCT
iajs-3546	3	51	2department	2department	NUM
iajs-3546	3	52	of	of	ADP
iajs-3546	3	53	biology	biology	NOUN
iajs-3546	3	54	,	,	PUNCT
iajs-3546	3	55	collage	collage	NOUN
iajs-3546	3	56	of	of	ADP
iajs-3546	3	57	sciences	science	NOUN
iajs-3546	3	58	for	for	ADP
iajs-3546	3	59	women	woman	NOUN
iajs-3546	3	60	,	,	PUNCT
iajs-3546	3	61	university	university	NOUN
iajs-3546	3	62	of	of	ADP
iajs-3546	3	63	baghdad	baghdad	PROPN
iajs-3546	3	64	,	,	PUNCT
iajs-3546	3	65	baghdad	baghdad	PROPN
iajs-3546	3	66	,	,	PUNCT
iajs-3546	3	67	iraq	iraq	PROPN
iajs-3546	3	68	.	.	PUNCT
iajs-3546	4	1	3	3	NUM
iajs-3546	4	2	department	department	NOUN
iajs-3546	4	3	medicine	medicine	NOUN
iajs-3546	4	4	,	,	PUNCT
iajs-3546	4	5	collage	collage	NOUN
iajs-3546	4	6	of	of	ADP
iajs-3546	4	7	medicine	medicine	NOUN
iajs-3546	4	8	,	,	PUNCT
iajs-3546	4	9	ministry	ministry	PROPN
iajs-3546	4	10	of	of	ADP
iajs-3546	4	11	health	health	PROPN
iajs-3546	4	12	,	,	PUNCT
iajs-3546	4	13	baghdad	baghdad	PROPN
iajs-3546	4	14	,	,	PUNCT
iajs-3546	4	15	iraq	iraq	PROPN
iajs-3546	4	16	.	.	PUNCT
iajs-3546	5	1	*	*	PUNCT
iajs-3546	5	2	corresponding	correspond	VERB
iajs-3546	5	3	author	author	NOUN
iajs-3546	5	4	.	.	PUNCT
iajs-3546	6	1	received	receive	VERB
iajs-3546	6	2	:	:	PUNCT
iajs-3546	6	3	29	29	NUM
iajs-3546	6	4	may	may	AUX
iajs-3546	6	5	2023	2023	NUM
iajs-3546	6	6	accepted	accept	VERB
iajs-3546	6	7	:	:	PUNCT
iajs-3546	6	8	23	23	NUM
iajs-3546	6	9	july	july	PROPN
iajs-3546	6	10	2023	2023	NUM
iajs-3546	6	11	published	publish	VERB
iajs-3546	6	12	:	:	PUNCT
iajs-3546	6	13	20	20	NUM
iajs-3546	6	14	january	january	PROPN
iajs-3546	6	15	2025	2025	NUM
iajs-3546	6	16	doi.org/10.30526/38.1.34546	doi.org/10.30526/38.1.34546	NOUN
iajs-3546	6	17	abstract	abstract	ADJ
iajs-3546	6	18	people	people	NOUN
iajs-3546	6	19	often	often	ADV
iajs-3546	6	20	refer	refer	VERB
iajs-3546	6	21	to	to	ADP
iajs-3546	6	22	scabies	scabie	NOUN
iajs-3546	6	23	as	as	ADP
iajs-3546	6	24	the	the	DET
iajs-3546	6	25	"	"	PUNCT
iajs-3546	6	26	7	7	NUM
iajs-3546	6	27	-	-	PUNCT
iajs-3546	6	28	year	year	NOUN
iajs-3546	6	29	itch	itch	NOUN
iajs-3546	6	30	,	,	PUNCT
iajs-3546	6	31	"	"	PUNCT
iajs-3546	6	32	but	but	CCONJ
iajs-3546	6	33	it	it	PRON
iajs-3546	6	34	is	be	AUX
iajs-3546	6	35	more	more	ADV
iajs-3546	6	36	appropriate	appropriate	ADJ
iajs-3546	6	37	to	to	PART
iajs-3546	6	38	refer	refer	VERB
iajs-3546	6	39	to	to	ADP
iajs-3546	6	40	it	it	PRON
iajs-3546	6	41	as	as	ADP
iajs-3546	6	42	a	a	DET
iajs-3546	6	43	"	"	PUNCT
iajs-3546	6	44	family	family	NOUN
iajs-3546	6	45	disease	disease	NOUN
iajs-3546	6	46	"	"	PUNCT
iajs-3546	6	47	(	(	PUNCT
iajs-3546	6	48	1	1	NUM
iajs-3546	6	49	,	,	PUNCT
iajs-3546	6	50	15	15	NUM
iajs-3546	6	51	)	)	PUNCT
iajs-3546	6	52	.	.	PUNCT
iajs-3546	7	1	scabies	scabie	NOUN
iajs-3546	7	2	mites	mite	NOUN
iajs-3546	7	3	penetrate	penetrate	VERB
iajs-3546	7	4	the	the	DET
iajs-3546	7	5	stratum	stratum	NOUN
iajs-3546	7	6	corneum	corneum	VERB
iajs-3546	7	7	epidermis	epidermis	NOUN
iajs-3546	7	8	of	of	ADP
iajs-3546	7	9	the	the	DET
iajs-3546	7	10	skin	skin	NOUN
iajs-3546	7	11	at	at	ADP
iajs-3546	7	12	the	the	DET
iajs-3546	7	13	onset	onset	NOUN
iajs-3546	7	14	of	of	ADP
iajs-3546	7	15	infection	infection	NOUN
iajs-3546	7	16	(	(	PUNCT
iajs-3546	7	17	2	2	NUM
iajs-3546	7	18	,	,	PUNCT
iajs-3546	7	19	16	16	NUM
iajs-3546	7	20	)	)	PUNCT
iajs-3546	7	21	.	.	PUNCT
iajs-3546	8	1	the	the	DET
iajs-3546	8	2	current	current	ADJ
iajs-3546	8	3	study	study	NOUN
iajs-3546	8	4	involved	involve	VERB
iajs-3546	8	5	the	the	DET
iajs-3546	8	6	collection	collection	NOUN
iajs-3546	8	7	of	of	ADP
iajs-3546	8	8	blood	blood	NOUN
iajs-3546	8	9	samples	sample	NOUN
iajs-3546	8	10	from	from	ADP
iajs-3546	8	11	a	a	DET
iajs-3546	8	12	patient	patient	ADJ
iajs-3546	8	13	group	group	NOUN
iajs-3546	8	14	infected	infect	VERB
iajs-3546	8	15	with	with	ADP
iajs-3546	8	16	scabies	scabie	NOUN
iajs-3546	8	17	disease	disease	NOUN
iajs-3546	8	18	,	,	PUNCT
iajs-3546	8	19	comprising	comprise	VERB
iajs-3546	8	20	sixty	sixty	NUM
iajs-3546	8	21	individuals	individual	NOUN
iajs-3546	8	22	,	,	PUNCT
iajs-3546	8	23	and	and	CCONJ
iajs-3546	8	24	a	a	DET
iajs-3546	8	25	control	control	NOUN
iajs-3546	8	26	group	group	NOUN
iajs-3546	8	27	of	of	ADP
iajs-3546	8	28	sixty	sixty	NUM
iajs-3546	8	29	individuals	individual	NOUN
iajs-3546	8	30	who	who	PRON
iajs-3546	8	31	were	be	AUX
iajs-3546	8	32	in	in	ADP
iajs-3546	8	33	good	good	ADJ
iajs-3546	8	34	health	health	NOUN
iajs-3546	8	35	.	.	PUNCT
iajs-3546	9	1	the	the	DET
iajs-3546	9	2	tests	test	NOUN
iajs-3546	9	3	showed	show	VERB
iajs-3546	9	4	that	that	SCONJ
iajs-3546	9	5	there	there	PRON
iajs-3546	9	6	were	be	VERB
iajs-3546	9	7	no	no	DET
iajs-3546	9	8	statistically	statistically	ADV
iajs-3546	9	9	significant	significant	ADJ
iajs-3546	9	10	differences	difference	NOUN
iajs-3546	9	11	between	between	ADP
iajs-3546	9	12	the	the	DET
iajs-3546	9	13	scabies	scabie	NOUN
iajs-3546	9	14	patients	patient	NOUN
iajs-3546	9	15	and	and	CCONJ
iajs-3546	9	16	the	the	DET
iajs-3546	9	17	control	control	NOUN
iajs-3546	9	18	group	group	NOUN
iajs-3546	9	19	for	for	ADP
iajs-3546	9	20	hb	hb	PROPN
iajs-3546	9	21	(	(	PUNCT
iajs-3546	9	22	12.86±	12.86±	NUM
iajs-3546	9	23	0.31	0.31	NUM
iajs-3546	9	24	,	,	PUNCT
iajs-3546	9	25	12.88±	12.88±	NUM
iajs-3546	9	26	0.20	0.20	NUM
iajs-3546	9	27	)	)	PUNCT
iajs-3546	9	28	,	,	PUNCT
iajs-3546	9	29	pcv	pcv	NOUN
iajs-3546	9	30	(	(	PUNCT
iajs-3546	9	31	34.40±0.94	34.40±0.94	NUM
iajs-3546	9	32	,	,	PUNCT
iajs-3546	9	33	40.35±0.59	40.35±0.59	NUM
iajs-3546	9	34	)	)	PUNCT
iajs-3546	9	35	,	,	PUNCT
iajs-3546	9	36	and	and	CCONJ
iajs-3546	9	37	platelets	platelet	NOUN
iajs-3546	9	38	(	(	PUNCT
iajs-3546	9	39	244.80±9.58	244.80±9.58	NUM
iajs-3546	9	40	,	,	PUNCT
iajs-3546	9	41	237.23±8.97	237.23±8.97	NOUN
iajs-3546	9	42	)	)	PUNCT
iajs-3546	9	43	,	,	PUNCT
iajs-3546	9	44	respectively	respectively	ADV
iajs-3546	9	45	.	.	PUNCT
iajs-3546	10	1	there	there	PRON
iajs-3546	10	2	were	be	VERB
iajs-3546	10	3	also	also	ADV
iajs-3546	10	4	significant	significant	ADJ
iajs-3546	10	5	differences	difference	NOUN
iajs-3546	10	6	at	at	ADP
iajs-3546	10	7	the	the	DET
iajs-3546	10	8	0.001	0.001	NUM
iajs-3546	10	9	level	level	NOUN
iajs-3546	10	10	between	between	ADP
iajs-3546	10	11	the	the	DET
iajs-3546	10	12	two	two	NUM
iajs-3546	10	13	groups	group	NOUN
iajs-3546	10	14	of	of	ADP
iajs-3546	10	15	patients	patient	NOUN
iajs-3546	10	16	and	and	CCONJ
iajs-3546	10	17	the	the	DET
iajs-3546	10	18	control	control	NOUN
iajs-3546	10	19	group	group	NOUN
iajs-3546	10	20	for	for	ADP
iajs-3546	10	21	white	white	ADJ
iajs-3546	10	22	blood	blood	NOUN
iajs-3546	10	23	cells	cell	NOUN
iajs-3546	10	24	(	(	PUNCT
iajs-3546	10	25	wbc	wbc	PROPN
iajs-3546	10	26	)	)	PUNCT
iajs-3546	10	27	,	,	PUNCT
iajs-3546	10	28	lymphocytes	lymphocyte	VERB
iajs-3546	10	29	,	,	PUNCT
iajs-3546	10	30	neutrophils	neutrophil	NOUN
iajs-3546	10	31	,	,	PUNCT
iajs-3546	10	32	eosinophils	eosinophil	NOUN
iajs-3546	10	33	,	,	PUNCT
iajs-3546	10	34	monocytes	monocyte	NOUN
iajs-3546	10	35	,	,	PUNCT
iajs-3546	10	36	and	and	CCONJ
iajs-3546	10	37	basophils	basophils	PROPN
iajs-3546	10	38	.	.	PUNCT
iajs-3546	11	1	these	these	PRON
iajs-3546	11	2	were	be	AUX
iajs-3546	11	3	(	(	PUNCT
iajs-3546	11	4	11.09±0.20	11.09±0.20	NUM
iajs-3546	11	5	,	,	PUNCT
iajs-3546	11	6	7.50	7.50	NUM
iajs-3546	11	7	±0.16	±0.16	PROPN
iajs-3546	11	8	)	)	PUNCT
iajs-3546	11	9	,	,	PUNCT
iajs-3546	11	10	(	(	PUNCT
iajs-3546	11	11	5.05±0.16	5.05±0.16	NUM
iajs-3546	11	12	,	,	PUNCT
iajs-3546	11	13	2.27	2.27	NUM
iajs-3546	11	14	±0.06	±0.06	NOUN
iajs-3546	11	15	)	)	PUNCT
iajs-3546	11	16	,	,	PUNCT
iajs-3546	11	17	(	(	PUNCT
iajs-3546	11	18	8.23±0.10	8.23±0.10	NOUN
iajs-3546	11	19	,	,	PUNCT
iajs-3546	11	20	3.75±0.11	3.75±0.11	NUM
iajs-3546	11	21	)	)	PUNCT
iajs-3546	11	22	,	,	PUNCT
iajs-3546	11	23	(	(	PUNCT
iajs-3546	11	24	0.828±0.7	0.828±0.7	ADJ
iajs-3546	11	25	,	,	PUNCT
iajs-3546	11	26	0.415±0.03	0.415±0.03	NUM
iajs-3546	11	27	)	)	PUNCT
iajs-3546	11	28	,	,	PUNCT
iajs-3546	11	29	(	(	PUNCT
iajs-3546	11	30	0.498±0.02	0.498±0.02	NUM
iajs-3546	11	31	,	,	PUNCT
iajs-3546	11	32	0.459±0.03	0.459±0.03	NUM
iajs-3546	11	33	)	)	PUNCT
iajs-3546	11	34	,	,	PUNCT
iajs-3546	11	35	and	and	CCONJ
iajs-3546	11	36	(	(	PUNCT
iajs-3546	11	37	0.329±0.02	0.329±0.02	NUM
iajs-3546	11	38	,	,	PUNCT
iajs-3546	11	39	0.102	0.102	NUM
iajs-3546	11	40	±	±	NOUN
iajs-3546	11	41	0.01	0.01	NUM
iajs-3546	11	42	)	)	PUNCT
iajs-3546	11	43	,	,	PUNCT
iajs-3546	11	44	respectively	respectively	ADV
iajs-3546	11	45	.	.	PUNCT
iajs-3546	12	1	however	however	ADV
iajs-3546	12	2	,	,	PUNCT
iajs-3546	12	3	the	the	DET
iajs-3546	12	4	measurement	measurement	NOUN
iajs-3546	12	5	of	of	ADP
iajs-3546	12	6	immunoglobulins	immunoglobulin	NOUN
iajs-3546	12	7	(	(	PUNCT
iajs-3546	12	8	iga	iga	PROPN
iajs-3546	12	9	and	and	CCONJ
iajs-3546	12	10	ige	ige	PROPN
iajs-3546	12	11	)	)	PUNCT
iajs-3546	12	12	revealed	reveal	VERB
iajs-3546	12	13	non	non	ADJ
iajs-3546	12	14	-	-	ADJ
iajs-3546	12	15	significant	significant	ADJ
iajs-3546	12	16	differences	difference	NOUN
iajs-3546	12	17	in	in	ADP
iajs-3546	12	18	the	the	DET
iajs-3546	12	19	value	value	NOUN
iajs-3546	12	20	of	of	ADP
iajs-3546	12	21	iga	iga	PROPN
iajs-3546	12	22	for	for	ADP
iajs-3546	12	23	scabies	scabie	NOUN
iajs-3546	12	24	patients	patient	NOUN
iajs-3546	12	25	(	(	PUNCT
iajs-3546	12	26	130.73	130.73	NUM
iajs-3546	12	27	±	±	NUM
iajs-3546	12	28	10.38	10.38	NUM
iajs-3546	12	29	)	)	PUNCT
iajs-3546	12	30	compared	compare	VERB
iajs-3546	12	31	to	to	ADP
iajs-3546	12	32	the	the	DET
iajs-3546	12	33	control	control	NOUN
iajs-3546	12	34	group	group	NOUN
iajs-3546	12	35	(	(	PUNCT
iajs-3546	12	36	115.55	115.55	NUM
iajs-3546	12	37	±	±	NUM
iajs-3546	12	38	4.60	4.60	NUM
iajs-3546	12	39	)	)	PUNCT
iajs-3546	12	40	.	.	PUNCT
iajs-3546	13	1	however	however	ADV
iajs-3546	13	2	,	,	PUNCT
iajs-3546	13	3	the	the	DET
iajs-3546	13	4	ige	ige	PROPN
iajs-3546	13	5	ratio	ratio	NOUN
iajs-3546	13	6	resulted	result	VERB
iajs-3546	13	7	in	in	ADP
iajs-3546	13	8	high	high	ADJ
iajs-3546	13	9	significant	significant	ADJ
iajs-3546	13	10	differences	difference	NOUN
iajs-3546	13	11	at	at	ADP
iajs-3546	13	12	level	level	NOUN
iajs-3546	13	13	(	(	PUNCT
iajs-3546	13	14	p≤0.01	p≤0.01	NOUN
iajs-3546	13	15	)	)	PUNCT
iajs-3546	13	16	between	between	ADP
iajs-3546	13	17	patients	patient	NOUN
iajs-3546	13	18	(	(	PUNCT
iajs-3546	13	19	36.59	36.59	NUM
iajs-3546	13	20	±5.06	±5.06	NOUN
iajs-3546	13	21	)	)	PUNCT
iajs-3546	13	22	and	and	CCONJ
iajs-3546	13	23	control	control	NOUN
iajs-3546	13	24	(	(	PUNCT
iajs-3546	13	25	13.56	13.56	NUM
iajs-3546	13	26	±0.89	±0.89	NUM
iajs-3546	13	27	)	)	PUNCT
iajs-3546	13	28	.	.	PUNCT
iajs-3546	14	1	keywords	keyword	NOUN
iajs-3546	14	2	:	:	PUNCT
iajs-3546	14	3	sarcoptes	sarcopte	NOUN
iajs-3546	14	4	,	,	PUNCT
iajs-3546	14	5	cbc	cbc	NOUN
iajs-3546	14	6	parameters	parameter	NOUN
iajs-3546	14	7	,	,	PUNCT
iajs-3546	14	8	iga	iga	PROPN
iajs-3546	14	9	and	and	CCONJ
iajs-3546	14	10	ige	ige	PROPN
iajs-3546	14	11	and	and	CCONJ
iajs-3546	14	12	scabies	scabie	NOUN
iajs-3546	14	13	patients	patient	NOUN
iajs-3546	14	14	.	.	PUNCT
iajs-3546	15	1	1	1	X
iajs-3546	15	2	.	.	X
iajs-3546	15	3	introduction	introduction	NOUN
iajs-3546	15	4	:	:	PUNCT
iajs-3546	15	5	scabies	scabie	NOUN
iajs-3546	15	6	is	be	AUX
iajs-3546	15	7	an	an	DET
iajs-3546	15	8	ectoparasite	ectoparasite	ADJ
iajs-3546	15	9	due	due	ADP
iajs-3546	15	10	to	to	ADP
iajs-3546	15	11	the	the	DET
iajs-3546	15	12	mite	mite	NOUN
iajs-3546	15	13	sarcoptes	sarcopte	VERB
iajs-3546	15	14	scabiei	scabiei	PROPN
iajs-3546	15	15	var	var	NOUN
iajs-3546	15	16	.	.	PUNCT
iajs-3546	16	1	hominis	hominis	PROPN
iajs-3546	16	2	,	,	PUNCT
iajs-3546	16	3	these	these	DET
iajs-3546	16	4	tiny	tiny	ADJ
iajs-3546	16	5	insects	insect	NOUN
iajs-3546	16	6	crawl	crawl	NOUN
iajs-3546	16	7	into	into	ADP
iajs-3546	16	8	the	the	DET
iajs-3546	16	9	skin	skin	NOUN
iajs-3546	16	10	,	,	PUNCT
iajs-3546	16	11	creating	create	VERB
iajs-3546	16	12	small	small	ADJ
iajs-3546	16	13	red	red	ADJ
iajs-3546	16	14	lumps	lump	NOUN
iajs-3546	16	15	and	and	CCONJ
iajs-3546	16	16	severe	severe	ADJ
iajs-3546	16	17	itching	itching	NOUN
iajs-3546	16	18	,	,	PUNCT
iajs-3546	16	19	the	the	DET
iajs-3546	16	20	pathogen	pathogen	NOUN
iajs-3546	16	21	spreads	spread	VERB
iajs-3546	16	22	quickly	quickly	ADV
iajs-3546	16	23	from	from	ADP
iajs-3546	16	24	one	one	NUM
iajs-3546	16	25	person	person	NOUN
iajs-3546	16	26	to	to	ADP
iajs-3546	16	27	the	the	DET
iajs-3546	16	28	next	next	ADJ
iajs-3546	16	29	,	,	PUNCT
iajs-3546	16	30	especially	especially	ADV
iajs-3546	16	31	when	when	SCONJ
iajs-3546	16	32	individuals	individual	NOUN
iajs-3546	16	33	live	live	VERB
iajs-3546	16	34	near	near	ADP
iajs-3546	16	35	to	to	ADP
iajs-3546	16	36	another	another	DET
iajs-3546	16	37	one	one	NUM
iajs-3546	16	38	(	(	PUNCT
iajs-3546	16	39	1	1	NUM
iajs-3546	16	40	)	)	PUNCT
iajs-3546	16	41	.	.	PUNCT
iajs-3546	17	1	the	the	DET
iajs-3546	17	2	mites	mite	NOUN
iajs-3546	17	3	live	live	VERB
iajs-3546	17	4	in	in	ADP
iajs-3546	17	5	the	the	DET
iajs-3546	17	6	skin	skin	NOUN
iajs-3546	17	7	's	's	PART
iajs-3546	17	8	cracks	crack	NOUN
iajs-3546	17	9	and	and	CCONJ
iajs-3546	17	10	tiny	tiny	ADJ
iajs-3546	17	11	holes	hole	NOUN
iajs-3546	17	12	,	,	PUNCT
iajs-3546	17	13	in	in	ADP
iajs-3546	17	14	addition	addition	NOUN
iajs-3546	17	15	to	to	ADP
iajs-3546	17	16	the	the	DET
iajs-3546	17	17	classic	classic	ADJ
iajs-3546	17	18	form	form	NOUN
iajs-3546	17	19	,	,	PUNCT
iajs-3546	17	20	there	there	PRON
iajs-3546	17	21	are	be	VERB
iajs-3546	17	22	different	different	ADJ
iajs-3546	17	23	versions	version	NOUN
iajs-3546	17	24	(	(	PUNCT
iajs-3546	17	25	also	also	ADV
iajs-3546	17	26	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3546	17	27	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3546	17	28	https://orcid.org/0009-0009-2737-5762	https://orcid.org/0009-0009-2737-5762	PROPN
iajs-3546	17	29	mailto:maryam96654@gmail.com	mailto:maryam96654@gmail.com	PROPN
iajs-3546	17	30	https://orcid.org/0000-0001-8041-3814	https://orcid.org/0000-0001-8041-3814	PROPN
iajs-3546	17	31	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3546	17	32	https://orcid.org/0000-0001-8041-3814	https://orcid.org/0000-0001-8041-3814	PROPN
iajs-3546	17	33	.	.	PUNCT
iajs-3546	18	1	mailto:hibahm70@yahoo.com	mailto:hibahm70@yahoo.com	PROPN
iajs-3546	18	2	ihjpas	ihjpas	PROPN
iajs-3546	18	3	.	.	PUNCT
iajs-3546	19	1	2025	2025	NUM
iajs-3546	19	2	,	,	PUNCT
iajs-3546	19	3	38	38	NUM
iajs-3546	19	4	(	(	PUNCT
iajs-3546	19	5	1	1	NUM
iajs-3546	19	6	)	)	PUNCT
iajs-3546	19	7	61	61	NUM
iajs-3546	19	8	known	know	VERB
iajs-3546	19	9	as	as	ADP
iajs-3546	19	10	typical	typical	ADJ
iajs-3546	19	11	)	)	PUNCT
iajs-3546	19	12	,	,	PUNCT
iajs-3546	19	13	usually	usually	ADV
iajs-3546	19	14	,	,	PUNCT
iajs-3546	19	15	mostly	mostly	ADV
iajs-3546	19	16	located	locate	VERB
iajs-3546	19	17	in	in	ADP
iajs-3546	19	18	an	an	DET
iajs-3546	19	19	african	african	ADJ
iajs-3546	19	20	distribution	distribution	NOUN
iajs-3546	19	21	and	and	CCONJ
iajs-3546	19	22	a	a	DET
iajs-3546	19	23	larger	large	ADJ
iajs-3546	19	24	scale	scale	NOUN
iajs-3546	19	25	as	as	ADP
iajs-3546	19	26	a	a	DET
iajs-3546	19	27	population	population	NOUN
iajs-3546	19	28	level	level	NOUN
iajs-3546	19	29	health	health	NOUN
iajs-3546	19	30	issue	issue	NOUN
iajs-3546	19	31	that	that	PRON
iajs-3546	19	32	demands	demand	VERB
iajs-3546	19	33	attention	attention	NOUN
iajs-3546	19	34	in	in	ADP
iajs-3546	19	35	various	various	ADJ
iajs-3546	19	36	contexts	context	NOUN
iajs-3546	19	37	globally	globally	ADV
iajs-3546	19	38	(	(	PUNCT
iajs-3546	19	39	2	2	NUM
iajs-3546	19	40	)	)	PUNCT
iajs-3546	19	41	.	.	PUNCT
iajs-3546	20	1	scabies	scabie	NOUN
iajs-3546	20	2	can	can	AUX
iajs-3546	20	3	be	be	AUX
iajs-3546	20	4	seen	see	VERB
iajs-3546	20	5	as	as	ADP
iajs-3546	20	6	a	a	DET
iajs-3546	20	7	barrier	barrier	NOUN
iajs-3546	20	8	to	to	ADP
iajs-3546	20	9	the	the	DET
iajs-3546	20	10	fundamental	fundamental	ADJ
iajs-3546	20	11	human	human	ADJ
iajs-3546	20	12	right	right	NOUN
iajs-3546	20	13	to	to	PART
iajs-3546	20	14	live	live	VERB
iajs-3546	20	15	a	a	DET
iajs-3546	20	16	long	long	ADJ
iajs-3546	20	17	life	life	NOUN
iajs-3546	20	18	in	in	ADP
iajs-3546	20	19	good	good	ADJ
iajs-3546	20	20	health	health	NOUN
iajs-3546	20	21	,	,	PUNCT
iajs-3546	20	22	especially	especially	ADV
iajs-3546	20	23	for	for	ADP
iajs-3546	20	24	poor	poor	ADJ
iajs-3546	20	25	patients	patient	NOUN
iajs-3546	20	26	in	in	ADP
iajs-3546	20	27	less	less	ADJ
iajs-3546	20	28	developed	developed	ADJ
iajs-3546	20	29	nations	nation	NOUN
iajs-3546	20	30	(	(	PUNCT
iajs-3546	20	31	3	3	NUM
iajs-3546	20	32	)	)	PUNCT
iajs-3546	20	33	.	.	PUNCT
iajs-3546	21	1	crusted	crust	VERB
iajs-3546	21	2	norwegian	norwegian	PROPN
iajs-3546	21	3	often	often	ADV
iajs-3546	21	4	happens	happen	VERB
iajs-3546	21	5	in	in	ADP
iajs-3546	21	6	patients	patient	NOUN
iajs-3546	21	7	with	with	ADP
iajs-3546	21	8	weak	weak	ADJ
iajs-3546	21	9	immune	immune	ADJ
iajs-3546	21	10	systems	system	NOUN
iajs-3546	21	11	.	.	PUNCT
iajs-3546	22	1	it	it	PRON
iajs-3546	22	2	tends	tend	VERB
iajs-3546	22	3	to	to	PART
iajs-3546	22	4	form	form	VERB
iajs-3546	22	5	crusted	crust	VERB
iajs-3546	22	6	areas	area	NOUN
iajs-3546	22	7	covering	cover	VERB
iajs-3546	22	8	a	a	DET
iajs-3546	22	9	big	big	ADJ
iajs-3546	22	10	area	area	NOUN
iajs-3546	22	11	of	of	ADP
iajs-3546	22	12	skin	skin	NOUN
iajs-3546	22	13	,	,	PUNCT
iajs-3546	22	14	crusted	crust	VERB
iajs-3546	22	15	scabies	scabie	NOUN
iajs-3546	22	16	,	,	PUNCT
iajs-3546	22	17	may	may	AUX
iajs-3546	22	18	contain	contain	VERB
iajs-3546	22	19	millions	million	NOUN
iajs-3546	22	20	of	of	ADP
iajs-3546	22	21	mites	mite	NOUN
iajs-3546	22	22	instead	instead	ADV
iajs-3546	22	23	of	of	ADP
iajs-3546	22	24	the	the	DET
iajs-3546	22	25	10	10	NUM
iajs-3546	22	26	to	to	PART
iajs-3546	22	27	15	15	NUM
iajs-3546	22	28	mites	mite	NOUN
iajs-3546	22	29	common	common	ADJ
iajs-3546	22	30	with	with	ADP
iajs-3546	22	31	classic	classic	ADJ
iajs-3546	22	32	scabies	scabie	NOUN
iajs-3546	22	33	,	,	PUNCT
iajs-3546	22	34	while	while	SCONJ
iajs-3546	22	35	the	the	DET
iajs-3546	22	36	nodular	nodular	ADJ
iajs-3546	22	37	the	the	DET
iajs-3546	22	38	kind	kind	NOUN
iajs-3546	22	39	is	be	AUX
iajs-3546	22	40	more	more	ADV
iajs-3546	22	41	frequent	frequent	ADJ
iajs-3546	22	42	in	in	ADP
iajs-3546	22	43	youngsters	youngster	NOUN
iajs-3546	22	44	(	(	PUNCT
iajs-3546	22	45	4,26	4,26	NOUN
iajs-3546	22	46	)	)	PUNCT
iajs-3546	22	47	.	.	PUNCT
iajs-3546	23	1	bullous	bullous	ADJ
iajs-3546	23	2	type	type	NOUN
iajs-3546	23	3	is	be	AUX
iajs-3546	23	4	in	in	ADP
iajs-3546	23	5	adults	adult	NOUN
iajs-3546	23	6	of	of	ADP
iajs-3546	23	7	scabies	scabie	NOUN
iajs-3546	23	8	and	and	CCONJ
iajs-3546	23	9	can	can	AUX
iajs-3546	23	10	be	be	AUX
iajs-3546	23	11	confused	confuse	VERB
iajs-3546	23	12	with	with	ADP
iajs-3546	23	13	bullous	bullous	ADJ
iajs-3546	23	14	pemphigoid	pemphigoid	NOUN
iajs-3546	23	15	,	,	PUNCT
iajs-3546	23	16	it	it	PRON
iajs-3546	23	17	is	be	AUX
iajs-3546	23	18	another	another	DET
iajs-3546	23	19	causes	cause	NOUN
iajs-3546	23	20	infected	infect	VERB
iajs-3546	23	21	skin	skin	NOUN
iajs-3546	23	22	blisters	blister	NOUN
iajs-3546	23	23	,	,	PUNCT
iajs-3546	23	24	infected	infect	VERB
iajs-3546	23	25	and	and	CCONJ
iajs-3546	23	26	occurs	occur	VERB
iajs-3546	23	27	on	on	ADP
iajs-3546	23	28	scalp	scalp	NOUN
iajs-3546	23	29	and	and	CCONJ
iajs-3546	23	30	may	may	AUX
iajs-3546	23	31	not	not	PART
iajs-3546	23	32	present	present	VERB
iajs-3546	23	33	symptoms	symptom	NOUN
iajs-3546	23	34	except	except	SCONJ
iajs-3546	23	35	for	for	ADP
iajs-3546	23	36	scales	scale	NOUN
iajs-3546	23	37	that	that	PRON
iajs-3546	23	38	may	may	AUX
iajs-3546	23	39	resemble	resemble	VERB
iajs-3546	23	40	psoriasis	psoriasis	NOUN
iajs-3546	23	41	(	(	PUNCT
iajs-3546	23	42	5	5	NUM
iajs-3546	23	43	)	)	PUNCT
iajs-3546	23	44	.	.	PUNCT
iajs-3546	24	1	itching	itching	NOUN
iajs-3546	24	2	is	be	AUX
iajs-3546	24	3	the	the	DET
iajs-3546	24	4	most	most	ADV
iajs-3546	24	5	noticeable	noticeable	ADJ
iajs-3546	24	6	symptom	symptom	NOUN
iajs-3546	24	7	of	of	ADP
iajs-3546	24	8	scabies	scabie	NOUN
iajs-3546	24	9	,	,	PUNCT
iajs-3546	24	10	especially	especially	ADV
iajs-3546	24	11	at	at	ADP
iajs-3546	24	12	night	night	NOUN
iajs-3546	24	13	and	and	CCONJ
iajs-3546	24	14	it	it	PRON
iajs-3546	24	15	can	can	AUX
iajs-3546	24	16	be	be	AUX
iajs-3546	24	17	so	so	ADV
iajs-3546	24	18	severe	severe	ADJ
iajs-3546	24	19	that	that	SCONJ
iajs-3546	24	20	it	it	PRON
iajs-3546	24	21	keeps	keep	VERB
iajs-3546	24	22	a	a	DET
iajs-3546	24	23	person	person	NOUN
iajs-3546	24	24	awake	awake	ADJ
iajs-3546	24	25	at	at	ADP
iajs-3546	24	26	night	night	NOUN
iajs-3546	24	27	,	,	PUNCT
iajs-3546	24	28	other	other	ADJ
iajs-3546	24	29	symptoms	symptom	NOUN
iajs-3546	24	30	include	include	VERB
iajs-3546	24	31	rash	rash	ADJ
iajs-3546	24	32	sores	sore	NOUN
iajs-3546	24	33	and	and	CCONJ
iajs-3546	24	34	thick	thick	ADJ
iajs-3546	24	35	skin	skin	NOUN
iajs-3546	24	36	crusts	crust	NOUN
iajs-3546	24	37	(	(	PUNCT
iajs-3546	24	38	6	6	NUM
iajs-3546	24	39	,	,	PUNCT
iajs-3546	24	40	27	27	NUM
iajs-3546	24	41	)	)	PUNCT
iajs-3546	24	42	.	.	PUNCT
iajs-3546	25	1	despite	despite	SCONJ
iajs-3546	25	2	experiencing	experience	VERB
iajs-3546	25	3	a	a	DET
iajs-3546	25	4	wide	wide	ADJ
iajs-3546	25	5	range	range	NOUN
iajs-3546	25	6	of	of	ADP
iajs-3546	25	7	clinical	clinical	ADJ
iajs-3546	25	8	features	feature	NOUN
iajs-3546	25	9	that	that	PRON
iajs-3546	25	10	range	range	VERB
iajs-3546	25	11	from	from	ADP
iajs-3546	25	12	mild	mild	ADJ
iajs-3546	25	13	to	to	PART
iajs-3546	25	14	severely	severely	ADV
iajs-3546	25	15	harmful	harmful	ADJ
iajs-3546	25	16	which	which	PRON
iajs-3546	25	17	occurs	occur	VERB
iajs-3546	25	18	in	in	ADP
iajs-3546	25	19	scabies	scabie	NOUN
iajs-3546	25	20	patients	patient	NOUN
iajs-3546	25	21	,	,	PUNCT
iajs-3546	25	22	but	but	CCONJ
iajs-3546	25	23	the	the	DET
iajs-3546	25	24	immune	immune	ADJ
iajs-3546	25	25	and	and	CCONJ
iajs-3546	25	26	inflammatory	inflammatory	ADJ
iajs-3546	25	27	responses	response	NOUN
iajs-3546	25	28	connected	connect	VERB
iajs-3546	25	29	with	with	ADP
iajs-3546	25	30	the	the	DET
iajs-3546	25	31	different	different	ADJ
iajs-3546	25	32	clinical	clinical	ADJ
iajs-3546	25	33	manifestations	manifestation	NOUN
iajs-3546	25	34	are	be	AUX
iajs-3546	25	35	still	still	ADV
iajs-3546	25	36	insufficiently	insufficiently	ADV
iajs-3546	25	37	understood	understand	VERB
iajs-3546	25	38	characterized	characterize	VERB
iajs-3546	25	39	,	,	PUNCT
iajs-3546	25	40	although	although	SCONJ
iajs-3546	25	41	,	,	PUNCT
iajs-3546	25	42	people	people	NOUN
iajs-3546	25	43	with	with	ADP
iajs-3546	25	44	scabies	scabie	NOUN
iajs-3546	25	45	suffered	suffer	VERB
iajs-3546	25	46	from	from	ADP
iajs-3546	25	47	severe	severe	ADJ
iajs-3546	25	48	itching	itching	NOUN
iajs-3546	25	49	that	that	PRON
iajs-3546	25	50	was	be	AUX
iajs-3546	25	51	clear	clear	ADJ
iajs-3546	25	52	and	and	CCONJ
iajs-3546	25	53	allergic	allergic	ADJ
iajs-3546	25	54	in	in	ADP
iajs-3546	25	55	nature	nature	NOUN
iajs-3546	25	56	as	as	ADP
iajs-3546	25	57	chapter	chapter	NOUN
iajs-3546	25	58	one	one	NUM
iajs-3546	25	59	:	:	PUNCT
iajs-3546	25	60	introduction	introduction	NOUN
iajs-3546	25	61	2	2	NUM
iajs-3546	25	62	result	result	VERB
iajs-3546	25	63	inflammatory	inflammatory	ADJ
iajs-3546	25	64	reactions	reaction	NOUN
iajs-3546	25	65	for	for	ADP
iajs-3546	25	66	the	the	DET
iajs-3546	25	67	host	host	NOUN
iajs-3546	25	68	toward	toward	ADP
iajs-3546	25	69	the	the	DET
iajs-3546	25	70	mite	mite	NOUN
iajs-3546	25	71	and	and	CCONJ
iajs-3546	25	72	its	its	PRON
iajs-3546	25	73	products	product	NOUN
iajs-3546	25	74	.	.	PUNCT
iajs-3546	26	1	world	world	PROPN
iajs-3546	26	2	health	health	PROPN
iajs-3546	26	3	organization	organization	NOUN
iajs-3546	26	4	has	have	AUX
iajs-3546	26	5	legally	legally	ADV
iajs-3546	26	6	designated	designate	VERB
iajs-3546	26	7	scabies	scabie	NOUN
iajs-3546	26	8	as	as	ADP
iajs-3546	26	9	a	a	DET
iajs-3546	26	10	neglected	neglect	VERB
iajs-3546	26	11	tropical	tropical	ADJ
iajs-3546	26	12	disease	disease	NOUN
iajs-3546	26	13	and	and	CCONJ
iajs-3546	26	14	cs	cs	PROPN
iajs-3546	26	15	(	(	PUNCT
iajs-3546	26	16	crusted	crust	VERB
iajs-3546	26	17	scabies	scabie	NOUN
iajs-3546	26	18	)	)	PUNCT
iajs-3546	26	19	is	be	AUX
iajs-3546	26	20	an	an	DET
iajs-3546	26	21	even	even	ADV
iajs-3546	26	22	less	less	ADV
iajs-3546	26	23	-	-	PUNCT
iajs-3546	26	24	researched	research	VERB
iajs-3546	26	25	manifestation	manifestation	NOUN
iajs-3546	26	26	of	of	ADP
iajs-3546	26	27	this	this	DET
iajs-3546	26	28	sickness	sickness	NOUN
iajs-3546	26	29	that	that	PRON
iajs-3546	26	30	requires	require	VERB
iajs-3546	26	31	further	further	ADJ
iajs-3546	26	32	study	study	NOUN
iajs-3546	26	33	,	,	PUNCT
iajs-3546	26	34	microscopic	microscopic	ADJ
iajs-3546	26	35	analysis	analysis	NOUN
iajs-3546	26	36	of	of	ADP
iajs-3546	26	37	skin	skin	NOUN
iajs-3546	26	38	scrapings	scraping	NOUN
iajs-3546	26	39	identified	identify	VERB
iajs-3546	26	40	mites	mite	NOUN
iajs-3546	26	41	,	,	PUNCT
iajs-3546	26	42	eggs	egg	NOUN
iajs-3546	26	43	or	or	CCONJ
iajs-3546	26	44	faecal	faecal	ADJ
iajs-3546	26	45	pellets	pellet	NOUN
iajs-3546	26	46	(	(	PUNCT
iajs-3546	26	47	7	7	NUM
iajs-3546	26	48	,	,	PUNCT
iajs-3546	26	49	4	4	NUM
iajs-3546	26	50	)	)	PUNCT
iajs-3546	26	51	.	.	PUNCT
iajs-3546	27	1	the	the	DET
iajs-3546	27	2	research	research	NOUN
iajs-3546	27	3	indicates	indicate	VERB
iajs-3546	27	4	that	that	SCONJ
iajs-3546	27	5	sarcoptes	sarcopte	NOUN
iajs-3546	27	6	scabiei	scabiei	PROPN
iajs-3546	27	7	may	may	AUX
iajs-3546	27	8	be	be	AUX
iajs-3546	27	9	reducing	reduce	VERB
iajs-3546	27	10	the	the	DET
iajs-3546	27	11	early	early	ADJ
iajs-3546	27	12	immune	immune	ADJ
iajs-3546	27	13	responses	response	NOUN
iajs-3546	27	14	by	by	ADP
iajs-3546	27	15	down	down	ADP
iajs-3546	27	16	regulating	regulate	VERB
iajs-3546	27	17	the	the	DET
iajs-3546	27	18	expression	expression	NOUN
iajs-3546	27	19	of	of	ADP
iajs-3546	27	20	pro	pro	ADJ
iajs-3546	27	21	inflammatory	inflammatory	ADJ
iajs-3546	27	22	mediators	mediator	NOUN
iajs-3546	27	23	and	and	CCONJ
iajs-3546	27	24	cytokine	cytokine	NOUN
iajs-3546	27	25	.	.	PUNCT
iajs-3546	28	1	for	for	ADP
iajs-3546	28	2	instance	instance	NOUN
iajs-3546	28	3	,	,	PUNCT
iajs-3546	28	4	ige	ige	PROPN
iajs-3546	28	5	plays	play	VERB
iajs-3546	28	6	a	a	DET
iajs-3546	28	7	crucial	crucial	ADJ
iajs-3546	28	8	role	role	NOUN
iajs-3546	28	9	in	in	ADP
iajs-3546	28	10	the	the	DET
iajs-3546	28	11	host	host	NOUN
iajs-3546	28	12	defense	defense	NOUN
iajs-3546	28	13	against	against	ADP
iajs-3546	28	14	to	to	ADP
iajs-3546	28	15	a	a	DET
iajs-3546	28	16	variety	variety	NOUN
iajs-3546	28	17	of	of	ADP
iajs-3546	28	18	parasites	parasite	NOUN
iajs-3546	28	19	and	and	CCONJ
iajs-3546	28	20	along	along	ADP
iajs-3546	28	21	with	with	ADP
iajs-3546	28	22	mast	mast	NOUN
iajs-3546	28	23	cells	cell	NOUN
iajs-3546	28	24	,	,	PUNCT
iajs-3546	28	25	basophils	basophil	NOUN
iajs-3546	28	26	and	and	CCONJ
iajs-3546	28	27	eosinophil	eosinophil	ADJ
iajs-3546	28	28	’s	’s	PART
iajs-3546	28	29	,	,	PUNCT
iajs-3546	28	30	it	it	PRON
iajs-3546	28	31	forms	form	VERB
iajs-3546	28	32	a	a	DET
iajs-3546	28	33	crucial	crucial	ADJ
iajs-3546	28	34	component	component	NOUN
iajs-3546	28	35	of	of	ADP
iajs-3546	28	36	allergic	allergic	ADJ
iajs-3546	28	37	and	and	CCONJ
iajs-3546	28	38	parasitic	parasitic	ADJ
iajs-3546	28	39	inflammation	inflammation	NOUN
iajs-3546	28	40	,	,	PUNCT
iajs-3546	28	41	in	in	ADP
iajs-3546	28	42	humans	human	NOUN
iajs-3546	28	43	,	,	PUNCT
iajs-3546	28	44	earlier	early	ADJ
iajs-3546	28	45	studies	study	NOUN
iajs-3546	28	46	have	have	AUX
iajs-3546	28	47	found	find	VERB
iajs-3546	28	48	that	that	SCONJ
iajs-3546	28	49	scabies	scabie	NOUN
iajs-3546	28	50	causes	cause	VERB
iajs-3546	28	51	an	an	DET
iajs-3546	28	52	increase	increase	NOUN
iajs-3546	28	53	in	in	ADP
iajs-3546	28	54	production	production	NOUN
iajs-3546	28	55	of	of	ADP
iajs-3546	28	56	circulating	circulate	VERB
iajs-3546	28	57	ige	ige	PROPN
iajs-3546	28	58	antibodies	antibody	NOUN
iajs-3546	28	59	(	(	PUNCT
iajs-3546	28	60	8,4	8,4	NUM
iajs-3546	28	61	)	)	PUNCT
iajs-3546	28	62	.	.	PUNCT
iajs-3546	29	1	secretory	secretory	PROPN
iajs-3546	29	2	iga	iga	PROPN
iajs-3546	29	3	which	which	PRON
iajs-3546	29	4	is	be	AUX
iajs-3546	29	5	necessary	necessary	ADJ
iajs-3546	29	6	for	for	ADP
iajs-3546	29	7	immunological	immunological	ADJ
iajs-3546	29	8	activity	activity	NOUN
iajs-3546	29	9	in	in	ADP
iajs-3546	29	10	the	the	DET
iajs-3546	29	11	mucous	mucous	ADJ
iajs-3546	29	12	membranes	membrane	NOUN
iajs-3546	29	13	,	,	PUNCT
iajs-3546	29	14	is	be	AUX
iajs-3546	29	15	often	often	ADV
iajs-3546	29	16	more	more	ADV
iajs-3546	29	17	abundant	abundant	ADJ
iajs-3546	29	18	in	in	ADP
iajs-3546	29	19	mucosal	mucosal	ADJ
iajs-3546	29	20	regions	region	NOUN
iajs-3546	29	21	than	than	ADP
iajs-3546	29	22	in	in	ADP
iajs-3546	29	23	serum	serum	NOUN
iajs-3546	29	24	.	.	PUNCT
iajs-3546	30	1	and	and	CCONJ
iajs-3546	30	2	about	about	ADP
iajs-3546	30	3	immune	immune	ADJ
iajs-3546	30	4	cells	cell	NOUN
iajs-3546	30	5	,	,	PUNCT
iajs-3546	30	6	th2	th2	PROPN
iajs-3546	30	7	cells	cell	NOUN
iajs-3546	30	8	release	release	VERB
iajs-3546	30	9	il-4	il-4	NOUN
iajs-3546	30	10	,	,	PUNCT
iajs-3546	30	11	il-5	il-5	NOUN
iajs-3546	30	12	,	,	PUNCT
iajs-3546	30	13	and	and	CCONJ
iajs-3546	30	14	il-13	il-13	PUNCT
iajs-3546	30	15	and	and	CCONJ
iajs-3546	30	16	mediate	mediate	VERB
iajs-3546	30	17	humoral	humoral	ADJ
iajs-3546	30	18	immunity	immunity	NOUN
iajs-3546	30	19	by	by	ADP
iajs-3546	30	20	producing	produce	VERB
iajs-3546	30	21	more	more	ADJ
iajs-3546	30	22	antibodies	antibody	NOUN
iajs-3546	30	23	to	to	PART
iajs-3546	30	24	fight	fight	VERB
iajs-3546	30	25	extracellular	extracellular	ADJ
iajs-3546	30	26	parasites	parasite	NOUN
iajs-3546	30	27	and	and	CCONJ
iajs-3546	30	28	mediating	mediate	VERB
iajs-3546	30	29	humoral	humoral	ADJ
iajs-3546	30	30	immunity	immunity	NOUN
iajs-3546	30	31	,	,	PUNCT
iajs-3546	30	32	th2	th2	PROPN
iajs-3546	30	33	cells	cell	NOUN
iajs-3546	30	34	are	be	AUX
iajs-3546	30	35	also	also	ADV
iajs-3546	30	36	the	the	DET
iajs-3546	30	37	predominant	predominant	ADJ
iajs-3546	30	38	effector	effector	NOUN
iajs-3546	30	39	cells	cell	NOUN
iajs-3546	30	40	in	in	ADP
iajs-3546	30	41	the	the	DET
iajs-3546	30	42	pathogenesis	pathogenesis	NOUN
iajs-3546	30	43	of	of	ADP
iajs-3546	30	44	ige	ige	PROPN
iajs-3546	30	45	mediated	mediate	VERB
iajs-3546	30	46	hypersensitivity	hypersensitivity	NOUN
iajs-3546	30	47	in	in	ADP
iajs-3546	30	48	asthma	asthma	NOUN
iajs-3546	30	49	and	and	CCONJ
iajs-3546	30	50	other	other	ADJ
iajs-3546	30	51	allergic	allergic	ADJ
iajs-3546	30	52	inflammatory	inflammatory	ADJ
iajs-3546	30	53	diseases	disease	NOUN
iajs-3546	30	54	(	(	PUNCT
iajs-3546	30	55	9	9	NUM
iajs-3546	30	56	,	,	PUNCT
iajs-3546	30	57	4	4	NUM
iajs-3546	30	58	)	)	PUNCT
iajs-3546	30	59	.	.	PUNCT
iajs-3546	31	1	as	as	ADV
iajs-3546	31	2	well	well	ADV
iajs-3546	31	3	as	as	ADP
iajs-3546	31	4	,	,	PUNCT
iajs-3546	31	5	parasite	parasite	ADJ
iajs-3546	31	6	infection	infection	NOUN
iajs-3546	31	7	stimulate	stimulate	VERB
iajs-3546	31	8	increase	increase	NOUN
iajs-3546	31	9	production	production	NOUN
iajs-3546	31	10	of	of	ADP
iajs-3546	31	11	th17	th17	PROPN
iajs-3546	31	12	cytokines	cytokine	NOUN
iajs-3546	31	13	such	such	ADJ
iajs-3546	31	14	il-23	il-23	NOUN
iajs-3546	31	15	,	,	PUNCT
iajs-3546	31	16	il-17	il-17	NUM
iajs-3546	31	17	which	which	PRON
iajs-3546	31	18	is	be	AUX
iajs-3546	31	19	a	a	DET
iajs-3546	31	20	powerful	powerful	ADJ
iajs-3546	31	21	pro	pro	ADJ
iajs-3546	31	22	-	-	ADJ
iajs-3546	31	23	inflammatory	inflammatory	ADJ
iajs-3546	31	24	cytokine	cytokine	NOUN
iajs-3546	31	25	that	that	PRON
iajs-3546	31	26	is	be	AUX
iajs-3546	31	27	typically	typically	ADV
iajs-3546	31	28	released	release	VERB
iajs-3546	31	29	th17	th17	PROPN
iajs-3546	31	30	cells	cell	NOUN
iajs-3546	31	31	,	,	PUNCT
iajs-3546	31	32	however	however	ADV
iajs-3546	31	33	they	they	PRON
iajs-3546	31	34	can	can	AUX
iajs-3546	31	35	also	also	ADV
iajs-3546	31	36	secreted	secrete	VERB
iajs-3546	31	37	by	by	ADP
iajs-3546	31	38	other	other	ADJ
iajs-3546	31	39	cell	cell	NOUN
iajs-3546	31	40	types	type	NOUN
iajs-3546	31	41	such	such	ADJ
iajs-3546	31	42	as	as	ADP
iajs-3546	31	43	cd4	cd4	PROPN
iajs-3546	31	44	+	+	PROPN
iajs-3546	31	45	and	and	CCONJ
iajs-3546	31	46	cd8	cd8	PROPN
iajs-3546	31	47	+	+	PROPN
iajs-3546	31	48	t	t	NOUN
iajs-3546	31	49	cells	cell	NOUN
iajs-3546	31	50	.	.	PUNCT
iajs-3546	32	1	thus	thus	ADV
iajs-3546	32	2	,	,	PUNCT
iajs-3546	32	3	th17	th17	PROPN
iajs-3546	32	4	cell	cell	NOUN
iajs-3546	32	5	production	production	NOUN
iajs-3546	32	6	and	and	CCONJ
iajs-3546	32	7	il-17	il-17	ADV
iajs-3546	32	8	release	release	NOUN
iajs-3546	32	9	is	be	AUX
iajs-3546	32	10	promoted	promote	VERB
iajs-3546	32	11	through	through	ADP
iajs-3546	32	12	cytokine	cytokine	NOUN
iajs-3546	32	13	signaling	signal	VERB
iajs-3546	32	14	,	,	PUNCT
iajs-3546	32	15	indicating	indicate	VERB
iajs-3546	32	16	a	a	DET
iajs-3546	32	17	combination	combination	NOUN
iajs-3546	32	18	of	of	ADP
iajs-3546	32	19	non	non	ADJ
iajs-3546	32	20	-	-	ADJ
iajs-3546	32	21	protective	protective	ADJ
iajs-3546	32	22	allergy	allergy	NOUN
iajs-3546	32	23	th2	th2	PROPN
iajs-3546	32	24	chapter	chapter	NOUN
iajs-3546	32	25	one	one	NUM
iajs-3546	32	26	:	:	PUNCT
iajs-3546	32	27	introduction	introduction	NOUN
iajs-3546	32	28	3	3	NUM
iajs-3546	32	29	and	and	CCONJ
iajs-3546	32	30	il-17	il-17	ADV
iajs-3546	32	31	responses	response	NOUN
iajs-3546	32	32	contributing	contribute	VERB
iajs-3546	32	33	in	in	ADP
iajs-3546	32	34	disease	disease	NOUN
iajs-3546	32	35	pathogenesis	pathogenesis	NOUN
iajs-3546	32	36	(	(	PUNCT
iajs-3546	32	37	10	10	NUM
iajs-3546	32	38	,	,	PUNCT
iajs-3546	32	39	6	6	NUM
iajs-3546	32	40	)	)	PUNCT
iajs-3546	32	41	.	.	PUNCT
iajs-3546	33	1	2	2	X
iajs-3546	33	2	.	.	X
iajs-3546	33	3	materials	material	NOUN
iajs-3546	33	4	and	and	CCONJ
iajs-3546	33	5	methods	method	NOUN
iajs-3546	33	6	the	the	DET
iajs-3546	33	7	current	current	ADJ
iajs-3546	33	8	study	study	NOUN
iajs-3546	33	9	encompassed	encompass	VERB
iajs-3546	33	10	120	120	NUM
iajs-3546	33	11	participants	participant	NOUN
iajs-3546	33	12	,	,	PUNCT
iajs-3546	33	13	comprising	comprise	VERB
iajs-3546	33	14	60	60	NUM
iajs-3546	33	15	patients	patient	NOUN
iajs-3546	33	16	(	(	PUNCT
iajs-3546	33	17	30	30	NUM
iajs-3546	33	18	males	male	NOUN
iajs-3546	33	19	and	and	CCONJ
iajs-3546	33	20	30	30	NUM
iajs-3546	33	21	females	female	NOUN
iajs-3546	33	22	)	)	PUNCT
iajs-3546	33	23	with	with	ADP
iajs-3546	33	24	scabies	scabie	NOUN
iajs-3546	33	25	disease	disease	NOUN
iajs-3546	33	26	,	,	PUNCT
iajs-3546	33	27	ranging	range	VERB
iajs-3546	33	28	in	in	ADP
iajs-3546	33	29	age	age	NOUN
iajs-3546	33	30	from	from	ADP
iajs-3546	33	31	4	4	NUM
iajs-3546	33	32	to	to	PART
iajs-3546	33	33	63	63	NUM
iajs-3546	33	34	years	year	NOUN
iajs-3546	33	35	,	,	PUNCT
iajs-3546	33	36	and	and	CCONJ
iajs-3546	33	37	60	60	NUM
iajs-3546	33	38	healthy	healthy	ADJ
iajs-3546	33	39	individuals	individual	NOUN
iajs-3546	33	40	(	(	PUNCT
iajs-3546	33	41	40females	40females	NUM
iajs-3546	33	42	and	and	CCONJ
iajs-3546	33	43	20	20	NUM
iajs-3546	33	44	males	male	NOUN
iajs-3546	33	45	)	)	PUNCT
iajs-3546	33	46	with	with	ADP
iajs-3546	33	47	the	the	DET
iajs-3546	33	48	same	same	ADJ
iajs-3546	33	49	age	age	NOUN
iajs-3546	33	50	range	range	NOUN
iajs-3546	33	51	,	,	PUNCT
iajs-3546	33	52	from	from	ADP
iajs-3546	33	53	1st	1st	ADJ
iajs-3546	33	54	october	october	PROPN
iajs-3546	33	55	2022	2022	NUM
iajs-3546	33	56	to	to	ADP
iajs-3546	33	57	the	the	DET
iajs-3546	33	58	end	end	NOUN
iajs-3546	33	59	of	of	ADP
iajs-3546	33	60	january	january	PROPN
iajs-3546	33	61	ihjpas	ihjpas	PROPN
iajs-3546	33	62	.	.	PUNCT
iajs-3546	34	1	2025	2025	NUM
iajs-3546	34	2	,	,	PUNCT
iajs-3546	34	3	38	38	NUM
iajs-3546	34	4	(	(	PUNCT
iajs-3546	34	5	1	1	NUM
iajs-3546	34	6	)	)	PUNCT
iajs-3546	34	7	62	62	NUM
iajs-3546	34	8	2023	2023	NUM
iajs-3546	34	9	,	,	PUNCT
iajs-3546	34	10	from	from	ADP
iajs-3546	34	11	the	the	DET
iajs-3546	34	12	dermatology	dermatology	NOUN
iajs-3546	34	13	unit	unit	NOUN
iajs-3546	34	14	at	at	ADP
iajs-3546	34	15	baghdad	baghdad	PROPN
iajs-3546	34	16	teaching	teach	VERB
iajs-3546	34	17	hospital	hospital	NOUN
iajs-3546	34	18	/	/	SYM
iajs-3546	34	19	medical	medical	ADJ
iajs-3546	34	20	city	city	NOUN
iajs-3546	34	21	.	.	PUNCT
iajs-3546	35	1	collected	collect	VERB
iajs-3546	35	2	all	all	DET
iajs-3546	35	3	samples	sample	NOUN
iajs-3546	35	4	with	with	ADP
iajs-3546	35	5	the	the	DET
iajs-3546	35	6	patients	patient	NOUN
iajs-3546	35	7	'	'	PART
iajs-3546	35	8	consent	consent	NOUN
iajs-3546	35	9	before	before	ADP
iajs-3546	35	10	including	include	VERB
iajs-3546	35	11	them	they	PRON
iajs-3546	35	12	in	in	ADP
iajs-3546	35	13	the	the	DET
iajs-3546	35	14	study	study	NOUN
iajs-3546	35	15	.	.	PUNCT
iajs-3546	36	1	collection	collection	NOUN
iajs-3546	36	2	of	of	ADP
iajs-3546	36	3	blood	blood	NOUN
iajs-3546	36	4	samples	sample	NOUN
iajs-3546	36	5	:	:	PUNCT
iajs-3546	36	6	collected	collect	VERB
iajs-3546	36	7	the	the	DET
iajs-3546	36	8	blood	blood	NOUN
iajs-3546	36	9	samples	sample	NOUN
iajs-3546	36	10	(	(	PUNCT
iajs-3546	36	11	5ml	5ml	NOUN
iajs-3546	36	12	)	)	PUNCT
iajs-3546	36	13	from	from	ADP
iajs-3546	36	14	both	both	CCONJ
iajs-3546	36	15	the	the	DET
iajs-3546	36	16	patients	patient	NOUN
iajs-3546	36	17	and	and	CCONJ
iajs-3546	36	18	the	the	DET
iajs-3546	36	19	control	control	NOUN
iajs-3546	36	20	group	group	NOUN
iajs-3546	36	21	using	use	VERB
iajs-3546	36	22	a	a	DET
iajs-3546	36	23	disposable	disposable	ADJ
iajs-3546	36	24	syringe	syringe	NOUN
iajs-3546	36	25	.	.	PUNCT
iajs-3546	37	1	we	we	PRON
iajs-3546	37	2	divided	divide	VERB
iajs-3546	37	3	the	the	DET
iajs-3546	37	4	blood	blood	NOUN
iajs-3546	37	5	into	into	ADP
iajs-3546	37	6	two	two	NUM
iajs-3546	37	7	parts	part	NOUN
iajs-3546	37	8	:	:	PUNCT
iajs-3546	37	9	we	we	PRON
iajs-3546	37	10	placed	place	VERB
iajs-3546	37	11	2	2	NUM
iajs-3546	37	12	ml	ml	NOUN
iajs-3546	37	13	in	in	ADP
iajs-3546	37	14	a	a	DET
iajs-3546	37	15	plain	plain	ADJ
iajs-3546	37	16	tube	tube	NOUN
iajs-3546	37	17	with	with	ADP
iajs-3546	37	18	ethylene	ethylene	NOUN
iajs-3546	37	19	damien	damien	PROPN
iajs-3546	37	20	tetra	tetra	NOUN
iajs-3546	37	21	acetic	acetic	ADJ
iajs-3546	37	22	acid	acid	NOUN
iajs-3546	37	23	(	(	PUNCT
iajs-3546	37	24	edta	edta	NOUN
iajs-3546	37	25	)	)	PUNCT
iajs-3546	37	26	for	for	ADP
iajs-3546	37	27	blood	blood	NOUN
iajs-3546	37	28	tests	test	NOUN
iajs-3546	37	29	,	,	PUNCT
iajs-3546	37	30	and	and	CCONJ
iajs-3546	37	31	we	we	PRON
iajs-3546	37	32	centrifuged	centrifuge	VERB
iajs-3546	37	33	3	3	NUM
iajs-3546	37	34	ml	ml	NOUN
iajs-3546	37	35	of	of	ADP
iajs-3546	37	36	the	the	DET
iajs-3546	37	37	serum	serum	NOUN
iajs-3546	37	38	at	at	ADP
iajs-3546	37	39	3000	3000	NUM
iajs-3546	37	40	rpm	rpm	NOUN
iajs-3546	37	41	for	for	ADP
iajs-3546	37	42	10	10	NUM
iajs-3546	37	43	minutes	minute	NOUN
iajs-3546	37	44	to	to	PART
iajs-3546	37	45	separate	separate	VERB
iajs-3546	37	46	it	it	PRON
iajs-3546	37	47	.	.	PUNCT
iajs-3546	38	1	we	we	PRON
iajs-3546	38	2	then	then	ADV
iajs-3546	38	3	collected	collect	VERB
iajs-3546	38	4	the	the	DET
iajs-3546	38	5	serum	serum	NOUN
iajs-3546	38	6	in	in	ADP
iajs-3546	38	7	other	other	ADJ
iajs-3546	38	8	sterile	sterile	ADJ
iajs-3546	38	9	tubes	tube	NOUN
iajs-3546	38	10	and	and	CCONJ
iajs-3546	38	11	stored	store	VERB
iajs-3546	38	12	it	it	PRON
iajs-3546	38	13	at	at	ADP
iajs-3546	38	14	-20	-20	NUM
iajs-3546	38	15	°	°	PROPN
iajs-3546	38	16	c	c	NOUN
iajs-3546	38	17	until	until	ADP
iajs-3546	38	18	using	use	VERB
iajs-3546	38	19	.	.	PUNCT
iajs-3546	39	1	the	the	DET
iajs-3546	39	2	assay	assay	ADJ
iajs-3546	39	3	procedure	procedure	NOUN
iajs-3546	39	4	pertains	pertain	VERB
iajs-3546	39	5	to	to	ADP
iajs-3546	39	6	the	the	DET
iajs-3546	39	7	immunoglobulins	immunoglobulin	NOUN
iajs-3546	39	8	(	(	PUNCT
iajs-3546	39	9	iga	iga	PROPN
iajs-3546	39	10	and	and	CCONJ
iajs-3546	39	11	ige	ige	PROPN
iajs-3546	39	12	)	)	PUNCT
iajs-3546	39	13	.	.	PUNCT
iajs-3546	40	1	scientists	scientist	NOUN
iajs-3546	40	2	from	from	ADP
iajs-3546	40	3	bioassay	bioassay	PROPN
iajs-3546	40	4	technology	technology	PROPN
iajs-3546	40	5	laboratory	laboratory	PROPN
iajs-3546	40	6	in	in	ADP
iajs-3546	40	7	china	china	PROPN
iajs-3546	40	8	say	say	VERB
iajs-3546	40	9	that	that	SCONJ
iajs-3546	40	10	the	the	DET
iajs-3546	40	11	tests	test	NOUN
iajs-3546	40	12	for	for	ADP
iajs-3546	40	13	iga	iga	PROPN
iajs-3546	40	14	and	and	CCONJ
iajs-3546	40	15	ige	ige	PROPN
iajs-3546	40	16	,	,	PUNCT
iajs-3546	40	17	nos	nos	PROPN
iajs-3546	40	18	.	.	PROPN
iajs-3546	40	19	e0189hu	e0189hu	PROPN
iajs-3546	40	20	and	and	CCONJ
iajs-3546	40	21	sl0913hu	sl0913hu	PROPN
iajs-3546	40	22	,	,	PUNCT
iajs-3546	40	23	use	use	VERB
iajs-3546	40	24	a	a	DET
iajs-3546	40	25	method	method	NOUN
iajs-3546	40	26	called	call	VERB
iajs-3546	40	27	sandwich	sandwich	NOUN
iajs-3546	40	28	elisa	elisa	PROPN
iajs-3546	40	29	,	,	PUNCT
iajs-3546	40	30	which	which	PRON
iajs-3546	40	31	stands	stand	VERB
iajs-3546	40	32	for	for	ADP
iajs-3546	40	33	enzyme	enzyme	NOUN
iajs-3546	40	34	-	-	PUNCT
iajs-3546	40	35	linked	link	VERB
iajs-3546	40	36	immune	immune	NOUN
iajs-3546	40	37	-	-	PUNCT
iajs-3546	40	38	sorbent	sorbent	NOUN
iajs-3546	40	39	assay	assay	NOUN
iajs-3546	40	40	.	.	PUNCT
iajs-3546	41	1	3	3	X
iajs-3546	41	2	.	.	NOUN
iajs-3546	41	3	results	result	VERB
iajs-3546	41	4	3.1	3.1	NUM
iajs-3546	41	5	.	.	PUNCT
iajs-3546	42	1	measurement	measurement	NOUN
iajs-3546	42	2	complete	complete	ADJ
iajs-3546	42	3	blood	blood	NOUN
iajs-3546	42	4	count	count	NOUN
iajs-3546	42	5	(	(	PUNCT
iajs-3546	42	6	cbc	cbc	NOUN
iajs-3546	42	7	)	)	PUNCT
iajs-3546	42	8	level	level	NOUN
iajs-3546	42	9	the	the	DET
iajs-3546	42	10	results	result	NOUN
iajs-3546	42	11	showed	show	VERB
iajs-3546	42	12	that	that	SCONJ
iajs-3546	42	13	there	there	PRON
iajs-3546	42	14	were	be	VERB
iajs-3546	42	15	non	non	ADJ
iajs-3546	42	16	-	-	ADJ
iajs-3546	42	17	significant	significant	ADJ
iajs-3546	42	18	differences	difference	NOUN
iajs-3546	42	19	at	at	ADP
iajs-3546	42	20	the	the	DET
iajs-3546	42	21	<	<	X
iajs-3546	42	22	0.05	0.05	NUM
iajs-3546	42	23	level	level	NOUN
iajs-3546	42	24	for	for	ADP
iajs-3546	42	25	measuring	measure	VERB
iajs-3546	42	26	hb	hb	PROPN
iajs-3546	42	27	,	,	PUNCT
iajs-3546	42	28	pcv	pcv	NOUN
iajs-3546	42	29	,	,	PUNCT
iajs-3546	42	30	and	and	CCONJ
iajs-3546	42	31	platelets	platelet	NOUN
iajs-3546	42	32	(	(	PUNCT
iajs-3546	42	33	12.86±	12.86±	NUM
iajs-3546	42	34	0.31	0.31	NUM
iajs-3546	42	35	,	,	PUNCT
iajs-3546	42	36	12.88	12.88	NUM
iajs-3546	42	37	±	±	NUM
iajs-3546	42	38	0.20	0.20	NUM
iajs-3546	42	39	)	)	PUNCT
iajs-3546	42	40	,	,	PUNCT
iajs-3546	42	41	(	(	PUNCT
iajs-3546	42	42	34.40±0.94	34.40±0.94	NUM
iajs-3546	42	43	,	,	PUNCT
iajs-3546	42	44	40.35±0.59	40.35±0.59	NUM
iajs-3546	42	45	)	)	PUNCT
iajs-3546	42	46	,	,	PUNCT
iajs-3546	42	47	and	and	CCONJ
iajs-3546	42	48	(	(	PUNCT
iajs-3546	42	49	244.80±9.58	244.80±9.58	NUM
iajs-3546	42	50	,	,	PUNCT
iajs-3546	42	51	237	237	NUM
iajs-3546	42	52	,	,	PUNCT
iajs-3546	42	53	23±8.97	23±8.97	NOUN
iajs-3546	42	54	)	)	PUNCT
iajs-3546	42	55	respectively	respectively	ADV
iajs-3546	42	56	between	between	ADP
iajs-3546	42	57	the	the	DET
iajs-3546	42	58	scabies	scabie	NOUN
iajs-3546	42	59	patients	patient	NOUN
iajs-3546	42	60	and	and	CCONJ
iajs-3546	42	61	control	control	NOUN
iajs-3546	42	62	group	group	NOUN
iajs-3546	42	63	,	,	PUNCT
iajs-3546	42	64	as	as	SCONJ
iajs-3546	42	65	shown	show	VERB
iajs-3546	42	66	in	in	ADP
iajs-3546	42	67	table	table	NOUN
iajs-3546	42	68	1	1	NUM
iajs-3546	42	69	.	.	PUNCT
iajs-3546	42	70	table	table	NOUN
iajs-3546	42	71	1	1	NUM
iajs-3546	42	72	.	.	PUNCT
iajs-3546	42	73	comparison	comparison	NOUN
iajs-3546	42	74	between	between	ADP
iajs-3546	42	75	hb	hb	PROPN
iajs-3546	42	76	,	,	PUNCT
iajs-3546	42	77	pcv	pcv	NOUN
iajs-3546	42	78	and	and	CCONJ
iajs-3546	42	79	plt	plt	NOUN
iajs-3546	42	80	parameters	parameter	NOUN
iajs-3546	42	81	of	of	ADP
iajs-3546	42	82	patients	patient	NOUN
iajs-3546	42	83	and	and	CCONJ
iajs-3546	42	84	control	control	NOUN
iajs-3546	42	85	group	group	NOUN
iajs-3546	42	86	hb	hb	PROPN
iajs-3546	42	87	(	(	PUNCT
iajs-3546	42	88	g	g	PROPN
iajs-3546	42	89	/	/	SYM
iajs-3546	42	90	dl	dl	PROPN
iajs-3546	42	91	)	)	PUNCT
iajs-3546	42	92	pcv	pcv	NOUN
iajs-3546	42	93	(	(	PUNCT
iajs-3546	42	94	%	%	INTJ
iajs-3546	42	95	)	)	PUNCT
iajs-3546	42	96	platelet	platelet	NOUN
iajs-3546	42	97	(	(	PUNCT
iajs-3546	42	98	10	10	NUM
iajs-3546	42	99	^	^	SYM
iajs-3546	42	100	3/µl	3/µl	NUM
iajs-3546	42	101	)	)	PUNCT
iajs-3546	42	102	patients	patient	NOUN
iajs-3546	42	103	12.86	12.86	NUM
iajs-3546	42	104	±0.31	±0.31	PROPN
iajs-3546	42	105	34.40	34.40	NUM
iajs-3546	42	106	±0.94	±0.94	PROPN
iajs-3546	42	107	244.80	244.80	NUM
iajs-3546	42	108	±9.58	±9.58	PROPN
iajs-3546	42	109	control	control	NOUN
iajs-3546	42	110	12.88	12.88	NUM
iajs-3546	42	111	±0.20	±0.20	NOUN
iajs-3546	42	112	40.35	40.35	NUM
iajs-3546	42	113	±0.59	±0.59	PROPN
iajs-3546	42	114	237.23	237.23	NUM
iajs-3546	42	115	±8.97	±8.97	PROPN
iajs-3546	42	116	t	t	PROPN
iajs-3546	42	117	-	-	PUNCT
iajs-3546	42	118	test	test	NOUN
iajs-3546	42	119	0.732	0.732	NUM
iajs-3546	42	120	ns	ns	NUM
iajs-3546	42	121	2.20	2.20	NUM
iajs-3546	42	122	ns	ns	NUM
iajs-3546	42	123	26.004	26.004	NUM
iajs-3546	42	124	ns	ns	NUM
iajs-3546	42	125	p	p	NOUN
iajs-3546	42	126	-	-	PUNCT
iajs-3546	42	127	value	value	NOUN
iajs-3546	42	128	0.978	0.978	NUM
iajs-3546	42	129	0.082	0.082	NUM
iajs-3546	42	130	0.565	0.565	NUM
iajs-3546	42	131	in	in	ADP
iajs-3546	42	132	the	the	DET
iajs-3546	42	133	table	table	NOUN
iajs-3546	42	134	2	2	NUM
iajs-3546	42	135	there	there	PRON
iajs-3546	42	136	were	be	VERB
iajs-3546	42	137	significant	significant	ADJ
iajs-3546	42	138	differences	difference	NOUN
iajs-3546	42	139	at	at	ADP
iajs-3546	42	140	the	the	DET
iajs-3546	42	141	0.001	0.001	NUM
iajs-3546	42	142	level	level	NOUN
iajs-3546	42	143	between	between	ADP
iajs-3546	42	144	the	the	DET
iajs-3546	42	145	two	two	NUM
iajs-3546	42	146	groups	group	NOUN
iajs-3546	42	147	of	of	ADP
iajs-3546	42	148	patients	patient	NOUN
iajs-3546	42	149	and	and	CCONJ
iajs-3546	42	150	the	the	DET
iajs-3546	42	151	control	control	NOUN
iajs-3546	42	152	.	.	PUNCT
iajs-3546	43	1	these	these	DET
iajs-3546	43	2	differences	difference	NOUN
iajs-3546	43	3	were	be	AUX
iajs-3546	43	4	for	for	ADP
iajs-3546	43	5	white	white	ADJ
iajs-3546	43	6	blood	blood	NOUN
iajs-3546	43	7	cells	cell	NOUN
iajs-3546	43	8	(	(	PUNCT
iajs-3546	43	9	wbc	wbc	PROPN
iajs-3546	43	10	)	)	PUNCT
iajs-3546	43	11	,	,	PUNCT
iajs-3546	43	12	lymphocytes	lymphocyte	VERB
iajs-3546	43	13	,	,	PUNCT
iajs-3546	43	14	neutrophils	neutrophil	NOUN
iajs-3546	43	15	,	,	PUNCT
iajs-3546	43	16	eosinophils	eosinophil	NOUN
iajs-3546	43	17	,	,	PUNCT
iajs-3546	43	18	monocytes	monocyte	NOUN
iajs-3546	43	19	,	,	PUNCT
iajs-3546	43	20	and	and	CCONJ
iajs-3546	43	21	basophils	basophils	PROPN
iajs-3546	43	22	.	.	PUNCT
iajs-3546	44	1	they	they	PRON
iajs-3546	44	2	were	be	AUX
iajs-3546	44	3	(	(	PUNCT
iajs-3546	44	4	11.09	11.09	NUM
iajs-3546	44	5	+	+	NOUN
iajs-3546	44	6	0.20	0.20	NUM
iajs-3546	44	7	,	,	PUNCT
iajs-3546	44	8	7.50	7.50	NUM
iajs-3546	44	9	±0.16	±0.16	PROPN
iajs-3546	44	10	)	)	PUNCT
iajs-3546	44	11	,	,	PUNCT
iajs-3546	44	12	(	(	PUNCT
iajs-3546	44	13	5.05±0.16	5.05±0.16	NUM
iajs-3546	44	14	,	,	PUNCT
iajs-3546	44	15	2.27	2.27	NUM
iajs-3546	44	16	±0.06	±0.06	NOUN
iajs-3546	44	17	)	)	PUNCT
iajs-3546	44	18	,	,	PUNCT
iajs-3546	44	19	(	(	PUNCT
iajs-3546	44	20	8.23±0.10	8.23±0.10	NOUN
iajs-3546	44	21	,	,	PUNCT
iajs-3546	44	22	3.75±0.11	3.75±0.11	NUM
iajs-3546	44	23	)	)	PUNCT
iajs-3546	44	24	,	,	PUNCT
iajs-3546	44	25	(	(	PUNCT
iajs-3546	44	26	0.828±0.7	0.828±0.7	ADJ
iajs-3546	44	27	,	,	PUNCT
iajs-3546	44	28	0.415±0.03	0.415±0.03	NUM
iajs-3546	44	29	)	)	PUNCT
iajs-3546	44	30	,	,	PUNCT
iajs-3546	44	31	(	(	PUNCT
iajs-3546	44	32	0.498±0.02	0.498±0.02	NUM
iajs-3546	44	33	,	,	PUNCT
iajs-3546	44	34	0.459±0.03	0.459±0.03	NUM
iajs-3546	44	35	)	)	PUNCT
iajs-3546	44	36	,	,	PUNCT
iajs-3546	44	37	and	and	CCONJ
iajs-3546	44	38	(	(	PUNCT
iajs-3546	44	39	0.329±0.02	0.329±0.02	NUM
iajs-3546	44	40	,	,	PUNCT
iajs-3546	44	41	0.102	0.102	NUM
iajs-3546	44	42	±	±	NUM
iajs-3546	44	43	0.01	0.01	NUM
iajs-3546	44	44	)	)	PUNCT
iajs-3546	44	45	respectively	respectively	ADV
iajs-3546	44	46	.	.	PUNCT
iajs-3546	45	1	table	table	NOUN
iajs-3546	45	2	2	2	NUM
iajs-3546	45	3	.	.	X
iajs-3546	45	4	comparison	comparison	NOUN
iajs-3546	45	5	between	between	ADP
iajs-3546	45	6	different	different	ADJ
iajs-3546	45	7	cell	cell	NOUN
iajs-3546	45	8	of	of	ADP
iajs-3546	45	9	complete	complete	ADJ
iajs-3546	45	10	blood	blood	NOUN
iajs-3546	45	11	count	count	NOUN
iajs-3546	45	12	for	for	ADP
iajs-3546	45	13	patients	patient	NOUN
iajs-3546	45	14	and	and	CCONJ
iajs-3546	45	15	control	control	PROPN
iajs-3546	45	16	group	group	NOUN
iajs-3546	45	17	wbc	wbc	PROPN
iajs-3546	45	18	(	(	PUNCT
iajs-3546	45	19	106	106	NUM
iajs-3546	45	20	g	g	NOUN
iajs-3546	45	21	/	/	SYM
iajs-3546	45	22	l	l	NOUN
iajs-3546	45	23	)	)	PUNCT
iajs-3546	45	24	lymphocyte	lymphocyte	NOUN
iajs-3546	45	25	(	(	PUNCT
iajs-3546	45	26	106	106	NUM
iajs-3546	45	27	g	g	NOUN
iajs-3546	45	28	/	/	SYM
iajs-3546	45	29	l	l	NOUN
iajs-3546	45	30	)	)	PUNCT
iajs-3546	45	31	neutrophil	neutrophil	NOUN
iajs-3546	45	32	(	(	PUNCT
iajs-3546	45	33	106	106	NUM
iajs-3546	45	34	g	g	NOUN
iajs-3546	45	35	/	/	SYM
iajs-3546	45	36	l	l	NOUN
iajs-3546	45	37	)	)	PUNCT
iajs-3546	46	1	eosinophil	eosinophil	ADJ
iajs-3546	46	2	(	(	PUNCT
iajs-3546	46	3	106	106	NUM
iajs-3546	46	4	g	g	NOUN
iajs-3546	46	5	/	/	SYM
iajs-3546	46	6	l	l	NOUN
iajs-3546	46	7	)	)	PUNCT
iajs-3546	46	8	monocyte	monocyte	NOUN
iajs-3546	46	9	(	(	PUNCT
iajs-3546	46	10	%	%	INTJ
iajs-3546	46	11	)	)	PUNCT
iajs-3546	46	12	basophile	basophile	NOUN
iajs-3546	46	13	(	(	PUNCT
iajs-3546	46	14	106	106	NUM
iajs-3546	46	15	g	g	NOUN
iajs-3546	46	16	/	/	SYM
iajs-3546	46	17	l	l	NOUN
iajs-3546	46	18	)	)	PUNCT
iajs-3546	46	19	11.09	11.09	NUM
iajs-3546	46	20	±0.20	±0.20	X
iajs-3546	46	21	5.05	5.05	NUM
iajs-3546	46	22	±0.16	±0.16	PROPN
iajs-3546	46	23	8.23	8.23	NUM
iajs-3546	46	24	±0.10	±0.10	PROPN
iajs-3546	46	25	0.828	0.828	NUM
iajs-3546	46	26	±0.7	±0.7	PROPN
iajs-3546	46	27	0.498	0.498	NUM
iajs-3546	46	28	±0.02	±0.02	PROPN
iajs-3546	46	29	0.329	0.329	NUM
iajs-3546	46	30	±0.02	±0.02	PROPN
iajs-3546	46	31	7.50	7.50	NUM
iajs-3546	46	32	±0.16	±0.16	PROPN
iajs-3546	46	33	2.27	2.27	NUM
iajs-3546	46	34	±0.06	±0.06	PROPN
iajs-3546	46	35	3.75	3.75	NUM
iajs-3546	46	36	±0.11	±0.11	ADJ
iajs-3546	46	37	0.415	0.415	NUM
iajs-3546	46	38	±0.03	±0.03	PROPN
iajs-3546	46	39	0.459	0.459	NUM
iajs-3546	46	40	±0.03	±0.03	PROPN
iajs-3546	46	41	0.102	0.102	NUM
iajs-3546	46	42	±0.01	±0.01	NOUN
iajs-3546	46	43	0.511	0.511	NUM
iajs-3546	46	44	*	*	PUNCT
iajs-3546	47	1	*	*	PUNCT
iajs-3546	47	2	0.334	0.334	NUM
iajs-3546	47	3	*	*	PUNCT
iajs-3546	47	4	*	*	PUNCT
iajs-3546	47	5	0.301	0.301	NUM
iajs-3546	47	6	*	*	PUNCT
iajs-3546	47	7	*	*	PUNCT
iajs-3546	48	1	0.167	0.167	NUM
iajs-3546	48	2	*	*	PUNCT
iajs-3546	48	3	*	*	PUNCT
iajs-3546	48	4	0.083	0.083	NUM
iajs-3546	48	5	ns	ns	NUM
iajs-3546	48	6	0.044	0.044	NUM
iajs-3546	48	7	*	*	PUNCT
iajs-3546	48	8	*	*	PUNCT
iajs-3546	48	9	0.0001	0.0001	NUM
iajs-3546	48	10	0.0001	0.0001	NUM
iajs-3546	48	11	0.0001	0.0001	NUM
iajs-3546	48	12	0.0001	0.0001	NUM
iajs-3546	48	13	0.361	0.361	NUM
iajs-3546	48	14	0.0001	0.0001	NUM
iajs-3546	48	15	ihjpas	ihjpa	NOUN
iajs-3546	48	16	.	.	PUNCT
iajs-3546	49	1	2025	2025	NUM
iajs-3546	49	2	,	,	PUNCT
iajs-3546	49	3	38	38	NUM
iajs-3546	49	4	(	(	PUNCT
iajs-3546	49	5	1	1	NUM
iajs-3546	49	6	)	)	PUNCT
iajs-3546	49	7	63	63	NUM
iajs-3546	49	8	3.2	3.2	NUM
iajs-3546	49	9	.	.	PUNCT
iajs-3546	50	1	serum	serum	NOUN
iajs-3546	50	2	level	level	NOUN
iajs-3546	50	3	of	of	ADP
iajs-3546	50	4	the	the	DET
iajs-3546	50	5	immunoglobulins	immunoglobulin	NOUN
iajs-3546	50	6	(	(	PUNCT
iajs-3546	50	7	iga	iga	PROPN
iajs-3546	50	8	and	and	CCONJ
iajs-3546	50	9	ige	ige	PROPN
iajs-3546	50	10	)	)	PUNCT
iajs-3546	50	11	the	the	DET
iajs-3546	50	12	result	result	NOUN
iajs-3546	50	13	of	of	ADP
iajs-3546	50	14	the	the	DET
iajs-3546	50	15	present	present	ADJ
iajs-3546	50	16	study	study	NOUN
iajs-3546	50	17	investigated	investigate	VERB
iajs-3546	50	18	non	non	ADJ
iajs-3546	50	19	-	-	ADJ
iajs-3546	50	20	significant	significant	ADJ
iajs-3546	50	21	differences	difference	NOUN
iajs-3546	50	22	in	in	ADP
iajs-3546	50	23	the	the	DET
iajs-3546	50	24	value	value	NOUN
iajs-3546	50	25	of	of	ADP
iajs-3546	50	26	iga	iga	PROPN
iajs-3546	50	27	for	for	ADP
iajs-3546	50	28	scabies	scabie	NOUN
iajs-3546	50	29	patients	patient	NOUN
iajs-3546	50	30	(	(	PUNCT
iajs-3546	50	31	130.73	130.73	NUM
iajs-3546	50	32	±	±	NUM
iajs-3546	50	33	10.38	10.38	NUM
iajs-3546	50	34	)	)	PUNCT
iajs-3546	50	35	compared	compare	VERB
iajs-3546	50	36	with	with	ADP
iajs-3546	50	37	the	the	DET
iajs-3546	50	38	control	control	NOUN
iajs-3546	50	39	group	group	NOUN
iajs-3546	50	40	(	(	PUNCT
iajs-3546	50	41	115.55	115.55	NUM
iajs-3546	50	42	±	±	NUM
iajs-3546	50	43	4.60	4.60	NUM
iajs-3546	50	44	)	)	PUNCT
iajs-3546	50	45	.	.	PUNCT
iajs-3546	51	1	but	but	CCONJ
iajs-3546	51	2	the	the	DET
iajs-3546	51	3	result	result	NOUN
iajs-3546	51	4	of	of	ADP
iajs-3546	51	5	the	the	DET
iajs-3546	51	6	ige	ige	PROPN
iajs-3546	51	7	ratio	ratio	NOUN
iajs-3546	51	8	represented	represent	VERB
iajs-3546	51	9	high	high	ADJ
iajs-3546	51	10	significant	significant	ADJ
iajs-3546	51	11	differences	difference	NOUN
iajs-3546	51	12	at	at	ADP
iajs-3546	51	13	level	level	NOUN
iajs-3546	51	14	(	(	PUNCT
iajs-3546	51	15	p≤0.01	p≤0.01	NOUN
iajs-3546	51	16	)	)	PUNCT
iajs-3546	51	17	between	between	ADP
iajs-3546	51	18	patients	patient	NOUN
iajs-3546	51	19	(	(	PUNCT
iajs-3546	51	20	36.59	36.59	NUM
iajs-3546	51	21	±5.06	±5.06	NOUN
iajs-3546	51	22	)	)	PUNCT
iajs-3546	51	23	and	and	CCONJ
iajs-3546	51	24	control	control	NOUN
iajs-3546	51	25	(	(	PUNCT
iajs-3546	51	26	13.56	13.56	NUM
iajs-3546	51	27	±0.89	±0.89	NOUN
iajs-3546	51	28	)	)	PUNCT
iajs-3546	51	29	(	(	PUNCT
iajs-3546	51	30	table	table	NOUN
iajs-3546	51	31	3	3	NUM
iajs-3546	51	32	)	)	PUNCT
iajs-3546	51	33	.	.	PUNCT
iajs-3546	52	1	table	table	NOUN
iajs-3546	53	1	3	3	NUM
iajs-3546	53	2	.	.	X
iajs-3546	53	3	comparison	comparison	NOUN
iajs-3546	53	4	between	between	ADP
iajs-3546	53	5	scabies	scabie	NOUN
iajs-3546	53	6	patients	patient	NOUN
iajs-3546	53	7	and	and	CCONJ
iajs-3546	53	8	control	control	NOUN
iajs-3546	53	9	group	group	NOUN
iajs-3546	53	10	according	accord	VERB
iajs-3546	53	11	to	to	ADP
iajs-3546	53	12	level	level	NOUN
iajs-3546	53	13	of	of	ADP
iajs-3546	53	14	iga	iga	PROPN
iajs-3546	53	15	and	and	CCONJ
iajs-3546	53	16	ige	ige	PROPN
iajs-3546	53	17	iga	iga	PROPN
iajs-3546	53	18	(	(	PUNCT
iajs-3546	53	19	mg	mg	PROPN
iajs-3546	53	20	/	/	SYM
iajs-3546	53	21	ml	ml	NOUN
iajs-3546	53	22	)	)	PUNCT
iajs-3546	53	23	ige(mg	ige(mg	NOUN
iajs-3546	53	24	/	/	SYM
iajs-3546	53	25	ml	ml	NOUN
iajs-3546	53	26	)	)	PUNCT
iajs-3546	53	27	patients	patient	NOUN
iajs-3546	53	28	130.73	130.73	NUM
iajs-3546	53	29	±10.38	±10.38	ADP
iajs-3546	53	30	36.59	36.59	NUM
iajs-3546	53	31	±5.06	±5.06	NOUN
iajs-3546	53	32	control	control	PROPN
iajs-3546	53	33	115.55	115.55	NUM
iajs-3546	53	34	±4.60	±4.60	PROPN
iajs-3546	53	35	13.56	13.56	NUM
iajs-3546	53	36	±0.89	±0.89	PROPN
iajs-3546	53	37	t	t	PROPN
iajs-3546	53	38	-	-	PUNCT
iajs-3546	53	39	test	test	NOUN
iajs-3546	53	40	22.489	22.489	NUM
iajs-3546	53	41	ns	ns	NUM
iajs-3546	53	42	10.19	10.19	NUM
iajs-3546	53	43	*	*	PUNCT
iajs-3546	53	44	*	*	PUNCT
iajs-3546	54	1	p	p	NOUN
iajs-3546	54	2	-	-	PUNCT
iajs-3546	54	3	value	value	NOUN
iajs-3546	54	4	0.183	0.183	NUM
iajs-3546	54	5	0.0001	0.0001	NUM
iajs-3546	54	6	figure1	figure1	X
iajs-3546	54	7	.	.	PUNCT
iajs-3546	55	1	comparison	comparison	NOUN
iajs-3546	55	2	between	between	ADP
iajs-3546	55	3	patients	patient	NOUN
iajs-3546	55	4	and	and	CCONJ
iajs-3546	55	5	control	control	NOUN
iajs-3546	55	6	groups	group	NOUN
iajs-3546	55	7	in	in	ADP
iajs-3546	55	8	iga	iga	PROPN
iajs-3546	55	9	.	.	PUNCT
iajs-3546	56	1	figure2	figure2	PROPN
iajs-3546	56	2	.	.	PUNCT
iajs-3546	57	1	comparison	comparison	NOUN
iajs-3546	57	2	between	between	ADP
iajs-3546	57	3	patients	patient	NOUN
iajs-3546	57	4	and	and	CCONJ
iajs-3546	57	5	control	control	NOUN
iajs-3546	57	6	groups	group	NOUN
iajs-3546	57	7	in	in	ADP
iajs-3546	57	8	ige	ige	PROPN
iajs-3546	57	9	.	.	PROPN
iajs-3546	57	10	ihjpas	ihjpas	PROPN
iajs-3546	57	11	.	.	PUNCT
iajs-3546	58	1	2025	2025	NUM
iajs-3546	58	2	,	,	PUNCT
iajs-3546	58	3	38	38	NUM
iajs-3546	58	4	(	(	PUNCT
iajs-3546	58	5	1	1	NUM
iajs-3546	58	6	)	)	PUNCT
iajs-3546	58	7	64	64	NUM
iajs-3546	58	8	figure	figure	NOUN
iajs-3546	58	9	3	3	NUM
iajs-3546	58	10	.	.	PUNCT
iajs-3546	58	11	skin	skin	NOUN
iajs-3546	58	12	burrow	burrow	NOUN
iajs-3546	58	13	(	(	PUNCT
iajs-3546	58	14	scabietic	scabietic	ADJ
iajs-3546	58	15	nodules	nodule	NOUN
iajs-3546	58	16	)	)	PUNCT
iajs-3546	58	17	4	4	NUM
iajs-3546	58	18	.	.	X
iajs-3546	58	19	discussion	discussion	NOUN
iajs-3546	58	20	the	the	DET
iajs-3546	58	21	study	study	NOUN
iajs-3546	58	22	results	result	NOUN
iajs-3546	58	23	showed	show	VERB
iajs-3546	58	24	that	that	SCONJ
iajs-3546	58	25	there	there	PRON
iajs-3546	58	26	were	be	VERB
iajs-3546	58	27	non	non	ADJ
iajs-3546	58	28	-	-	ADJ
iajs-3546	58	29	significant	significant	ADJ
iajs-3546	58	30	differences	difference	NOUN
iajs-3546	58	31	at	at	ADP
iajs-3546	58	32	<	<	X
iajs-3546	58	33	0.05	0.05	NUM
iajs-3546	58	34	level	level	NOUN
iajs-3546	58	35	for	for	ADP
iajs-3546	58	36	measuring	measure	VERB
iajs-3546	58	37	(	(	PUNCT
iajs-3546	58	38	hb	hb	PROPN
iajs-3546	58	39	,	,	PUNCT
iajs-3546	58	40	pcv	pcv	NOUN
iajs-3546	58	41	and	and	CCONJ
iajs-3546	58	42	platelet	platelet	NOUN
iajs-3546	58	43	)	)	PUNCT
iajs-3546	58	44	was	be	AUX
iajs-3546	58	45	12.86±	12.86±	NUM
iajs-3546	58	46	0.31	0.31	NUM
iajs-3546	58	47	,	,	PUNCT
iajs-3546	58	48	12.88	12.88	NUM
iajs-3546	58	49	±0.20	±0.20	ADP
iajs-3546	58	50	g	g	NOUN
iajs-3546	58	51	/	/	SYM
iajs-3546	58	52	dl	dl	PROPN
iajs-3546	58	53	,	,	PUNCT
iajs-3546	58	54	34.40±0,94	34.40±0,94	NUM
iajs-3546	58	55	,	,	PUNCT
iajs-3546	58	56	40.35±0.59	40.35±0.59	NUM
iajs-3546	58	57	%	%	NOUN
iajs-3546	58	58	and	and	CCONJ
iajs-3546	58	59	244.80±9.58	244.80±9.58	NUM
iajs-3546	58	60	,	,	PUNCT
iajs-3546	58	61	237,23±8.97	237,23±8.97	PROPN
iajs-3546	58	62	103	103	NUM
iajs-3546	58	63	/	/	SYM
iajs-3546	58	64	ml	ml	NOUN
iajs-3546	58	65	respectively	respectively	ADV
iajs-3546	58	66	between	between	ADP
iajs-3546	58	67	the	the	DET
iajs-3546	58	68	scabies	scabie	NOUN
iajs-3546	58	69	patients	patient	NOUN
iajs-3546	58	70	and	and	CCONJ
iajs-3546	58	71	control	control	NOUN
iajs-3546	58	72	group	group	NOUN
iajs-3546	58	73	.	.	PUNCT
iajs-3546	59	1	the	the	DET
iajs-3546	59	2	results	result	NOUN
iajs-3546	59	3	manifestation	manifestation	NOUN
iajs-3546	59	4	that	that	SCONJ
iajs-3546	59	5	no	no	DET
iajs-3546	59	6	considerable	considerable	ADJ
iajs-3546	59	7	differences	difference	NOUN
iajs-3546	59	8	of	of	ADP
iajs-3546	59	9	hb	hb	PROPN
iajs-3546	59	10	and	and	CCONJ
iajs-3546	59	11	pcv	pcv	NOUN
iajs-3546	59	12	and	and	CCONJ
iajs-3546	59	13	platelets	platelet	VERB
iajs-3546	59	14	tests	test	NOUN
iajs-3546	59	15	due	due	ADJ
iajs-3546	59	16	to	to	ADP
iajs-3546	59	17	the	the	DET
iajs-3546	59	18	blood	blood	NOUN
iajs-3546	59	19	components	component	NOUN
iajs-3546	59	20	may	may	AUX
iajs-3546	59	21	be	be	AUX
iajs-3546	59	22	is	be	AUX
iajs-3546	59	23	influenced	influence	VERB
iajs-3546	59	24	by	by	ADP
iajs-3546	59	25	several	several	ADJ
iajs-3546	59	26	factors	factor	NOUN
iajs-3546	59	27	such	such	ADJ
iajs-3546	59	28	as	as	ADP
iajs-3546	59	29	fibrinogen	fibrinogen	NOUN
iajs-3546	59	30	concentration	concentration	NOUN
iajs-3546	59	31	and	and	CCONJ
iajs-3546	59	32	other	other	ADJ
iajs-3546	59	33	acute	acute	ADJ
iajs-3546	59	34	phase	phase	NOUN
iajs-3546	59	35	proteins	protein	NOUN
iajs-3546	59	36	,	,	PUNCT
iajs-3546	59	37	the	the	DET
iajs-3546	59	38	immunoglobulin	immunoglobulin	NOUN
iajs-3546	59	39	concentration	concentration	NOUN
iajs-3546	59	40	,	,	PUNCT
iajs-3546	59	41	number	number	NOUN
iajs-3546	59	42	,	,	PUNCT
iajs-3546	59	43	size	size	NOUN
iajs-3546	59	44	and	and	CCONJ
iajs-3546	59	45	shape	shape	NOUN
iajs-3546	59	46	of	of	ADP
iajs-3546	59	47	the	the	DET
iajs-3546	59	48	erythrocytes	erythrocyte	NOUN
iajs-3546	59	49	and	and	CCONJ
iajs-3546	59	50	patient	patient	ADJ
iajs-3546	59	51	age	age	NOUN
iajs-3546	59	52	and	and	CCONJ
iajs-3546	59	53	the	the	DET
iajs-3546	59	54	gender	gender	NOUN
iajs-3546	59	55	,	,	PUNCT
iajs-3546	59	56	so	so	ADV
iajs-3546	59	57	,	,	PUNCT
iajs-3546	59	58	sometimes	sometimes	ADV
iajs-3546	59	59	makes	make	VERB
iajs-3546	59	60	it	it	PRON
iajs-3546	59	61	less	less	ADV
iajs-3546	59	62	suitable	suitable	ADJ
iajs-3546	59	63	for	for	ADP
iajs-3546	59	64	the	the	DET
iajs-3546	59	65	diagnosis	diagnosis	NOUN
iajs-3546	59	66	of	of	ADP
iajs-3546	59	67	inflammatory	inflammatory	ADJ
iajs-3546	59	68	and	and	CCONJ
iajs-3546	59	69	infectious	infectious	ADJ
iajs-3546	59	70	diseases	disease	NOUN
iajs-3546	59	71	(	(	PUNCT
iajs-3546	59	72	11	11	NUM
iajs-3546	59	73	,	,	PUNCT
iajs-3546	59	74	28	28	NUM
iajs-3546	59	75	)	)	PUNCT
iajs-3546	59	76	.	.	PUNCT
iajs-3546	60	1	the	the	DET
iajs-3546	60	2	present	present	ADJ
iajs-3546	60	3	results	result	NOUN
iajs-3546	60	4	is	be	AUX
iajs-3546	60	5	approved	approve	VERB
iajs-3546	60	6	with	with	ADP
iajs-3546	60	7	past	past	ADJ
iajs-3546	60	8	results	result	NOUN
iajs-3546	60	9	done	do	VERB
iajs-3546	60	10	by	by	ADP
iajs-3546	60	11	(	(	PUNCT
iajs-3546	60	12	14	14	NUM
iajs-3546	60	13	,	,	PUNCT
iajs-3546	60	14	13	13	NUM
iajs-3546	60	15	,	,	PUNCT
iajs-3546	60	16	and	and	CCONJ
iajs-3546	60	17	12	12	NUM
iajs-3546	60	18	)	)	PUNCT
iajs-3546	60	19	.	.	PUNCT
iajs-3546	61	1	where	where	SCONJ
iajs-3546	61	2	they	they	PRON
iajs-3546	61	3	recorded	record	VERB
iajs-3546	61	4	that	that	SCONJ
iajs-3546	61	5	not	not	PART
iajs-3546	61	6	significant	significant	ADJ
iajs-3546	61	7	variations	variation	NOUN
iajs-3546	61	8	for	for	ADP
iajs-3546	61	9	measuring	measure	VERB
iajs-3546	61	10	these	these	DET
iajs-3546	61	11	tests	test	NOUN
iajs-3546	61	12	between	between	ADP
iajs-3546	61	13	the	the	DET
iajs-3546	61	14	patients	patient	NOUN
iajs-3546	61	15	and	and	CCONJ
iajs-3546	61	16	control	control	NOUN
iajs-3546	61	17	groups	group	NOUN
iajs-3546	61	18	.	.	PUNCT
iajs-3546	62	1	while	while	SCONJ
iajs-3546	62	2	the	the	DET
iajs-3546	62	3	other	other	ADJ
iajs-3546	62	4	results	result	NOUN
iajs-3546	62	5	of	of	ADP
iajs-3546	62	6	this	this	DET
iajs-3546	62	7	table	table	NOUN
iajs-3546	62	8	include	include	VERB
iajs-3546	62	9	total	total	ADJ
iajs-3546	62	10	number	number	NOUN
iajs-3546	62	11	of	of	ADP
iajs-3546	62	12	wbc	wbc	PROPN
iajs-3546	62	13	,	,	PUNCT
iajs-3546	62	14	lymphocyte	lymphocyte	ADJ
iajs-3546	62	15	,	,	PUNCT
iajs-3546	62	16	neutrophil	neutrophil	ADJ
iajs-3546	62	17	,	,	PUNCT
iajs-3546	62	18	esinophil	esinophil	ADJ
iajs-3546	62	19	,	,	PUNCT
iajs-3546	62	20	monocyte	monocyte	NOUN
iajs-3546	62	21	and	and	CCONJ
iajs-3546	62	22	basophil	basophil	NOUN
iajs-3546	62	23	)	)	PUNCT
iajs-3546	62	24	revealed	reveal	VERB
iajs-3546	62	25	significant	significant	ADJ
iajs-3546	62	26	differences	difference	NOUN
iajs-3546	62	27	at	at	ADP
iajs-3546	62	28	≤0.001	≤0.001	NOUN
iajs-3546	62	29	level	level	NOUN
iajs-3546	62	30	was	be	AUX
iajs-3546	62	31	11.09	11.09	NUM
iajs-3546	62	32	+	+	NUM
iajs-3546	62	33	0.20	0.20	NUM
iajs-3546	62	34	,	,	PUNCT
iajs-3546	62	35	7.50	7.50	NUM
iajs-3546	62	36	±0.16	±0.16	PROPN
iajs-3546	62	37	103	103	NUM
iajs-3546	62	38	/	/	SYM
iajs-3546	62	39	ml	ml	NOUN
iajs-3546	62	40	,	,	PUNCT
iajs-3546	62	41	5.05±0.16	5.05±0.16	PROPN
iajs-3546	62	42	,	,	PUNCT
iajs-3546	62	43	2.27±0.06	2.27±0.06	NUM
iajs-3546	62	44	,	,	PUNCT
iajs-3546	62	45	8.23±0.10	8.23±0.10	NOUN
iajs-3546	62	46	,	,	PUNCT
iajs-3546	62	47	3.75±0.11	3.75±0.11	NUM
iajs-3546	62	48	,	,	PUNCT
iajs-3546	62	49	0.828±0.7	0.828±0.7	NUM
iajs-3546	62	50	,	,	PUNCT
iajs-3546	62	51	0.415±0.03	0.415±0.03	NOUN
iajs-3546	62	52	,	,	PUNCT
iajs-3546	62	53	0.498±0.02,0.459±0.03	0.498±0.02,0.459±0.03	NUM
iajs-3546	62	54	and	and	CCONJ
iajs-3546	62	55	0.329±0.02	0.329±0.02	NUM
iajs-3546	62	56	,	,	PUNCT
iajs-3546	62	57	0.102	0.102	NUM
iajs-3546	62	58	±	±	NUM
iajs-3546	62	59	0.01	0.01	NUM
iajs-3546	62	60	%	%	NOUN
iajs-3546	62	61	respictively	respictively	ADV
iajs-3546	62	62	between	between	ADP
iajs-3546	62	63	two	two	NUM
iajs-3546	62	64	groups	group	NOUN
iajs-3546	62	65	,	,	PUNCT
iajs-3546	62	66	patients	patient	NOUN
iajs-3546	62	67	and	and	CCONJ
iajs-3546	62	68	control	control	NOUN
iajs-3546	62	69	.	.	PUNCT
iajs-3546	63	1	whereas	whereas	SCONJ
iajs-3546	63	2	,	,	PUNCT
iajs-3546	63	3	the	the	DET
iajs-3546	63	4	reason	reason	NOUN
iajs-3546	63	5	for	for	ADP
iajs-3546	63	6	the	the	DET
iajs-3546	63	7	increase	increase	NOUN
iajs-3546	63	8	of	of	ADP
iajs-3546	63	9	these	these	DET
iajs-3546	63	10	cells	cell	NOUN
iajs-3546	63	11	such	such	ADJ
iajs-3546	63	12	wbc	wbc	PROPN
iajs-3546	63	13	,	,	PUNCT
iajs-3546	63	14	neutrophil	neutrophil	ADJ
iajs-3546	63	15	and	and	CCONJ
iajs-3546	63	16	eosinophil	eosinophil	ADJ
iajs-3546	63	17	is	be	AUX
iajs-3546	63	18	the	the	DET
iajs-3546	63	19	scabies	scabie	NOUN
iajs-3546	63	20	infection	infection	NOUN
iajs-3546	63	21	stimulate	stimulate	VERB
iajs-3546	63	22	the	the	DET
iajs-3546	63	23	innate	innate	ADJ
iajs-3546	63	24	immunity	immunity	NOUN
iajs-3546	63	25	in	in	ADP
iajs-3546	63	26	addition	addition	NOUN
iajs-3546	63	27	to	to	ADP
iajs-3546	63	28	humoral	humoral	ADJ
iajs-3546	63	29	and	and	CCONJ
iajs-3546	63	30	cellular	cellular	ADJ
iajs-3546	63	31	immunes	immune	NOUN
iajs-3546	63	32	(	(	PUNCT
iajs-3546	63	33	15	15	NUM
iajs-3546	63	34	,	,	PUNCT
iajs-3546	63	35	29	29	NUM
iajs-3546	63	36	)	)	PUNCT
iajs-3546	63	37	and	and	CCONJ
iajs-3546	63	38	this	this	DET
iajs-3546	63	39	result	result	NOUN
iajs-3546	63	40	convention	convention	NOUN
iajs-3546	63	41	with	with	ADP
iajs-3546	63	42	(	(	PUNCT
iajs-3546	63	43	16,17,13	16,17,13	NUM
iajs-3546	63	44	)	)	PUNCT
iajs-3546	63	45	.	.	PUNCT
iajs-3546	64	1	as	as	ADV
iajs-3546	64	2	well	well	ADV
iajs-3546	64	3	as	as	ADP
iajs-3546	64	4	,	,	PUNCT
iajs-3546	64	5	the	the	DET
iajs-3546	64	6	increment	increment	NOUN
iajs-3546	64	7	of	of	ADP
iajs-3546	64	8	basophile	basophile	NOUN
iajs-3546	64	9	value	value	NOUN
iajs-3546	64	10	,	,	PUNCT
iajs-3546	64	11	as	as	ADP
iajs-3546	64	12	the	the	DET
iajs-3546	64	13	cause	cause	NOUN
iajs-3546	64	14	of	of	ADP
iajs-3546	64	15	allergic	allergic	ADJ
iajs-3546	64	16	reactions	reaction	NOUN
iajs-3546	64	17	in	in	ADP
iajs-3546	64	18	patients	patient	NOUN
iajs-3546	64	19	with	with	ADP
iajs-3546	64	20	scabies	scabie	NOUN
iajs-3546	64	21	,	,	PUNCT
iajs-3546	64	22	of	of	ADP
iajs-3546	64	23	which	which	PRON
iajs-3546	64	24	is	be	AUX
iajs-3546	64	25	one	one	NUM
iajs-3546	64	26	important	important	ADJ
iajs-3546	64	27	of	of	ADP
iajs-3546	64	28	its	its	PRON
iajs-3546	64	29	symptoms	symptom	NOUN
iajs-3546	64	30	.	.	PUNCT
iajs-3546	65	1	this	this	DET
iajs-3546	65	2	result	result	NOUN
iajs-3546	65	3	compatible	compatible	ADJ
iajs-3546	65	4	with	with	ADP
iajs-3546	65	5	the	the	DET
iajs-3546	65	6	results	result	NOUN
iajs-3546	65	7	of	of	ADP
iajs-3546	65	8	study	study	NOUN
iajs-3546	65	9	(	(	PUNCT
iajs-3546	65	10	18	18	NUM
iajs-3546	65	11	,	,	PUNCT
iajs-3546	65	12	19	19	NUM
iajs-3546	65	13	,	,	PUNCT
iajs-3546	65	14	15	15	NUM
iajs-3546	65	15	)	)	PUNCT
iajs-3546	65	16	,	,	PUNCT
iajs-3546	65	17	that	that	PRON
iajs-3546	65	18	reported	report	VERB
iajs-3546	65	19	the	the	DET
iajs-3546	65	20	increase	increase	NOUN
iajs-3546	65	21	in	in	ADP
iajs-3546	65	22	eosinophil	eosinophil	ADJ
iajs-3546	65	23	of	of	ADP
iajs-3546	65	24	scabies	scabie	NOUN
iajs-3546	65	25	patients	patient	NOUN
iajs-3546	65	26	could	could	AUX
iajs-3546	65	27	produce	produce	VERB
iajs-3546	65	28	some	some	DET
iajs-3546	65	29	kinds	kind	NOUN
iajs-3546	65	30	of	of	ADP
iajs-3546	65	31	allergens	allergen	NOUN
iajs-3546	65	32	which	which	PRON
iajs-3546	65	33	reach	reach	VERB
iajs-3546	65	34	some	some	PRON
iajs-3546	65	35	a	a	DET
iajs-3546	65	36	deeper	deep	ADJ
iajs-3546	65	37	layer	layer	NOUN
iajs-3546	65	38	of	of	ADP
iajs-3546	65	39	mucosa	mucosa	NOUN
iajs-3546	65	40	during	during	ADP
iajs-3546	65	41	the	the	DET
iajs-3546	65	42	infection	infection	NOUN
iajs-3546	65	43	.	.	PUNCT
iajs-3546	66	1	as	as	ADP
iajs-3546	66	2	for	for	ADP
iajs-3546	66	3	the	the	DET
iajs-3546	66	4	monocytes	monocyte	NOUN
iajs-3546	66	5	,	,	PUNCT
iajs-3546	66	6	when	when	SCONJ
iajs-3546	66	7	they	they	PRON
iajs-3546	66	8	first	first	ADV
iajs-3546	66	9	leave	leave	VERB
iajs-3546	66	10	the	the	DET
iajs-3546	66	11	circulation	circulation	NOUN
iajs-3546	66	12	to	to	PART
iajs-3546	66	13	respond	respond	VERB
iajs-3546	66	14	to	to	ADP
iajs-3546	66	15	(	(	PUNCT
iajs-3546	66	16	sarcoptes	sarcoptes	PROPN
iajs-3546	66	17	s.	s.	PROPN
iajs-3546	66	18	)	)	PUNCT
iajs-3546	66	19	in	in	ADP
iajs-3546	66	20	one	one	NUM
iajs-3546	66	21	way	way	NOUN
iajs-3546	66	22	,	,	PUNCT
iajs-3546	66	23	this	this	DET
iajs-3546	66	24	response	response	NOUN
iajs-3546	66	25	changes	change	VERB
iajs-3546	66	26	for	for	ADP
iajs-3546	66	27	these	these	DET
iajs-3546	66	28	cells	cell	NOUN
iajs-3546	66	29	in	in	SCONJ
iajs-3546	66	30	transformed	transform	VERB
iajs-3546	66	31	into	into	ADP
iajs-3546	66	32	macrophage	macrophage	NOUN
iajs-3546	66	33	that	that	PRON
iajs-3546	66	34	can	can	AUX
iajs-3546	66	35	then	then	ADV
iajs-3546	66	36	internalize	internalize	VERB
iajs-3546	66	37	and	and	CCONJ
iajs-3546	66	38	present	present	ADJ
iajs-3546	66	39	antigen	antigen	ADV
iajs-3546	66	40	,	,	PUNCT
iajs-3546	66	41	also	also	ADV
iajs-3546	66	42	possible	possible	ADJ
iajs-3546	66	43	that	that	SCONJ
iajs-3546	66	44	the	the	DET
iajs-3546	66	45	cytokines	cytokine	NOUN
iajs-3546	66	46	produced	produce	VERB
iajs-3546	66	47	by	by	ADP
iajs-3546	66	48	t	t	PROPN
iajs-3546	66	49	and	and	CCONJ
iajs-3546	66	50	b	b	PROPN
iajs-3546	66	51	lymphocytes	lymphocyte	NOUN
iajs-3546	66	52	in	in	ADP
iajs-3546	66	53	the	the	DET
iajs-3546	66	54	pbmc	pbmc	NOUN
iajs-3546	66	55	(	(	PUNCT
iajs-3546	66	56	peripheral	peripheral	ADJ
iajs-3546	66	57	blood	blood	NOUN
iajs-3546	66	58	mononuclear	mononuclear	ADJ
iajs-3546	66	59	cells	cell	NOUN
iajs-3546	66	60	)	)	PUNCT
iajs-3546	66	61	in	in	ADP
iajs-3546	66	62	response	response	NOUN
iajs-3546	66	63	to	to	ADP
iajs-3546	66	64	parasite	parasite	NOUN
iajs-3546	66	65	,	,	PUNCT
iajs-3546	66	66	may	may	AUX
iajs-3546	66	67	that	that	DET
iajs-3546	66	68	influencing	influence	VERB
iajs-3546	66	69	on	on	ADP
iajs-3546	66	70	monocyte	monocyte	NOUN
iajs-3546	66	71	production	production	NOUN
iajs-3546	66	72	(	(	PUNCT
iajs-3546	66	73	20	20	NUM
iajs-3546	66	74	)	)	PUNCT
iajs-3546	66	75	.	.	PUNCT
iajs-3546	67	1	the	the	DET
iajs-3546	67	2	present	present	ADJ
iajs-3546	67	3	results	result	NOUN
iajs-3546	67	4	is	be	AUX
iajs-3546	67	5	approved	approve	VERB
iajs-3546	67	6	with	with	ADP
iajs-3546	67	7	prior	prior	ADJ
iajs-3546	67	8	results	result	NOUN
iajs-3546	67	9	done	do	VERB
iajs-3546	67	10	by	by	ADP
iajs-3546	67	11	(	(	PUNCT
iajs-3546	67	12	14	14	NUM
iajs-3546	67	13	,	,	PUNCT
iajs-3546	67	14	13	13	NUM
iajs-3546	67	15	and	and	CCONJ
iajs-3546	67	16	12	12	NUM
iajs-3546	67	17	)	)	PUNCT
iajs-3546	67	18	.	.	PUNCT
iajs-3546	68	1	where	where	SCONJ
iajs-3546	68	2	they	they	PRON
iajs-3546	68	3	recorded	record	VERB
iajs-3546	68	4	that	that	SCONJ
iajs-3546	68	5	not	not	PART
iajs-3546	68	6	significant	significant	ADJ
iajs-3546	68	7	variations	variation	NOUN
iajs-3546	68	8	for	for	ADP
iajs-3546	68	9	measuring	measure	VERB
iajs-3546	68	10	these	these	DET
iajs-3546	68	11	tests	test	NOUN
iajs-3546	68	12	between	between	ADP
iajs-3546	68	13	the	the	DET
iajs-3546	68	14	patients	patient	NOUN
iajs-3546	68	15	and	and	CCONJ
iajs-3546	68	16	control	control	NOUN
iajs-3546	68	17	groups	group	NOUN
iajs-3546	68	18	.	.	PUNCT
iajs-3546	69	1	ihjpas	ihjpas	PROPN
iajs-3546	69	2	.	.	PUNCT
iajs-3546	70	1	2025	2025	NUM
iajs-3546	70	2	,	,	PUNCT
iajs-3546	70	3	38	38	NUM
iajs-3546	70	4	(	(	PUNCT
iajs-3546	70	5	1	1	NUM
iajs-3546	70	6	)	)	PUNCT
iajs-3546	70	7	65	65	NUM
iajs-3546	70	8	although	although	SCONJ
iajs-3546	70	9	,	,	PUNCT
iajs-3546	70	10	the	the	DET
iajs-3546	70	11	increasing	increase	VERB
iajs-3546	70	12	level	level	NOUN
iajs-3546	70	13	of	of	ADP
iajs-3546	70	14	ige	ige	PROPN
iajs-3546	70	15	in	in	ADP
iajs-3546	70	16	scabies	scabie	NOUN
iajs-3546	70	17	patients	patient	NOUN
iajs-3546	70	18	serum	serum	VERB
iajs-3546	70	19	because	because	SCONJ
iajs-3546	70	20	the	the	DET
iajs-3546	70	21	parasitic	parasitic	ADJ
iajs-3546	70	22	infections	infection	NOUN
iajs-3546	70	23	that	that	PRON
iajs-3546	70	24	have	have	VERB
iajs-3546	70	25	allergy	allergy	NOUN
iajs-3546	70	26	reactions	reaction	NOUN
iajs-3546	70	27	which	which	PRON
iajs-3546	70	28	is	be	AUX
iajs-3546	70	29	one	one	NUM
iajs-3546	70	30	of	of	ADP
iajs-3546	70	31	the	the	DET
iajs-3546	70	32	most	most	ADV
iajs-3546	70	33	important	important	ADJ
iajs-3546	70	34	symptoms	symptom	NOUN
iajs-3546	70	35	of	of	ADP
iajs-3546	70	36	scabies	scabie	NOUN
iajs-3546	70	37	,	,	PUNCT
iajs-3546	70	38	that	that	PRON
iajs-3546	70	39	work	work	VERB
iajs-3546	70	40	to	to	PART
iajs-3546	70	41	stimulate	stimulate	VERB
iajs-3546	70	42	the	the	DET
iajs-3546	70	43	secretion	secretion	NOUN
iajs-3546	70	44	of	of	ADP
iajs-3546	70	45	ige	ige	PROPN
iajs-3546	70	46	whose	whose	DET
iajs-3546	70	47	participate	participate	NOUN
iajs-3546	70	48	to	to	ADP
iajs-3546	70	49	the	the	DET
iajs-3546	70	50	local	local	ADJ
iajs-3546	70	51	inflammatory	inflammatory	ADJ
iajs-3546	70	52	reaction	reaction	NOUN
iajs-3546	70	53	and	and	CCONJ
iajs-3546	70	54	is	be	AUX
iajs-3546	70	55	associated	associate	VERB
iajs-3546	70	56	with	with	ADP
iajs-3546	70	57	the	the	DET
iajs-3546	70	58	skin	skin	NOUN
iajs-3546	70	59	inflammation	inflammation	NOUN
iajs-3546	70	60	and	and	CCONJ
iajs-3546	70	61	in	in	ADP
iajs-3546	70	62	addition	addition	NOUN
iajs-3546	70	63	to	to	ADP
iajs-3546	70	64	the	the	DET
iajs-3546	70	65	it	it	PRON
iajs-3546	70	66	is	be	AUX
iajs-3546	70	67	role	role	NOUN
iajs-3546	70	68	in	in	ADP
iajs-3546	70	69	the	the	DET
iajs-3546	70	70	activation	activation	NOUN
iajs-3546	70	71	to	to	ADP
iajs-3546	70	72	producing	produce	VERB
iajs-3546	70	73	cd4	cd4	PROPN
iajs-3546	70	74	+	+	CCONJ
iajs-3546	70	75	(	(	PUNCT
iajs-3546	70	76	t	t	NOUN
iajs-3546	70	77	-	-	PUNCT
iajs-3546	70	78	helper	helper	NOUN
iajs-3546	70	79	)	)	PUNCT
iajs-3546	70	80	(	(	PUNCT
iajs-3546	70	81	21	21	NUM
iajs-3546	70	82	,	,	PUNCT
iajs-3546	70	83	30	30	NUM
iajs-3546	70	84	)	)	PUNCT
iajs-3546	70	85	.	.	PUNCT
iajs-3546	71	1	therefore	therefore	ADV
iajs-3546	71	2	the	the	DET
iajs-3546	71	3	infection	infection	NOUN
iajs-3546	71	4	with	with	ADP
iajs-3546	71	5	ectoparasite	ectoparasite	ADJ
iajs-3546	71	6	(	(	PUNCT
iajs-3546	71	7	sarcoptes	sarcopte	NOUN
iajs-3546	71	8	scabiei	scabiei	PROPN
iajs-3546	71	9	)	)	PUNCT
iajs-3546	71	10	causes	cause	VERB
iajs-3546	71	11	stimulation	stimulation	VERB
iajs-3546	71	12	humoral	humoral	ADJ
iajs-3546	71	13	and	and	CCONJ
iajs-3546	71	14	cellular	cellular	ADJ
iajs-3546	71	15	immune	immune	ADJ
iajs-3546	71	16	system	system	NOUN
iajs-3546	71	17	of	of	ADP
iajs-3546	71	18	the	the	DET
iajs-3546	71	19	host	host	NOUN
iajs-3546	71	20	(	(	PUNCT
iajs-3546	71	21	22	22	NUM
iajs-3546	71	22	,	,	PUNCT
iajs-3546	71	23	31	31	NUM
iajs-3546	71	24	)	)	PUNCT
iajs-3546	71	25	.	.	PUNCT
iajs-3546	72	1	present	present	ADJ
iajs-3546	72	2	results	result	NOUN
iajs-3546	72	3	consistent	consistent	ADJ
iajs-3546	72	4	with	with	ADP
iajs-3546	72	5	previous	previous	ADJ
iajs-3546	72	6	results	result	NOUN
iajs-3546	72	7	conducted	conduct	VERB
iajs-3546	72	8	by	by	ADP
iajs-3546	72	9	(	(	PUNCT
iajs-3546	72	10	23	23	NUM
iajs-3546	72	11	,	,	PUNCT
iajs-3546	72	12	21	21	NUM
iajs-3546	72	13	)	)	PUNCT
iajs-3546	72	14	.	.	PUNCT
iajs-3546	73	1	that	that	PRON
iajs-3546	73	2	reported	report	VERB
iajs-3546	73	3	great	great	ADJ
iajs-3546	73	4	levels	level	NOUN
iajs-3546	73	5	of	of	ADP
iajs-3546	73	6	ige	ige	PROPN
iajs-3546	73	7	in	in	ADP
iajs-3546	73	8	scabies	scabie	NOUN
iajs-3546	73	9	patients	patient	NOUN
iajs-3546	73	10	.	.	PUNCT
iajs-3546	74	1	immunoglobulin	immunoglobulin	NOUN
iajs-3546	74	2	(	(	PUNCT
iajs-3546	74	3	iga	iga	PROPN
iajs-3546	74	4	)	)	PUNCT
iajs-3546	74	5	an	an	DET
iajs-3546	74	6	antibody	antibody	NOUN
iajs-3546	74	7	has	have	VERB
iajs-3546	74	8	a	a	DET
iajs-3546	74	9	major	major	ADJ
iajs-3546	74	10	role	role	NOUN
iajs-3546	74	11	in	in	ADP
iajs-3546	74	12	the	the	DET
iajs-3546	74	13	immune	immune	ADJ
iajs-3546	74	14	system	system	NOUN
iajs-3546	74	15	in	in	ADP
iajs-3546	74	16	combat	combat	NOUN
iajs-3546	74	17	diseases	disease	NOUN
iajs-3546	74	18	that	that	PRON
iajs-3546	74	19	invade	invade	VERB
iajs-3546	74	20	the	the	DET
iajs-3546	74	21	body	body	NOUN
iajs-3546	74	22	and	and	CCONJ
iajs-3546	74	23	struggle	struggle	NOUN
iajs-3546	74	24	infection	infection	NOUN
iajs-3546	74	25	,	,	PUNCT
iajs-3546	74	26	which	which	PRON
iajs-3546	74	27	is	be	AUX
iajs-3546	74	28	renewed	renew	VERB
iajs-3546	74	29	all	all	DET
iajs-3546	74	30	six	six	NUM
iajs-3546	74	31	days	day	NOUN
iajs-3546	74	32	as	as	SCONJ
iajs-3546	74	33	it	it	PRON
iajs-3546	74	34	is	be	AUX
iajs-3546	74	35	excreted	excrete	VERB
iajs-3546	74	36	in	in	ADP
iajs-3546	74	37	the	the	DET
iajs-3546	74	38	mucous	mucous	ADJ
iajs-3546	74	39	membranes	membrane	NOUN
iajs-3546	74	40	(	(	PUNCT
iajs-3546	74	41	such	such	ADJ
iajs-3546	74	42	as	as	ADP
iajs-3546	74	43	respiratory	respiratory	ADJ
iajs-3546	74	44	and	and	CCONJ
iajs-3546	74	45	digestive	digestive	ADJ
iajs-3546	74	46	system	system	NOUN
iajs-3546	74	47	,	,	PUNCT
iajs-3546	74	48	saliva	saliva	NOUN
iajs-3546	74	49	,	,	PUNCT
iajs-3546	74	50	tear	tear	NOUN
iajs-3546	74	51	and	and	CCONJ
iajs-3546	74	52	breast	breast	NOUN
iajs-3546	74	53	milk	milk	NOUN
iajs-3546	74	54	)	)	PUNCT
iajs-3546	74	55	and	and	CCONJ
iajs-3546	74	56	has	have	VERB
iajs-3546	74	57	the	the	DET
iajs-3546	74	58	might	might	NOUN
iajs-3546	74	59	to	to	PART
iajs-3546	74	60	defend	defend	VERB
iajs-3546	74	61	versus	versus	ADP
iajs-3546	74	62	sepsis	sepsis	NOUN
iajs-3546	74	63	and	and	CCONJ
iajs-3546	74	64	immunity	immunity	NOUN
iajs-3546	74	65	particular	particular	ADJ
iajs-3546	74	66	in	in	ADP
iajs-3546	74	67	the	the	DET
iajs-3546	74	68	mucous	mucous	ADJ
iajs-3546	74	69	membranes	membrane	NOUN
iajs-3546	74	70	,	,	PUNCT
iajs-3546	74	71	therefore	therefore	ADV
iajs-3546	74	72	it	it	PRON
iajs-3546	74	73	is	be	AUX
iajs-3546	74	74	called	call	VERB
iajs-3546	74	75	secretory	secretory	ADJ
iajs-3546	74	76	iga	iga	PROPN
iajs-3546	74	77	because	because	SCONJ
iajs-3546	74	78	it	it	PRON
iajs-3546	74	79	is	be	AUX
iajs-3546	74	80	found	find	VERB
iajs-3546	74	81	in	in	ADP
iajs-3546	74	82	the	the	DET
iajs-3546	74	83	mucous	mucous	ADJ
iajs-3546	74	84	tissues	tissue	NOUN
iajs-3546	74	85	more	more	ADJ
iajs-3546	74	86	than	than	ADP
iajs-3546	74	87	the	the	DET
iajs-3546	74	88	serum	serum	NOUN
iajs-3546	74	89	(	(	PUNCT
iajs-3546	74	90	24	24	NUM
iajs-3546	74	91	,	,	PUNCT
iajs-3546	74	92	32	32	NUM
iajs-3546	74	93	)	)	PUNCT
iajs-3546	74	94	.	.	PUNCT
iajs-3546	75	1	thus	thus	ADV
iajs-3546	75	2	,	,	PUNCT
iajs-3546	75	3	the	the	DET
iajs-3546	75	4	current	current	ADJ
iajs-3546	75	5	result	result	NOUN
iajs-3546	75	6	demonstrated	demonstrate	VERB
iajs-3546	75	7	non	non	ADJ
iajs-3546	75	8	-	-	ADJ
iajs-3546	75	9	significant	significant	ADJ
iajs-3546	75	10	differences	difference	NOUN
iajs-3546	75	11	between	between	ADP
iajs-3546	75	12	scabies	scabie	NOUN
iajs-3546	75	13	patients	patient	NOUN
iajs-3546	75	14	and	and	CCONJ
iajs-3546	75	15	control	control	NOUN
iajs-3546	75	16	group	group	NOUN
iajs-3546	75	17	,	,	PUNCT
iajs-3546	75	18	so	so	ADV
iajs-3546	75	19	,	,	PUNCT
iajs-3546	75	20	this	this	DET
iajs-3546	75	21	result	result	NOUN
iajs-3546	75	22	convention	convention	NOUN
iajs-3546	75	23	with	with	ADP
iajs-3546	75	24	(	(	PUNCT
iajs-3546	75	25	25	25	NUM
iajs-3546	75	26	)	)	PUNCT
iajs-3546	75	27	.	.	PUNCT
iajs-3546	76	1	but	but	CCONJ
iajs-3546	76	2	this	this	PRON
iajs-3546	76	3	result	result	NOUN
iajs-3546	76	4	disagreement	disagreement	NOUN
iajs-3546	76	5	with	with	ADP
iajs-3546	76	6	(	(	PUNCT
iajs-3546	76	7	26	26	NUM
iajs-3546	76	8	,	,	PUNCT
iajs-3546	76	9	33	33	NUM
iajs-3546	76	10	)	)	PUNCT
iajs-3546	76	11	study	study	NOUN
iajs-3546	76	12	,	,	PUNCT
iajs-3546	76	13	that	that	PRON
iajs-3546	76	14	reported	report	VERB
iajs-3546	76	15	was	be	AUX
iajs-3546	76	16	the	the	DET
iajs-3546	76	17	higher	high	ADJ
iajs-3546	76	18	significant	significant	ADJ
iajs-3546	76	19	rates	rate	NOUN
iajs-3546	76	20	of	of	ADP
iajs-3546	76	21	iga	iga	PROPN
iajs-3546	76	22	for	for	ADP
iajs-3546	76	23	patients	patient	NOUN
iajs-3546	76	24	group	group	NOUN
iajs-3546	76	25	compare	compare	VERB
iajs-3546	76	26	with	with	ADP
iajs-3546	76	27	control	control	NOUN
iajs-3546	76	28	by	by	ADP
iajs-3546	76	29	conducted	conduct	VERB
iajs-3546	76	30	on	on	ADP
iajs-3546	76	31	indirect	indirect	ADJ
iajs-3546	76	32	induction	induction	NOUN
iajs-3546	76	33	of	of	ADP
iajs-3546	76	34	scabies	scabie	NOUN
iajs-3546	76	35	disease	disease	NOUN
iajs-3546	76	36	to	to	ADP
iajs-3546	76	37	the	the	DET
iajs-3546	76	38	emergence	emergence	NOUN
iajs-3546	76	39	of	of	ADP
iajs-3546	76	40	an	an	DET
iajs-3546	76	41	autoimmune	autoimmune	ADJ
iajs-3546	76	42	disease	disease	NOUN
iajs-3546	76	43	(	(	PUNCT
iajs-3546	76	44	sle	sle	PROPN
iajs-3546	76	45	)	)	PUNCT
iajs-3546	76	46	in	in	ADP
iajs-3546	76	47	the	the	DET
iajs-3546	76	48	province	province	NOUN
iajs-3546	76	49	of	of	ADP
iajs-3546	76	50	thi	thi	PROPN
iajs-3546	76	51	qar	qar	PROPN
iajs-3546	76	52	.	.	PUNCT
iajs-3546	77	1	5	5	X
iajs-3546	77	2	.	.	X
iajs-3546	77	3	conclusion	conclusion	NOUN
iajs-3546	77	4	:	:	PUNCT
iajs-3546	77	5	the	the	DET
iajs-3546	77	6	hematological	hematological	ADJ
iajs-3546	77	7	parameters	parameter	NOUN
iajs-3546	77	8	in	in	ADP
iajs-3546	77	9	present	present	ADJ
iajs-3546	77	10	study	study	NOUN
iajs-3546	77	11	represented	represent	VERB
iajs-3546	77	12	there	there	PRON
iajs-3546	77	13	were	be	VERB
iajs-3546	77	14	no	no	PRON
iajs-3546	77	15	-	-	PUNCT
iajs-3546	77	16	significant	significant	ADJ
iajs-3546	77	17	differences	difference	NOUN
iajs-3546	77	18	for	for	ADP
iajs-3546	77	19	hb	hb	PROPN
iajs-3546	77	20	,	,	PUNCT
iajs-3546	77	21	pcv	pcv	PROPN
iajs-3546	77	22	,	,	PUNCT
iajs-3546	77	23	monocyte	monocyte	NOUN
iajs-3546	77	24	and	and	CCONJ
iajs-3546	77	25	platelets	platelet	NOUN
iajs-3546	77	26	,	,	PUNCT
iajs-3546	77	27	whereas	whereas	SCONJ
iajs-3546	77	28	,	,	PUNCT
iajs-3546	77	29	revealed	reveal	VERB
iajs-3546	77	30	significant	significant	ADJ
iajs-3546	77	31	differences	difference	NOUN
iajs-3546	77	32	with	with	ADP
iajs-3546	77	33	total	total	ADJ
iajs-3546	77	34	number	number	NOUN
iajs-3546	77	35	of	of	ADP
iajs-3546	77	36	wbc	wbc	PROPN
iajs-3546	77	37	,	,	PUNCT
iajs-3546	77	38	lymphocyte	lymphocyte	ADJ
iajs-3546	77	39	,	,	PUNCT
iajs-3546	77	40	neutrophil	neutrophil	ADJ
iajs-3546	77	41	,	,	PUNCT
iajs-3546	77	42	eosinophil	eosinophil	ADJ
iajs-3546	77	43	and	and	CCONJ
iajs-3546	77	44	basophil	basophil	ADJ
iajs-3546	77	45	percentage	percentage	NOUN
iajs-3546	77	46	between	between	ADP
iajs-3546	77	47	patients	patient	NOUN
iajs-3546	77	48	and	and	CCONJ
iajs-3546	77	49	control	control	NOUN
iajs-3546	77	50	group	group	NOUN
iajs-3546	77	51	.	.	PUNCT
iajs-3546	78	1	the	the	DET
iajs-3546	78	2	present	present	ADJ
iajs-3546	78	3	study	study	NOUN
iajs-3546	78	4	investigated	investigate	VERB
iajs-3546	78	5	no	no	DET
iajs-3546	78	6	-	-	PUNCT
iajs-3546	78	7	significant	significant	ADJ
iajs-3546	78	8	differences	difference	NOUN
iajs-3546	78	9	in	in	ADP
iajs-3546	78	10	the	the	DET
iajs-3546	78	11	values	value	NOUN
iajs-3546	78	12	of	of	ADP
iajs-3546	78	13	immunoglobulin	immunoglobulin	PROPN
iajs-3546	78	14	iga	iga	PROPN
iajs-3546	78	15	for	for	ADP
iajs-3546	78	16	parasitic	parasitic	ADJ
iajs-3546	78	17	infection	infection	NOUN
iajs-3546	78	18	,	,	PUNCT
iajs-3546	78	19	but	but	CCONJ
iajs-3546	78	20	ige	ige	PROPN
iajs-3546	78	21	ratio	ratio	NOUN
iajs-3546	78	22	represented	represent	VERB
iajs-3546	78	23	high	high	ADJ
iajs-3546	78	24	significant	significant	ADJ
iajs-3546	78	25	differences	difference	NOUN
iajs-3546	78	26	in	in	ADP
iajs-3546	78	27	scabies	scabie	NOUN
iajs-3546	78	28	patients	patient	NOUN
iajs-3546	78	29	.	.	PUNCT
iajs-3546	79	1	acknowledgment	acknowledgment	NOUN
iajs-3546	79	2	:	:	PUNCT
iajs-3546	79	3	the	the	DET
iajs-3546	79	4	writers	writer	NOUN
iajs-3546	79	5	extend	extend	VERB
iajs-3546	79	6	their	their	PRON
iajs-3546	79	7	sincere	sincere	ADJ
iajs-3546	79	8	thanks	thank	NOUN
iajs-3546	79	9	to	to	ADP
iajs-3546	79	10	the	the	DET
iajs-3546	79	11	respected	respected	ADJ
iajs-3546	79	12	doctors	doctor	NOUN
iajs-3546	79	13	and	and	CCONJ
iajs-3546	79	14	professors	professor	NOUN
iajs-3546	79	15	,	,	PUNCT
iajs-3546	79	16	as	as	ADV
iajs-3546	79	17	well	well	ADV
iajs-3546	79	18	as	as	ADP
iajs-3546	79	19	all	all	DET
iajs-3546	79	20	thanks	thank	NOUN
iajs-3546	79	21	to	to	ADP
iajs-3546	79	22	the	the	DET
iajs-3546	79	23	staff	staff	NOUN
iajs-3546	79	24	of	of	ADP
iajs-3546	79	25	the	the	DET
iajs-3546	79	26	city	city	NOUN
iajs-3546	79	27	of	of	ADP
iajs-3546	79	28	medical	medical	ADJ
iajs-3546	79	29	teaching	teaching	NOUN
iajs-3546	79	30	hospital	hospital	NOUN
iajs-3546	79	31	,	,	PUNCT
iajs-3546	79	32	department	department	NOUN
iajs-3546	79	33	of	of	ADP
iajs-3546	79	34	dermatology	dermatology	NOUN
iajs-3546	79	35	,	,	PUNCT
iajs-3546	79	36	as	as	ADV
iajs-3546	79	37	wel	wel	PROPN
iajs-3546	79	38	as	as	ADP
iajs-3546	79	39	the	the	DET
iajs-3546	79	40	staff	staff	NOUN
iajs-3546	79	41	of	of	ADP
iajs-3546	79	42	the	the	DET
iajs-3546	79	43	immunology	immunology	NOUN
iajs-3546	79	44	laboratories	laboratory	NOUN
iajs-3546	79	45	at	at	ADP
iajs-3546	79	46	the	the	DET
iajs-3546	79	47	college	college	NOUN
iajs-3546	79	48	of	of	ADP
iajs-3546	79	49	medicine	medicine	NOUN
iajs-3546	79	50	nahrain	nahrain	PROPN
iajs-3546	79	51	.	.	PUNCT
iajs-3546	80	1	conflict	conflict	NOUN
iajs-3546	80	2	of	of	ADP
iajs-3546	80	3	interest	interest	NOUN
iajs-3546	80	4	:	:	PUNCT
iajs-3546	80	5	the	the	DET
iajs-3546	80	6	writers	writer	NOUN
iajs-3546	80	7	say	say	VERB
iajs-3546	80	8	they	they	PRON
iajs-3546	80	9	have	have	VERB
iajs-3546	80	10	nothing	nothing	PRON
iajs-3546	80	11	to	to	PART
iajs-3546	80	12	disclose	disclose	VERB
iajs-3546	80	13	about	about	ADP
iajs-3546	80	14	conflicts	conflict	NOUN
iajs-3546	80	15	of	of	ADP
iajs-3546	80	16	interest	interest	NOUN
iajs-3546	80	17	.	.	PUNCT
iajs-3546	81	1	ethical	ethical	ADJ
iajs-3546	81	2	clearance	clearance	NOUN
iajs-3546	81	3	statistical	statistical	ADJ
iajs-3546	81	4	analysis	analysis	NOUN
iajs-3546	81	5	data	datum	NOUN
iajs-3546	81	6	analysis	analysis	NOUN
iajs-3546	81	7	was	be	AUX
iajs-3546	81	8	done	do	VERB
iajs-3546	81	9	by	by	ADP
iajs-3546	81	10	spss	spss	PROPN
iajs-3546	81	11	program	program	NOUN
iajs-3546	81	12	,	,	PUNCT
iajs-3546	81	13	while	while	SCONJ
iajs-3546	81	14	qualitative	qualitative	ADJ
iajs-3546	81	15	data	datum	NOUN
iajs-3546	81	16	were	be	AUX
iajs-3546	81	17	expressed	express	VERB
iajs-3546	81	18	as	as	ADP
iajs-3546	81	19	a	a	DET
iajs-3546	81	20	number	number	NOUN
iajs-3546	81	21	,	,	PUNCT
iajs-3546	81	22	percentage	percentage	NOUN
iajs-3546	81	23	and	and	CCONJ
iajs-3546	81	24	quantitative	quantitative	ADJ
iajs-3546	81	25	data	datum	NOUN
iajs-3546	81	26	by	by	ADP
iajs-3546	81	27	chi	chi	PROPN
iajs-3546	81	28	square	square	PROPN
iajs-3546	81	29	test	test	NOUN
iajs-3546	81	30	and	and	CCONJ
iajs-3546	81	31	utilized	utilize	VERB
iajs-3546	81	32	t	t	PROPN
iajs-3546	81	33	test	test	NOUN
iajs-3546	81	34	and	and	CCONJ
iajs-3546	81	35	pearson	pearson	PROPN
iajs-3546	81	36	correlation	correlation	NOUN
iajs-3546	81	37	coefficient	coefficient	NOUN
iajs-3546	81	38	were	be	AUX
iajs-3546	81	39	also	also	ADV
iajs-3546	81	40	applied	apply	VERB
iajs-3546	81	41	to	to	ADP
iajs-3546	81	42	p	p	NOUN
iajs-3546	81	43	value	value	NOUN
iajs-3546	81	44	of	of	ADP
iajs-3546	81	45	0.01	0.01	NUM
iajs-3546	81	46	and	and	CCONJ
iajs-3546	81	47	0.05	0.05	NUM
iajs-3546	81	48	was	be	AUX
iajs-3546	81	49	used	use	VERB
iajs-3546	81	50	to	to	PART
iajs-3546	81	51	indicate	indicate	VERB
iajs-3546	81	52	if	if	SCONJ
iajs-3546	81	53	the	the	DET
iajs-3546	81	54	results	result	NOUN
iajs-3546	81	55	are	be	AUX
iajs-3546	81	56	significant	significant	ADJ
iajs-3546	81	57	.	.	PUNCT
iajs-3546	82	1	ihjpas	ihjpas	PROPN
iajs-3546	82	2	.	.	PUNCT
iajs-3546	83	1	2025	2025	NUM
iajs-3546	83	2	,	,	PUNCT
iajs-3546	83	3	38	38	NUM
iajs-3546	83	4	(	(	PUNCT
iajs-3546	83	5	1	1	NUM
iajs-3546	83	6	)	)	PUNCT
iajs-3546	83	7	66	66	NUM
iajs-3546	83	8	references	reference	NOUN
iajs-3546	83	9	1	1	NUM
iajs-3546	83	10	.	.	PUNCT
iajs-3546	83	11	currier	currier	PROPN
iajs-3546	83	12	r.	r.	PROPN
iajs-3546	83	13	;	;	PUNCT
iajs-3546	83	14	walton	walton	PROPN
iajs-3546	83	15	s.	s.	PROPN
iajs-3546	83	16	and	and	CCONJ
iajs-3546	83	17	currie	currie	PROPN
iajs-3546	83	18	b.	b.	PROPN
iajs-3546	83	19	scabies	scabie	NOUN
iajs-3546	83	20	in	in	ADP
iajs-3546	83	21	animals	animal	NOUN
iajs-3546	83	22	and	and	CCONJ
iajs-3546	83	23	humans	human	NOUN
iajs-3546	83	24	:	:	PUNCT
iajs-3546	83	25	history	history	NOUN
iajs-3546	83	26	,	,	PUNCT
iajs-3546	83	27	evolutionary	evolutionary	ADJ
iajs-3546	83	28	perspectives	perspective	NOUN
iajs-3546	83	29	,	,	PUNCT
iajs-3546	83	30	and	and	CCONJ
iajs-3546	83	31	modern	modern	ADJ
iajs-3546	83	32	clinical	clinical	ADJ
iajs-3546	83	33	management	management	NOUN
iajs-3546	83	34	.	.	PUNCT
iajs-3546	84	1	annals	annal	NOUN
iajs-3546	84	2	of	of	ADP
iajs-3546	84	3	the	the	DET
iajs-3546	84	4	new	new	PROPN
iajs-3546	84	5	york	york	PROPN
iajs-3546	84	6	academy	academy	PROPN
iajs-3546	84	7	of	of	ADP
iajs-3546	84	8	sciences	science	NOUN
iajs-3546	84	9	2011	2011	NUM
iajs-3546	84	10	,	,	PUNCT
iajs-3546	84	11	1230(1	1230(1	NUM
iajs-3546	84	12	):	):	PUNCT
iajs-3546	84	13	50	50	NUM
iajs-3546	84	14	–	–	SYM
iajs-3546	84	15	60	60	NUM
iajs-3546	84	16	.	.	PUNCT
iajs-3546	85	1	https://doi.org/10.1111/j.1749-6632.2011.06364	https://doi.org/10.1111/j.1749-6632.2011.06364	NOUN
iajs-3546	85	2	.	.	PUNCT
iajs-3546	86	1	2	2	NUM
iajs-3546	86	2	.	.	X
iajs-3546	86	3	el	el	NOUN
iajs-3546	86	4	-	-	ADJ
iajs-3546	86	5	moamly	moamly	PROPN
iajs-3546	86	6	a.et	a.et	PROPN
iajs-3546	86	7	al	al	PROPN
iajs-3546	86	8	.	.	PROPN
iajs-3546	86	9	scabies	scabie	NOUN
iajs-3546	86	10	as	as	ADP
iajs-3546	86	11	a	a	DET
iajs-3546	86	12	part	part	NOUN
iajs-3546	86	13	of	of	ADP
iajs-3546	86	14	the	the	DET
iajs-3546	86	15	world	world	PROPN
iajs-3546	86	16	health	health	PROPN
iajs-3546	86	17	organization	organization	NOUN
iajs-3546	86	18	roadmap	roadmap	NOUN
iajs-3546	86	19	for	for	ADP
iajs-3546	86	20	neglected	neglect	VERB
iajs-3546	86	21	tropical	tropical	ADJ
iajs-3546	86	22	diseases	disease	NOUN
iajs-3546	86	23	2021–2030	2021–2030	NUM
iajs-3546	86	24	:	:	PUNCT
iajs-3546	86	25	what	what	PRON
iajs-3546	86	26	we	we	PRON
iajs-3546	86	27	know	know	VERB
iajs-3546	86	28	and	and	CCONJ
iajs-3546	86	29	what	what	PRON
iajs-3546	86	30	we	we	PRON
iajs-3546	86	31	need	need	VERB
iajs-3546	86	32	to	to	PART
iajs-3546	86	33	do	do	VERB
iajs-3546	86	34	for	for	ADP
iajs-3546	86	35	global	global	ADJ
iajs-3546	86	36	control	control	NOUN
iajs-3546	86	37	.	.	PUNCT
iajs-3546	87	1	tropical	tropical	ADJ
iajs-3546	87	2	medicine	medicine	NOUN
iajs-3546	87	3	and	and	CCONJ
iajs-3546	87	4	health	health	NOUN
iajs-3546	87	5	2021	2021	NUM
iajs-3546	87	6	,	,	PUNCT
iajs-3546	87	7	49(1	49(1	NUM
iajs-3546	87	8	):	):	PUNCT
iajs-3546	87	9	1–11	1–11	PROPN
iajs-3546	87	10	.	.	PUNCT
iajs-3546	88	1	3	3	X
iajs-3546	88	2	.	.	X
iajs-3546	88	3	karimkhani	karimkhani	PROPN
iajs-3546	88	4	c.	c.	PROPN
iajs-3546	88	5	;	;	PUNCT
iajs-3546	88	6	colobara	colobara	PROPN
iajs-3546	88	7	d.	d.	PROPN
iajs-3546	88	8	;	;	PUNCT
iajs-3546	88	9	drucker	drucker	PROPN
iajs-3546	88	10	a.	a.	PROPN
iajs-3546	88	11	;	;	PUNCT
iajs-3546	88	12	norton	norton	PROPN
iajs-3546	88	13	s.	s.	PROPN
iajs-3546	88	14	;	;	PUNCT
iajs-3546	88	15	hay	hay	PROPN
iajs-3546	88	16	r.	r.	PROPN
iajs-3546	88	17	and	and	CCONJ
iajs-3546	88	18	engelman	engelman	PROPN
iajs-3546	88	19	d.	d.	PROPN
iajs-3546	88	20	the	the	DET
iajs-3546	88	21	global	global	ADJ
iajs-3546	88	22	burden	burden	NOUN
iajs-3546	88	23	of	of	ADP
iajs-3546	88	24	scabies	scabie	NOUN
iajs-3546	88	25	:	:	PUNCT
iajs-3546	88	26	a	a	DET
iajs-3546	88	27	cross	cross	ADJ
iajs-3546	88	28	-	-	ADJ
iajs-3546	88	29	sectional	sectional	ADJ
iajs-3546	88	30	analysis	analysis	NOUN
iajs-3546	88	31	from	from	ADP
iajs-3546	88	32	the	the	DET
iajs-3546	88	33	global	global	ADJ
iajs-3546	88	34	burden	burden	NOUN
iajs-3546	88	35	of	of	ADP
iajs-3546	88	36	disease	disease	NOUN
iajs-3546	88	37	study	study	NOUN
iajs-3546	88	38	2015	2015	NUM
iajs-3546	88	39	.	.	PUNCT
iajs-3546	89	1	the	the	DET
iajs-3546	89	2	lancet	lancet	ADJ
iajs-3546	89	3	infectious	infectious	ADJ
iajs-3546	89	4	diseases	disease	NOUN
iajs-3546	89	5	2017	2017	NUM
iajs-3546	89	6	,	,	PUNCT
iajs-3546	89	7	17(12	17(12	NUM
iajs-3546	89	8	):	):	PUNCT
iajs-3546	89	9	1247–1254	1247–1254	NUM
iajs-3546	89	10	.	.	PUNCT
iajs-3546	90	1	4	4	X
iajs-3546	90	2	.	.	X
iajs-3546	90	3	engelman	engelman	PROPN
iajs-3546	90	4	d.	d.	PROPN
iajs-3546	90	5	et	et	PROPN
iajs-3546	90	6	al	al	PROPN
iajs-3546	90	7	.	.	PROPN
iajs-3546	90	8	,	,	PUNCT
iajs-3546	90	9	“	"	PUNCT
iajs-3546	90	10	a	a	DET
iajs-3546	90	11	framework	framework	NOUN
iajs-3546	90	12	for	for	ADP
iajs-3546	90	13	scabies	scabie	NOUN
iajs-3546	90	14	control	control	NOUN
iajs-3546	90	15	,	,	PUNCT
iajs-3546	90	16	”	"	PUNCT
iajs-3546	90	17	plos	plos	PROPN
iajs-3546	90	18	negl	negl	PROPN
iajs-3546	90	19	.	.	PUNCT
iajs-3546	91	1	trop	trop	PROPN
iajs-3546	91	2	.	.	PUNCT
iajs-3546	92	1	dis	dis	PROPN
iajs-3546	92	2	.	.	PROPN
iajs-3546	92	3	2021	2021	NUM
iajs-3546	92	4	,	,	PUNCT
iajs-3546	92	5	vol	vol	NOUN
iajs-3546	92	6	.	.	PROPN
iajs-3546	92	7	15	15	NUM
iajs-3546	92	8	,	,	PUNCT
iajs-3546	92	9	no	no	INTJ
iajs-3546	92	10	.	.	NOUN
iajs-3546	92	11	9	9	NUM
iajs-3546	92	12	,	,	PUNCT
iajs-3546	92	13	p.	p.	NOUN
iajs-3546	92	14	e0009661	e0009661	PROPN
iajs-3546	92	15	.	.	PUNCT
iajs-3546	93	1	https://doi.org/10.1371/journal.pntd.0009661	https://doi.org/10.1371/journal.pntd.0009661	ADJ
iajs-3546	93	2	.	.	PUNCT
iajs-3546	94	1	5	5	X
iajs-3546	94	2	.	.	X
iajs-3546	94	3	bhat	bhat	PROPN
iajs-3546	94	4	s.	s.	PROPN
iajs-3546	94	5	mounsey	mounsey	PROPN
iajs-3546	94	6	k.	k.	PROPN
iajs-3546	94	7	;	;	PUNCT
iajs-3546	94	8	liu	liu	PROPN
iajs-3546	94	9	x.	x.	PROPN
iajs-3546	94	10	and	and	CCONJ
iajs-3546	94	11	shelley	shelley	PROPN
iajs-3546	94	12	f.	f.	PROPN
iajs-3546	94	13	host	host	PROPN
iajs-3546	94	14	immune	immune	PROPN
iajs-3546	94	15	responses	response	NOUN
iajs-3546	94	16	to	to	ADP
iajs-3546	94	17	the	the	DET
iajs-3546	94	18	itch	itch	NOUN
iajs-3546	94	19	mite	mite	NOUN
iajs-3546	94	20	,	,	PUNCT
iajs-3546	94	21	sarcoptes	sarcopte	VERB
iajs-3546	94	22	scabiei	scabiei	X
iajs-3546	94	23	,	,	PUNCT
iajs-3546	94	24	in	in	ADP
iajs-3546	94	25	humans	human	NOUN
iajs-3546	94	26	.	.	PUNCT
iajs-3546	95	1	parasites	parasite	NOUN
iajs-3546	95	2	and	and	CCONJ
iajs-3546	95	3	vectors	vector	NOUN
iajs-3546	95	4	2017	2017	NUM
iajs-3546	95	5	,	,	PUNCT
iajs-3546	95	6	10	10	NUM
iajs-3546	95	7	(	(	PUNCT
iajs-3546	95	8	1):1–12	1):1–12	NUM
iajs-3546	95	9	.	.	NOUN
iajs-3546	95	10	6	6	NUM
iajs-3546	95	11	.	.	PUNCT
iajs-3546	95	12	chandler	chandler	PROPN
iajs-3546	95	13	d.	d.	PROPN
iajs-3546	95	14	and	and	CCONJ
iajs-3546	95	15	lucinda	lucinda	PROPN
iajs-3546	95	16	f.	f.	PROPN
iajs-3546	95	17	a	a	DET
iajs-3546	95	18	review	review	NOUN
iajs-3546	95	19	of	of	ADP
iajs-3546	95	20	scabies	scabie	NOUN
iajs-3546	95	21	:	:	PUNCT
iajs-3546	95	22	an	an	DET
iajs-3546	95	23	infestation	infestation	NOUN
iajs-3546	95	24	more	more	ADJ
iajs-3546	95	25	than	than	ADP
iajs-3546	95	26	skin	skin	NOUN
iajs-3546	95	27	deep	deep	ADJ
iajs-3546	95	28	.	.	PUNCT
iajs-3546	96	1	dermatology	dermatology	NOUN
iajs-3546	96	2	2019	2019	NUM
iajs-3546	96	3	,	,	PUNCT
iajs-3546	96	4	235(2	235(2	NUM
iajs-3546	96	5	):	):	PUNCT
iajs-3546	96	6	79	79	NUM
iajs-3546	96	7	-	-	SYM
iajs-3546	96	8	90	90	NUM
iajs-3546	96	9	.	.	PUNCT
iajs-3546	97	1	https://doi.org/10.1159/000495290	https://doi.org/10.1159/000495290	VERB
iajs-3546	97	2	.	.	PUNCT
iajs-3546	98	1	7	7	X
iajs-3546	98	2	.	.	X
iajs-3546	98	3	hasan	hasan	PROPN
iajs-3546	98	4	t	t	PROPN
iajs-3546	98	5	.	.	PUNCT
iajs-3546	98	6	;	;	PUNCT
iajs-3546	98	7	krause	krause	PROPN
iajs-3546	98	8	v.	v.	PROPN
iajs-3546	98	9	;	;	PUNCT
iajs-3546	98	10	james	james	PROPN
iajs-3546	98	11	c.	c.	PROPN
iajs-3546	98	12	;	;	PUNCT
iajs-3546	98	13	currie	currie	PROPN
iajs-3546	98	14	b.	b.	PROPN
iajs-3546	98	15	crusted	crust	VERB
iajs-3546	98	16	scabies	scabie	NOUN
iajs-3546	98	17	;	;	PUNCT
iajs-3546	98	18	a	a	DET
iajs-3546	98	19	2	2	NUM
iajs-3546	98	20	-	-	PUNCT
iajs-3546	98	21	year	year	NOUN
iajs-3546	98	22	prospective	prospective	ADJ
iajs-3546	98	23	study	study	NOUN
iajs-3546	98	24	from	from	ADP
iajs-3546	98	25	the	the	DET
iajs-3546	98	26	northern	northern	ADJ
iajs-3546	98	27	territory	territory	NOUN
iajs-3546	98	28	of	of	ADP
iajs-3546	98	29	australia	australia	PROPN
iajs-3546	98	30	.	.	PUNCT
iajs-3546	99	1	plos	plos	PROPN
iajs-3546	99	2	public	public	PROPN
iajs-3546	99	3	library	library	PROPN
iajs-3546	99	4	of	of	ADP
iajs-3546	99	5	science	science	NOUN
iajs-3546	99	6	neglected	neglect	VERB
iajs-3546	99	7	tropical	tropical	ADJ
iajs-3546	99	8	diseases	disease	NOUN
iajs-3546	99	9	2020	2020	NUM
iajs-3546	99	10	,	,	PUNCT
iajs-3546	99	11	14(12	14(12	NUM
iajs-3546	99	12	)	)	PUNCT
iajs-3546	99	13	.	.	PUNCT
iajs-3546	100	1	https://doi.org/10.1371/journal.pntd.0008994	https://doi.org/10.1371/journal.pntd.0008994	PROPN
iajs-3546	100	2	.	.	NOUN
iajs-3546	101	1	8	8	X
iajs-3546	101	2	.	.	PUNCT
iajs-3546	101	3	chosidow	chosidow	NOUN
iajs-3546	101	4	o.	o.	NOUN
iajs-3546	101	5	and	and	CCONJ
iajs-3546	101	6	fuller	full	ADJ
iajs-3546	101	7	l.	l.	NOUN
iajs-3546	101	8	,	,	PUNCT
iajs-3546	101	9	“	"	PUNCT
iajs-3546	101	10	scratching	scratch	VERB
iajs-3546	101	11	the	the	DET
iajs-3546	101	12	itch	itch	NOUN
iajs-3546	101	13	:	:	PUNCT
iajs-3546	101	14	is	be	AUX
iajs-3546	101	15	scabies	scabie	NOUN
iajs-3546	101	16	a	a	DET
iajs-3546	101	17	truly	truly	ADV
iajs-3546	101	18	neglected	neglect	VERB
iajs-3546	101	19	disease	disease	NOUN
iajs-3546	101	20	?	?	PUNCT
iajs-3546	101	21	”	"	PUNCT
iajs-3546	102	1	lancet	lancet	NOUN
iajs-3546	102	2	infect	infect	NOUN
iajs-3546	102	3	.	.	PUNCT
iajs-3546	103	1	dis	dis	PROPN
iajs-3546	103	2	.	.	PROPN
iajs-3546	104	1	2017	2017	NUM
iajs-3546	104	2	,	,	PUNCT
iajs-3546	104	3	vol	vol	NOUN
iajs-3546	104	4	.	.	PROPN
iajs-3546	104	5	17	17	NUM
iajs-3546	104	6	,	,	PUNCT
iajs-3546	104	7	no	no	INTJ
iajs-3546	104	8	.	.	NOUN
iajs-3546	104	9	12	12	NUM
iajs-3546	104	10	,	,	PUNCT
iajs-3546	104	11	pp	pp	ADJ
iajs-3546	104	12	.	.	PUNCT
iajs-3546	105	1	1220–1221	1220–1221	NUM
iajs-3546	105	2	.	.	PUNCT
iajs-3546	106	1	9	9	NUM
iajs-3546	106	2	.	.	X
iajs-3546	106	3	molan	molan	PROPN
iajs-3546	106	4	a.	a.	PROPN
iajs-3546	106	5	;	;	PUNCT
iajs-3546	106	6	faraj	faraj	ADJ
iajs-3546	106	7	a.	a.	NOUN
iajs-3546	106	8	and	and	CCONJ
iajs-3546	106	9	hiday	hiday	NOUN
iajs-3546	106	10	a.	a.	NOUN
iajs-3546	106	11	m	m	PROPN
iajs-3546	106	12	practical	practical	ADJ
iajs-3546	106	13	of	of	ADP
iajs-3546	106	14	medicalentomology	medicalentomology	NOUN
iajs-3546	106	15	.	.	PUNCT
iajs-3546	107	1	dar	dar	PROPN
iajs-3546	107	2	erbil	erbil	PROPN
iajs-3546	107	3	–	–	PUNCT
iajs-3546	107	4	printing	printing	NOUN
iajs-3546	107	5	and	and	CCONJ
iajs-3546	107	6	publishing	publishing	NOUN
iajs-3546	107	7	2012	2012	NUM
iajs-3546	107	8	,	,	PUNCT
iajs-3546	107	9	150	150	NUM
iajs-3546	107	10	.	.	NOUN
iajs-3546	107	11	10	10	NUM
iajs-3546	107	12	.	.	PUNCT
iajs-3546	108	1	mcgeachy	mcgeachy	NOUN
iajs-3546	108	2	m.	m.	NOUN
iajs-3546	108	3	and	and	CCONJ
iajs-3546	108	4	cua	cua	VERB
iajs-3546	108	5	d.	d.	PROPN
iajs-3546	108	6	th17	th17	PROPN
iajs-3546	108	7	cell	cell	NOUN
iajs-3546	108	8	differentiation	differentiation	NOUN
iajs-3546	108	9	:	:	PUNCT
iajs-3546	108	10	the	the	DET
iajs-3546	108	11	long	long	ADJ
iajs-3546	108	12	and	and	CCONJ
iajs-3546	108	13	winding	wind	VERB
iajs-3546	108	14	road	road	NOUN
iajs-3546	108	15	.	.	PUNCT
iajs-3546	109	1	immunity	immunity	NOUN
iajs-3546	109	2	2008	2008	NUM
iajs-3546	109	3	,	,	PUNCT
iajs-3546	109	4	28(4	28(4	NUM
iajs-3546	109	5	):	):	PUNCT
iajs-3546	109	6	445–453	445–453	NUM
iajs-3546	109	7	.	.	PUNCT
iajs-3546	110	1	11	11	NUM
iajs-3546	110	2	.	.	PUNCT
iajs-3546	111	1	mohammad	mohammad	PROPN
iajs-3546	111	2	a.	a.	PROPN
iajs-3546	111	3	;	;	PUNCT
iajs-3546	111	4	kawen	kawen	PROPN
iajs-3546	111	5	a.	a.	PROPN
iajs-3546	111	6	;	;	PUNCT
iajs-3546	111	7	sharma	sharma	PROPN
iajs-3546	111	8	r	r	PROPN
iajs-3546	111	9	and	and	CCONJ
iajs-3546	111	10	hadi	hadi	PROPN
iajs-3546	111	11	n.	n.	PROPN
iajs-3546	111	12	immunological	immunological	ADJ
iajs-3546	111	13	aspects	aspect	NOUN
iajs-3546	111	14	of	of	ADP
iajs-3546	111	15	patients	patient	NOUN
iajs-3546	111	16	infested	infest	VERB
iajs-3546	111	17	with	with	ADP
iajs-3546	111	18	scabies	scabie	NOUN
iajs-3546	111	19	in	in	ADP
iajs-3546	111	20	thi	thi	PROPN
iajs-3546	111	21	-	-	PUNCT
iajs-3546	111	22	qar	qar	PROPN
iajs-3546	111	23	.	.	PUNCT
iajs-3546	112	1	medico	medico	ADJ
iajs-3546	112	2	-	-	ADJ
iajs-3546	112	3	legal	legal	ADJ
iajs-3546	112	4	update	update	NOUN
iajs-3546	112	5	2020	2020	NUM
iajs-3546	112	6	,	,	PUNCT
iajs-3546	112	7	20(3	20(3	NOUN
iajs-3546	112	8	)	)	PUNCT
iajs-3546	112	9	.	.	PUNCT
iajs-3546	113	1	12	12	NUM
iajs-3546	113	2	.	.	PUNCT
iajs-3546	114	1	al	al	PROPN
iajs-3546	114	2	-	-	PUNCT
iajs-3546	114	3	hadraawy	hadraawy	PROPN
iajs-3546	114	4	s.	s.	PROPN
iajs-3546	114	5	and	and	CCONJ
iajs-3546	114	6	hessen	hessen	PROPN
iajs-3546	114	7	h.	h.	PROPN
iajs-3546	114	8	hematological	hematological	PROPN
iajs-3546	114	9	and	and	CCONJ
iajs-3546	114	10	epidemiological	epidemiological	ADJ
iajs-3546	114	11	study	study	NOUN
iajs-3546	114	12	for	for	ADP
iajs-3546	114	13	patients	patient	NOUN
iajs-3546	114	14	infected	infect	VERB
iajs-3546	114	15	with	with	ADP
iajs-3546	114	16	scabies	scabie	NOUN
iajs-3546	114	17	.	.	PUNCT
iajs-3546	115	1	journal	journal	NOUN
iajs-3546	115	2	of	of	ADP
iajs-3546	115	3	pharmaceutical	pharmaceutical	NOUN
iajs-3546	115	4	sciences	science	NOUN
iajs-3546	115	5	and	and	CCONJ
iajs-3546	115	6	research	research	NOUN
iajs-3546	115	7	2017	2017	NUM
iajs-3546	115	8	,	,	PUNCT
iajs-3546	115	9	9(6):897	9(6):897	NUM
iajs-3546	115	10	.	.	NOUN
iajs-3546	115	11	13	13	NUM
iajs-3546	115	12	.	.	PUNCT
iajs-3546	116	1	mohammad	mohammad	PROPN
iajs-3546	116	2	a.	a.	PROPN
iajs-3546	116	3	;	;	PUNCT
iajs-3546	116	4	kawen	kawen	PROPN
iajs-3546	116	5	a.	a.	PROPN
iajs-3546	116	6	;	;	PUNCT
iajs-3546	116	7	sharma	sharma	PROPN
iajs-3546	116	8	r	r	PROPN
iajs-3546	116	9	and	and	CCONJ
iajs-3546	116	10	hadi	hadi	PROPN
iajs-3546	116	11	n.	n.	PROPN
iajs-3546	116	12	immunological	immunological	ADJ
iajs-3546	116	13	aspects	aspect	NOUN
iajs-3546	116	14	of	of	ADP
iajs-3546	116	15	patients	patient	NOUN
iajs-3546	116	16	infested	infest	VERB
iajs-3546	116	17	with	with	ADP
iajs-3546	116	18	scabies	scabie	NOUN
iajs-3546	116	19	in	in	ADP
iajs-3546	116	20	thi	thi	PROPN
iajs-3546	116	21	-	-	PUNCT
iajs-3546	116	22	qar	qar	PROPN
iajs-3546	116	23	.	.	PUNCT
iajs-3546	117	1	medico	medico	ADJ
iajs-3546	117	2	-	-	ADJ
iajs-3546	117	3	legal	legal	ADJ
iajs-3546	117	4	update	update	NOUN
iajs-3546	117	5	2020	2020	NUM
iajs-3546	117	6	,	,	PUNCT
iajs-3546	117	7	20(3	20(3	NOUN
iajs-3546	117	8	)	)	PUNCT
iajs-3546	117	9	.	.	PUNCT
iajs-3546	118	1	14	14	NUM
iajs-3546	118	2	.	.	PUNCT
iajs-3546	119	1	nielsen	nielsen	PROPN
iajs-3546	119	2	c.	c.	PROPN
iajs-3546	119	3	evidence	evidence	PROPN
iajs-3546	119	4	underscoring	underscore	VERB
iajs-3546	119	5	immunological	immunological	ADJ
iajs-3546	119	6	and	and	CCONJ
iajs-3546	119	7	clinical	clinical	ADJ
iajs-3546	119	8	pathological	pathological	ADJ
iajs-3546	119	9	changes	change	NOUN
iajs-3546	119	10	associated	associate	VERB
iajs-3546	119	11	with	with	ADP
iajs-3546	119	12	sarcoptes	sarcopte	NOUN
iajs-3546	119	13	scabiei	scabiei	ADJ
iajs-3546	119	14	infection	infection	NOUN
iajs-3546	119	15	:	:	PUNCT
iajs-3546	119	16	synthesis	synthesis	NOUN
iajs-3546	119	17	and	and	CCONJ
iajs-3546	119	18	meta-analysis.bmc	meta-analysis.bmc	NOUN
iajs-3546	119	19	infection	infection	NOUN
iajs-3546	119	20	diseases	disease	NOUN
iajs-3546	119	21	2022	2022	NUM
iajs-3546	119	22	,	,	PUNCT
iajs-3546	119	23	22(658	22(658	NUM
iajs-3546	119	24	)	)	PUNCT
iajs-3546	119	25	.	.	PUNCT
iajs-3546	120	1	15	15	NUM
iajs-3546	120	2	.	.	X
iajs-3546	121	1	onoja	onoja	ADJ
iajs-3546	121	2	a.	a.	PROPN
iajs-3546	121	3	redford	redford	PROPN
iajs-3546	121	4	p.	p.	PROPN
iajs-3546	121	5	;	;	PUNCT
iajs-3546	121	6	mcnab	mcnab	PROPN
iajs-3546	121	7	f.	f.	PROPN
iajs-3546	121	8	;	;	PUNCT
iajs-3546	121	9	hloe	hloe	PROPN
iajs-3546	121	10	i.	i.	PROPN
iajs-3546	121	11	bloom	bloom	PROPN
iajs-3546	121	12	c.	c.	PROPN
iajs-3546	121	13	;	;	PUNCT
iajs-3546	121	14	wilkinson	wilkinson	PROPN
iajs-3546	121	15	r.	r.	PROPN
iajs-3546	121	16	;	;	PUNCT
iajs-3546	121	17	and	and	CCONJ
iajs-3546	121	18	berry	berry	VERB
iajs-3546	121	19	m	m	PROPN
iajs-3546	121	20	.	.	PUNCT
iajs-3546	122	1	the	the	DET
iajs-3546	122	2	immune	immune	ADJ
iajs-3546	122	3	response	response	NOUN
iajs-3546	122	4	in	in	ADP
iajs-3546	122	5	tuberculosis	tuberculosis	NOUN
iajs-3546	122	6	.	.	PUNCT
iajs-3546	123	1	annual	annual	ADJ
iajs-3546	123	2	review	review	NOUN
iajs-3546	123	3	of	of	ADP
iajs-3546	123	4	immunology	immunology	NOUN
iajs-3546	123	5	2013	2013	NUM
iajs-3546	123	6	,	,	PUNCT
iajs-3546	123	7	31	31	NUM
iajs-3546	123	8	:	:	PUNCT
iajs-3546	123	9	475–527	475–527	NUM
iajs-3546	123	10	.	.	PUNCT
iajs-3546	124	1	https://doi.org/10.1146/annurevimmunol-032712-095939	https://doi.org/10.1146/annurevimmunol-032712-095939	PROPN
iajs-3546	124	2	.	.	PUNCT
iajs-3546	125	1	16	16	NUM
iajs-3546	125	2	.	.	PUNCT
iajs-3546	126	1	mohy	mohy	NOUN
iajs-3546	126	2	a.	a.	PROPN
iajs-3546	126	3	;	;	PUNCT
iajs-3546	126	4	aljanaby	aljanaby	NOUN
iajs-3546	126	5	a.	a.	NOUN
iajs-3546	126	6	and	and	CCONJ
iajs-3546	126	7	al	al	PROPN
iajs-3546	126	8	-	-	PUNCT
iajs-3546	126	9	hadraawy	hadraawy	PROPN
iajs-3546	126	10	s.	s.	PROPN
iajs-3546	126	11	evaluation	evaluation	NOUN
iajs-3546	126	12	of	of	ADP
iajs-3546	126	13	eosinophilic	eosinophilic	ADJ
iajs-3546	126	14	cationic	cationic	ADJ
iajs-3546	126	15	protein	protein	NOUN
iajs-3546	126	16	and	and	CCONJ
iajs-3546	126	17	some	some	DET
iajs-3546	126	18	immunological	immunological	ADJ
iajs-3546	126	19	markers	marker	NOUN
iajs-3546	126	20	in	in	ADP
iajs-3546	126	21	patients	patient	NOUN
iajs-3546	126	22	infected	infect	VERB
iajs-3546	126	23	with	with	ADP
iajs-3546	126	24	scabies	scabie	NOUN
iajs-3546	126	25	.	.	PUNCT
iajs-3546	127	1	j	j	PROPN
iajs-3546	127	2	pure	pure	ADJ
iajs-3546	127	3	appl	appl	PROPN
iajs-3546	127	4	microbiol	microbiol	PROPN
iajs-3546	127	5	2019	2019	NUM
iajs-3546	127	6	,	,	PUNCT
iajs-3546	127	7	13(3):1737	13(3):1737	NUM
iajs-3546	127	8	–	–	PUNCT
iajs-3546	127	9	1743	1743	NUM
iajs-3546	127	10	.	.	PUNCT
iajs-3546	128	1	https://doi.org/10.22207/jpam.13.3.48	https://doi.org/10.22207/jpam.13.3.48	PROPN
iajs-3546	128	2	17	17	NUM
iajs-3546	128	3	.	.	PUNCT
iajs-3546	129	1	abdel	abdel	PROPN
iajs-3546	129	2	hadi	hadi	PROPN
iajs-3546	129	3	h.	h.	PROPN
iajs-3546	129	4	study	study	PROPN
iajs-3546	129	5	of	of	ADP
iajs-3546	129	6	some	some	DET
iajs-3546	129	7	immunological	immunological	ADJ
iajs-3546	129	8	aspects	aspect	NOUN
iajs-3546	129	9	in	in	ADP
iajs-3546	129	10	scabietic	scabietic	ADJ
iajs-3546	129	11	patients	patient	NOUN
iajs-3546	129	12	.	.	PUNCT
iajs-3546	130	1	indian	indian	ADJ
iajs-3546	130	2	journal	journal	PROPN
iajs-3546	130	3	of	of	ADP
iajs-3546	130	4	forensic	forensic	ADJ
iajs-3546	130	5	medicine	medicine	NOUN
iajs-3546	130	6	and	and	CCONJ
iajs-3546	130	7	toxicology	toxicology	NOUN
iajs-3546	130	8	2020	2020	NUM
iajs-3546	130	9	,	,	PUNCT
iajs-3546	130	10	14(3):1380	14(3):1380	NUM
iajs-3546	130	11	-	-	SYM
iajs-3546	130	12	1384	1384	NUM
iajs-3546	130	13	.	.	PUNCT
iajs-3546	131	1	18	18	NUM
iajs-3546	131	2	.	.	PUNCT
iajs-3546	131	3	hashimoto	hashimoto	PROPN
iajs-3546	131	4	t.	t.	PROPN
iajs-3546	131	5	;	;	PUNCT
iajs-3546	131	6	satoh	satoh	NOUN
iajs-3546	131	7	t.	t.	NOUN
iajs-3546	131	8	and	and	CCONJ
iajs-3546	131	9	yokozeki	yokozeki	PROPN
iajs-3546	131	10	h.	h.	PROPN
iajs-3546	131	11	pruritus	pruritus	PROPN
iajs-3546	131	12	in	in	ADP
iajs-3546	131	13	ordinary	ordinary	ADJ
iajs-3546	131	14	scabies	scabie	NOUN
iajs-3546	131	15	:	:	PUNCT
iajs-3546	131	16	il-31	il-31	PUNCT
iajs-3546	131	17	from	from	ADP
iajs-3546	131	18	macrophages	macrophage	NOUN
iajs-3546	131	19	induced	induce	VERB
iajs-3546	131	20	by	by	ADP
iajs-3546	131	21	overexpression	overexpression	NOUN
iajs-3546	131	22	of	of	ADP
iajs-3546	131	23	thymic	thymic	ADJ
iajs-3546	131	24	stromal	stromal	ADJ
iajs-3546	131	25	lymphopoietin	lymphopoietin	NOUN
iajs-3546	131	26	and	and	CCONJ
iajs-3546	131	27	periostin	periostin	NOUN
iajs-3546	131	28	.	.	PUNCT
iajs-3546	132	1	europeon	europeon	PROPN
iajs-3546	132	2	.	.	PUNCT
iajs-3546	133	1	journal	journal	PROPN
iajs-3546	133	2	of	of	ADP
iajs-3546	133	3	allergy	allergy	PROPN
iajs-3546	133	4	and	and	CCONJ
iajs-3546	133	5	clinical	clinical	ADJ
iajs-3546	133	6	immunology	immunology	NOUN
iajs-3546	133	7	2019	2019	NUM
iajs-3546	133	8	,	,	PUNCT
iajs-3546	133	9	74(9):1727	74(9):1727	NUM
iajs-3546	133	10	-	-	SYM
iajs-3546	133	11	1737	1737	NUM
iajs-3546	133	12	.	.	PUNCT
iajs-3546	134	1	https://doi.org/10.1111/all.13870	https://doi.org/10.1111/all.13870	NOUN
iajs-3546	134	2	.	.	PUNCT
iajs-3546	135	1	https://doi.org/10.1111/j.1749-6632.2011.06364	https://doi.org/10.1111/j.1749-6632.2011.06364	PROPN
iajs-3546	135	2	.	.	PUNCT
iajs-3546	136	1	https://doi.org/10.1371/journal.pntd.0009661	https://doi.org/10.1371/journal.pntd.0009661	ADV
iajs-3546	136	2	https://doi.org/10.1159/000495290	https://doi.org/10.1159/000495290	VERB
iajs-3546	136	3	https://doi.org/10.1371/journal.pntd.0008994	https://doi.org/10.1371/journal.pntd.0008994	ADJ
iajs-3546	136	4	https://doi.org/10.1146/annurev-immunol-032712-095939	https://doi.org/10.1146/annurev-immunol-032712-095939	PROPN
iajs-3546	136	5	https://doi.org/10.1146/annurev-immunol-032712-095939	https://doi.org/10.1146/annurev-immunol-032712-095939	PROPN
iajs-3546	137	1	https://doi.org/10.22207/jpam.13.3.48	https://doi.org/10.22207/jpam.13.3.48	PROPN
iajs-3546	137	2	https://doi.org/10.22207/jpam.13.3.48	https://doi.org/10.22207/jpam.13.3.48	PROPN
iajs-3546	137	3	https://doi.org/10.1111/all.13870	https://doi.org/10.1111/all.13870	PROPN
iajs-3546	137	4	ihjpas	ihjpa	VERB
iajs-3546	137	5	.	.	PUNCT
iajs-3546	138	1	2025	2025	NUM
iajs-3546	138	2	,	,	PUNCT
iajs-3546	138	3	38	38	NUM
iajs-3546	138	4	(	(	PUNCT
iajs-3546	138	5	1	1	NUM
iajs-3546	138	6	)	)	PUNCT
iajs-3546	138	7	67	67	NUM
iajs-3546	138	8	19	19	NUM
iajs-3546	138	9	.	.	PUNCT
iajs-3546	139	1	satoh	satoh	NOUN
iajs-3546	139	2	t.	t.	PROPN
iajs-3546	139	3	;	;	PUNCT
iajs-3546	139	4	takayama	takayama	PROPN
iajs-3546	139	5	k.	k.	PROPN
iajs-3546	139	6	;	;	PUNCT
iajs-3546	139	7	and	and	CCONJ
iajs-3546	139	8	wallsa	wallsa	VERB
iajs-3546	139	9	.	.	PUNCT
iajs-3546	140	1	basophil	basophil	NOUN
iajs-3546	140	2	recruitment	recruitment	NOUN
iajs-3546	140	3	and	and	CCONJ
iajs-3546	140	4	activation	activation	NOUN
iajs-3546	140	5	in	in	ADP
iajs-3546	140	6	inflammatory	inflammatory	ADJ
iajs-3546	140	7	skin	skin	NOUN
iajs-3546	140	8	diseases	disease	NOUN
iajs-3546	140	9	.	.	PUNCT
iajs-3546	141	1	europeon	europeon	PROPN
iajs-3546	141	2	journal	journal	PROPN
iajs-3546	141	3	of	of	ADP
iajs-3546	141	4	allergy	allergy	PROPN
iajs-3546	141	5	and	and	CCONJ
iajs-3546	141	6	clinical	clinical	ADJ
iajs-3546	141	7	immunology	immunology	NOUN
iajs-3546	141	8	2011	2011	NUM
iajs-3546	141	9	,	,	PUNCT
iajs-3546	141	10	66(8):1107	66(8):1107	NUM
iajs-3546	141	11	1113	1113	NUM
iajs-3546	141	12	.	.	PUNCT
iajs-3546	142	1	https://doi.org/10.1111/j.1398-9995.2011.02570.x	https://doi.org/10.1111/j.1398-9995.2011.02570.x	NOUN
iajs-3546	142	2	20	20	NUM
iajs-3546	142	3	.	.	PUNCT
iajs-3546	143	1	arlian	arlian	PROPN
iajs-3546	143	2	l.	l.	PROPN
iajs-3546	143	3	;	;	PUNCT
iajs-3546	143	4	walton	walton	PROPN
iajs-3546	143	5	s.	s.	PROPN
iajs-3546	143	6	;	;	PUNCT
iajs-3546	143	7	dougall	dougall	PROPN
iajs-3546	143	8	a.	a.	NOUN
iajs-3546	143	9	genetic	genetic	ADJ
iajs-3546	143	10	epidemiology	epidemiology	NOUN
iajs-3546	143	11	of	of	ADP
iajs-3546	143	12	sarcoptes	sarcopte	NOUN
iajs-3546	143	13	scabiei	scabiei	PROPN
iajs-3546	143	14	(	(	PUNCT
iajs-3546	143	15	acari	acari	ADJ
iajs-3546	143	16	:	:	PUNCT
iajs-3546	143	17	sarcoptidae	sarcoptidae	NOUN
iajs-3546	143	18	)	)	PUNCT
iajs-3546	143	19	in	in	ADP
iajs-3546	143	20	northern	northern	ADJ
iajs-3546	143	21	australia	australia	PROPN
iajs-3546	143	22	.	.	PUNCT
iajs-3546	144	1	international	international	ADJ
iajs-3546	144	2	journal	journal	PROPN
iajs-3546	144	3	for	for	ADP
iajs-3546	144	4	parasitology	parasitology	NOUN
iajs-3546	144	5	2004	2004	NUM
iajs-3546	144	6	,	,	PUNCT
iajs-3546	144	7	34(7).839	34(7).839	NUM
iajs-3546	144	8	-	-	SYM
iajs-3546	144	9	849	849	NUM
iajs-3546	144	10	.	.	PUNCT
iajs-3546	144	11	https://doi.org/10.1016/j.ijpara.2004.04.002	https://doi.org/10.1016/j.ijpara.2004.04.002	NOUN
iajs-3546	144	12	.	.	PUNCT
iajs-3546	145	1	21	21	NUM
iajs-3546	145	2	.	.	PUNCT
iajs-3546	145	3	hahn	hahn	PROPN
iajs-3546	145	4	m.	m.	PROPN
iajs-3546	145	5	;	;	PUNCT
iajs-3546	145	6	klebow	klebow	PROPN
iajs-3546	145	7	s.	s.	PROPN
iajs-3546	145	8	;	;	PUNCT
iajs-3546	145	9	nikoalev	nikoalev	PROPN
iajs-3546	145	10	a.	a.	NOUN
iajs-3546	145	11	;	;	PUNCT
iajs-3546	145	12	wunderlich	wunderlich	PROPN
iajs-3546	145	13	f.	f.	PROPN
iajs-3546	145	14	;	;	PUNCT
iajs-3546	145	15	hövelmeyer	hövelmeyer	PROPN
iajs-3546	145	16	n.	n.	PROPN
iajs-3546	145	17	;	;	PUNCT
iajs-3546	145	18	karbach	karbach	PROPN
iajs-3546	145	19	s.	s.	PROPN
iajs-3546	145	20	;	;	PUNCT
iajs-3546	145	21	waisman	waisman	NOUN
iajs-3546	145	22	a.	a.	NOUN
iajs-3546	145	23	il-6	il-6	NOUN
iajs-3546	145	24	signaling	signal	VERB
iajs-3546	145	25	in	in	ADP
iajs-3546	145	26	myelo	myelo	ADJ
iajs-3546	145	27	monocytic	monocytic	ADJ
iajs-3546	145	28	celle	celle	PROPN
iajs-3546	145	29	references	reference	NOUN
iajs-3546	145	30	65	65	NUM
iajs-3546	145	31	is	be	AUX
iajs-3546	145	32	not	not	PART
iajs-3546	145	33	crucial	crucial	ADJ
iajs-3546	145	34	for	for	ADP
iajs-3546	145	35	the	the	DET
iajs-3546	145	36	development	development	NOUN
iajs-3546	145	37	of	of	ADP
iajs-3546	145	38	imqinduced	imqinduced	ADJ
iajs-3546	145	39	psoriasis	psoriasis	NOUN
iajs-3546	145	40	.	.	PUNCT
iajs-3546	146	1	plos	plos	PROPN
iajs-3546	146	2	one	one	NUM
iajs-3546	146	3	public	public	ADJ
iajs-3546	146	4	library	library	NOUN
iajs-3546	146	5	of	of	ADP
iajs-3546	146	6	science	science	NOUN
iajs-3546	146	7	2016	2016	NUM
iajs-3546	146	8	,	,	PUNCT
iajs-3546	146	9	11(3	11(3	NUM
iajs-3546	146	10	)	)	PUNCT
iajs-3546	146	11	.	.	PUNCT
iajs-3546	147	1	22	22	NUM
iajs-3546	147	2	.	.	PUNCT
iajs-3546	148	1	granholm	granholm	PROPN
iajs-3546	148	2	j.	j.	PROPN
iajs-3546	148	3	and	and	CCONJ
iajs-3546	148	4	olazewski	olazewski	PROPN
iajs-3546	148	5	j.	j.	PROPN
iajs-3546	148	6	scabies	scabies	PROPN
iajs-3546	148	7	prevention	prevention	PROPN
iajs-3546	148	8	and	and	CCONJ
iajs-3546	148	9	control	control	NOUN
iajs-3546	148	10	manual	manual	NOUN
iajs-3546	148	11	.	.	PUNCT
iajs-3546	149	1	michigan	michigan	PROPN
iajs-3546	149	2	department	department	PROPN
iajs-3546	149	3	of	of	ADP
iajs-3546	149	4	community	community	NOUN
iajs-3546	149	5	health	health	PROPN
iajs-3546	149	6	2005	2005	NUM
iajs-3546	149	7	,	,	PUNCT
iajs-3546	149	8	24(7	24(7	NUM
iajs-3546	149	9	)	)	PUNCT
iajs-3546	149	10	.	.	PUNCT
iajs-3546	150	1	23	23	NUM
iajs-3546	150	2	.	.	X
iajs-3546	151	1	abd	abd	PROPN
iajs-3546	151	2	el	el	PROPN
iajs-3546	151	3	-	-	PROPN
iajs-3546	151	4	aal	aal	PROPN
iajs-3546	151	5	a.	a.	NOUN
iajs-3546	151	6	;	;	PUNCT
iajs-3546	151	7	hassan	hassan	PROPN
iajs-3546	151	8	m.	m.	NOUN
iajs-3546	151	9	;	;	PUNCT
iajs-3546	151	10	barakat	barakat	PROPN
iajs-3546	151	11	m.	m.	PROPN
iajs-3546	151	12	immunonomodulatory	immunonomodulatory	PROPN
iajs-3546	151	13	impression	impression	NOUN
iajs-3546	151	14	of	of	ADP
iajs-3546	151	15	anti	anti	ADJ
iajs-3546	151	16	and	and	CCONJ
iajs-3546	151	17	pro	pro	ADJ
iajs-3546	151	18	-	-	ADJ
iajs-3546	151	19	inflammatory	inflammatory	ADJ
iajs-3546	151	20	cytokines	cytokine	NOUN
iajs-3546	151	21	in	in	ADP
iajs-3546	151	22	relation	relation	NOUN
iajs-3546	151	23	to	to	ADP
iajs-3546	151	24	humoral	humoral	ADJ
iajs-3546	151	25	immunity	immunity	NOUN
iajs-3546	151	26	in	in	ADP
iajs-3546	151	27	humam	humam	PROPN
iajs-3546	151	28	scabies	scabie	NOUN
iajs-3546	151	29	.	.	PUNCT
iajs-3546	152	1	international	international	ADJ
iajs-3546	152	2	journal	journal	PROPN
iajs-3546	152	3	of	of	ADP
iajs-3546	152	4	immunopathology	immunopathology	NOUN
iajs-3546	152	5	and	and	CCONJ
iajs-3546	152	6	pharmacology	pharmacology	NOUN
iajs-3546	152	7	2016	2016	NUM
iajs-3546	152	8	,	,	PUNCT
iajs-3546	152	9	26(6	26(6	NUM
iajs-3546	152	10	)	)	PUNCT
iajs-3546	152	11	.	.	PUNCT
iajs-3546	153	1	https://doi.org/10.1177/0394632015627464	https://doi.org/10.1177/0394632015627464	ADV
iajs-3546	153	2	.	.	PUNCT
iajs-3546	154	1	24	24	NUM
iajs-3546	154	2	.	.	PUNCT
iajs-3546	155	1	pereira	pereira	PROPN
iajs-3546	155	2	p.	p.	PROPN
iajs-3546	155	3	and	and	CCONJ
iajs-3546	155	4	woof	woof	VERB
iajs-3546	155	5	j.	j.	PROPN
iajs-3546	155	6	iga	iga	PROPN
iajs-3546	155	7	:	:	PUNCT
iajs-3546	155	8	structure	structure	NOUN
iajs-3546	155	9	,	,	PUNCT
iajs-3546	155	10	function	function	NOUN
iajs-3546	155	11	,	,	PUNCT
iajs-3546	155	12	and	and	CCONJ
iajs-3546	155	13	developability	developability	NOUN
iajs-3546	155	14	.	.	PUNCT
iajs-3546	156	1	antibodies	antibodie	VERB
iajs-3546	156	2	2019	2019	NUM
iajs-3546	156	3	,	,	PUNCT
iajs-3546	156	4	8(4):57	8(4):57	NUM
iajs-3546	156	5	.	.	PUNCT
iajs-3546	157	1	https://doi.org/10.3390/antib8040057	https://doi.org/10.3390/antib8040057	PROPN
iajs-3546	157	2	.	.	PUNCT
iajs-3546	158	1	25	25	NUM
iajs-3546	158	2	.	.	PUNCT
iajs-3546	159	1	hamdan	hamdan	PROPN
iajs-3546	159	2	a.	a.	PROPN
iajs-3546	159	3	and	and	CCONJ
iajs-3546	159	4	ali	ali	PROPN
iajs-3546	159	5	a.	a.	PROPN
iajs-3546	159	6	the	the	DET
iajs-3546	159	7	indirect	indirect	ADJ
iajs-3546	159	8	induction	induction	NOUN
iajs-3546	159	9	of	of	ADP
iajs-3546	159	10	human	human	ADJ
iajs-3546	159	11	scabies	scabie	NOUN
iajs-3546	159	12	to	to	ADP
iajs-3546	159	13	initiation	initiation	NOUN
iajs-3546	159	14	autoimmune	autoimmune	ADJ
iajs-3546	159	15	disease	disease	NOUN
iajs-3546	159	16	(	(	PUNCT
iajs-3546	159	17	sle	sle	PROPN
iajs-3546	159	18	):	):	PUNCT
iajs-3546	159	19	comprehensive	comprehensive	ADJ
iajs-3546	159	20	study	study	NOUN
iajs-3546	159	21	in	in	ADP
iajs-3546	159	22	marshes	marsh	NOUN
iajs-3546	159	23	population	population	NOUN
iajs-3546	159	24	of	of	ADP
iajs-3546	159	25	thi-qar.karbala	thi-qar.karbala	PROPN
iajs-3546	159	26	journal	journal	NOUN
iajs-3546	159	27	of	of	ADP
iajs-3546	159	28	pharmaceutical	pharmaceutical	PROPN
iajs-3546	159	29	sciences	science	NOUN
iajs-3546	159	30	2017	2017	NUM
iajs-3546	159	31	,	,	PUNCT
iajs-3546	159	32	13(15):152	13(15):152	NUM
iajs-3546	159	33	-	-	SYM
iajs-3546	159	34	166	166	NUM
iajs-3546	159	35	.	.	PUNCT
iajs-3546	160	1	herba	herba	PROPN
iajs-3546	160	2	f.	f.	PROPN
iajs-3546	160	3	1868	1868	NUM
iajs-3546	160	4	.	.	PUNCT
iajs-3546	161	1	on	on	ADP
iajs-3546	161	2	diseases	disease	NOUN
iajs-3546	161	3	of	of	ADP
iajs-3546	161	4	the	the	DET
iajs-3546	161	5	skin	skin	NOUN
iajs-3546	161	6	.	.	PUNCT
iajs-3546	162	1	london	london	PROPN
iajs-3546	162	2	,	,	PUNCT
iajs-3546	162	3	the	the	DET
iajs-3546	162	4	new	new	ADJ
iajs-3546	162	5	sydenham	sydenham	PROPN
iajs-3546	162	6	society	society	NOUN
iajs-3546	162	7	,	,	PUNCT
iajs-3546	162	8	1874	1874	NUM
iajs-3546	162	9	(	(	PUNCT
iajs-3546	162	10	3	3	NUM
iajs-3546	162	11	):	):	PUNCT
iajs-3546	162	12	180	180	NUM
iajs-3546	162	13	.	.	NOUN
iajs-3546	162	14	26	26	NUM
iajs-3546	162	15	.	.	PUNCT
iajs-3546	163	1	laura	laura	PROPN
iajs-3546	163	2	m.	m.	PROPN
iajs-3546	163	3	;	;	PUNCT
iajs-3546	163	4	leipzing	leipze	VERB
iajs-3546	163	5	n.	n.	NOUN
iajs-3546	163	6	;	;	PUNCT
iajs-3546	163	7	choichet	choichet	ADJ
iajs-3546	163	8	m.	m.	NOUN
iajs-3546	163	9	promoting	promote	VERB
iajs-3546	163	10	neuron	neuron	NOUN
iajs-3546	163	11	adhesion	adhesion	NOUN
iajs-3546	163	12	and	and	CCONJ
iajs-3546	163	13	growth	growth	NOUN
iajs-3546	163	14	.	.	PUNCT
iajs-3546	164	1	materialatoday	materialatoday	PROPN
iajs-3546	164	2	2009	2009	NUM
iajs-3546	164	3	,	,	PUNCT
iajs-3546	164	4	11(5):36	11(5):36	NUM
iajs-3546	164	5	-	-	SYM
iajs-3546	164	6	43	43	NUM
iajs-3546	164	7	.	.	PUNCT
iajs-3546	165	1	https://doi.org/10.1016/s1369-7021(08)70088-9	https://doi.org/10.1016/s1369-7021(08)70088-9	NOUN
iajs-3546	165	2	.	.	PUNCT
iajs-3546	166	1	27	27	NUM
iajs-3546	166	2	.	.	PUNCT
iajs-3546	167	1	walton	walton	PROPN
iajs-3546	167	2	s.	s.	PROPN
iajs-3546	167	3	;	;	PUNCT
iajs-3546	167	4	pizzutto	pizzutto	PROPN
iajs-3546	167	5	s.	s.	PROPN
iajs-3546	167	6	;	;	PUNCT
iajs-3546	167	7	slender	slender	PROPN
iajs-3546	167	8	a.	a.	NOUN
iajs-3546	167	9	;	;	PUNCT
iajs-3546	167	10	viberg	viberg	PROPN
iajs-3546	167	11	l.	l.	PROPN
iajs-3546	167	12	;	;	PUNCT
iajs-3546	167	13	holt	holt	PROPN
iajs-3546	167	14	d.	d.	PROPN
iajs-3546	167	15	;	;	PUNCT
iajs-3546	167	16	hales	hales	PROPN
iajs-3546	167	17	b.	b.	PROPN
iajs-3546	167	18	;	;	PUNCT
iajs-3546	167	19	kemp	kemp	PROPN
iajs-3546	167	20	d.	d.	PROPN
iajs-3546	167	21	;	;	PUNCT
iajs-3546	167	22	currie	currie	PROPN
iajs-3546	167	23	b.	b.	PROPN
iajs-3546	167	24	;	;	PUNCT
iajs-3546	167	25	rolland	rolland	PROPN
iajs-3546	167	26	j.	j.	PROPN
iajs-3546	167	27	;	;	PUNCT
iajs-3546	167	28	o'hehir	o'hehir	PROPN
iajs-3546	167	29	r.	r.	PROPN
iajs-3546	167	30	increased	increase	VERB
iajs-3546	167	31	allergic	allergic	ADJ
iajs-3546	167	32	immune	immune	ADJ
iajs-3546	167	33	response	response	NOUN
iajs-3546	167	34	to	to	PART
iajs-3546	167	35	sarcoptes	sarcopte	VERB
iajs-3546	167	36	scabiei	scabiei	ADJ
iajs-3546	167	37	antigens	antigen	NOUN
iajs-3546	167	38	in	in	ADP
iajs-3546	167	39	crusted	crust	VERB
iajs-3546	167	40	versus	versus	ADP
iajs-3546	167	41	ordinary	ordinary	ADJ
iajs-3546	167	42	scabies	scabie	NOUN
iajs-3546	167	43	.	.	PUNCT
iajs-3546	168	1	clinical	clinical	ADJ
iajs-3546	168	2	and	and	CCONJ
iajs-3546	168	3	vaccine	vaccine	NOUN
iajs-3546	168	4	immunology	immunology	NOUN
iajs-3546	168	5	2010	2010	NUM
iajs-3546	168	6	,	,	PUNCT
iajs-3546	168	7	17(9	17(9	NOUN
iajs-3546	168	8	):	):	PUNCT
iajs-3546	168	9	1428–1438	1428–1438	NUM
iajs-3546	168	10	.	.	PUNCT
iajs-3546	169	1	https://doi.org/10.1128/cvi.00195-10	https://doi.org/10.1128/cvi.00195-10	NOUN
iajs-3546	169	2	.	.	NOUN
iajs-3546	169	3	28	28	NUM
iajs-3546	169	4	.	.	PUNCT
iajs-3546	169	5	abbas	abbas	PROPN
iajs-3546	169	6	a.	a.	PROPN
iajs-3546	169	7	;	;	PUNCT
iajs-3546	169	8	al	al	PROPN
iajs-3546	169	9	-	-	PUNCT
iajs-3546	169	10	ahmer	ahmer	NOUN
iajs-3546	169	11	s.	s.	PROPN
iajs-3546	169	12	;	;	PUNCT
iajs-3546	169	13	muslim	muslim	PROPN
iajs-3546	169	14	a.	a.	PROPN
iajs-3546	169	15	;	;	PUNCT
iajs-3546	169	16	hussein	hussein	PROPN
iajs-3546	169	17	m.	m.	NOUN
iajs-3546	169	18	and	and	CCONJ
iajs-3546	169	19	abood	abood	PROPN
iajs-3546	169	20	z.	z.	PROPN
iajs-3546	169	21	epidemiological	epidemiological	ADJ
iajs-3546	169	22	and	and	CCONJ
iajs-3546	169	23	clinical	clinical	ADJ
iajs-3546	169	24	studies	study	NOUN
iajs-3546	169	25	for	for	ADP
iajs-3546	169	26	prevalence	prevalence	NOUN
iajs-3546	169	27	of	of	ADP
iajs-3546	169	28	scabies	scabie	NOUN
iajs-3546	169	29	in	in	ADP
iajs-3546	169	30	the	the	DET
iajs-3546	169	31	displaced	displace	VERB
iajs-3546	169	32	people	people	NOUN
iajs-3546	169	33	camps	camp	NOUN
iajs-3546	169	34	of	of	ADP
iajs-3546	169	35	iraq	iraq	PROPN
iajs-3546	169	36	.	.	PUNCT
iajs-3546	170	1	plant	plant	NOUN
iajs-3546	170	2	archives	archive	NOUN
iajs-3546	170	3	2021,v.21.no.1.p.p.20632067	2021,v.21.no.1.p.p.20632067	NUM
iajs-3546	170	4	.	.	PUNCT
iajs-3546	171	1	doi	doi	PROPN
iajs-3546	171	2	link	link	PROPN
iajs-3546	171	3	:	:	PUNCT
iajs-3546	171	4	https://doi.org/10.51470/plantarchives	https://doi.org/10.51470/plantarchive	NOUN
iajs-3546	171	5	.	.	PUNCT
iajs-3546	172	1	29	29	NUM
iajs-3546	172	2	.	.	PUNCT
iajs-3546	173	1	al	al	PROPN
iajs-3546	173	2	-	-	PUNCT
iajs-3546	173	3	wan	wan	PROPN
iajs-3546	173	4	n.	n.	PROPN
iajs-3546	173	5	;	;	PUNCT
iajs-3546	173	6	shkir	shkir	PROPN
iajs-3546	173	7	s.	s.	PROPN
iajs-3546	173	8	,	,	PUNCT
iajs-3546	173	9	and	and	CCONJ
iajs-3546	173	10	waheeb	waheeb	NOUN
iajs-3546	173	11	h.	h.	PROPN
iajs-3546	173	12	epidemiology	epidemiology	PROPN
iajs-3546	173	13	of	of	ADP
iajs-3546	173	14	skin	skin	NOUN
iajs-3546	173	15	diseases	disease	NOUN
iajs-3546	173	16	among	among	ADP
iajs-3546	173	17	displaced	displaced	ADJ
iajs-3546	173	18	people	people	NOUN
iajs-3546	173	19	in	in	ADP
iajs-3546	173	20	diayla	diayla	PROPN
iajs-3546	173	21	province	province	PROPN
iajs-3546	173	22	.	.	PUNCT
iajs-3546	174	1	journal	journal	PROPN
iajs-3546	174	2	of	of	ADP
iajs-3546	174	3	the	the	DET
iajs-3546	174	4	faculty	faculty	NOUN
iajs-3546	174	5	of	of	ADP
iajs-3546	174	6	medicine	medicine	NOUN
iajs-3546	174	7	,	,	PUNCT
iajs-3546	174	8	baghdad	baghdad	PROPN
iajs-3546	174	9	2018	2018	NUM
iajs-3546	174	10	,	,	PUNCT
iajs-3546	174	11	v.	v.	ADP
iajs-3546	174	12	60	60	NUM
iajs-3546	174	13	.	.	PUNCT
iajs-3546	175	1	no	no	INTJ
iajs-3546	175	2	.	.	NOUN
iajs-3546	176	1	1	1	X
iajs-3546	176	2	.	.	X
iajs-3546	176	3	https://doi.org/10.32007/jfacmedbagdad.60145	https://doi.org/10.32007/jfacmedbagdad.60145	NOUN
iajs-3546	176	4	.	.	PUNCT
iajs-3546	177	1	30	30	NUM
iajs-3546	177	2	.	.	PUNCT
iajs-3546	178	1	al	al	PROPN
iajs-3546	178	2	-kuraishy	-kuraishy	PROPN
iajs-3546	178	3	h.	h.	PROPN
iajs-3546	178	4	;	;	PUNCT
iajs-3546	178	5	al	al	PROPN
iajs-3546	178	6	-	-	PUNCT
iajs-3546	178	7	kuraishy	kuraishy	PROPN
iajs-3546	178	8	a.	a.	NOUN
iajs-3546	178	9	;	;	PUNCT
iajs-3546	178	10	al	al	PROPN
iajs-3546	178	11	-	-	PUNCT
iajs-3546	178	12	windy	windy	PROPN
iajs-3546	178	13	s.	s.	PROPN
iajs-3546	178	14	;	;	PUNCT
iajs-3546	178	15	al	al	PROPN
iajs-3546	178	16	-	-	PUNCT
iajs-3546	178	17	gareeb	gareeb	PROPN
iajs-3546	178	18	a.	a.	NOUN
iajs-3546	178	19	toxoplasmosis	toxoplasmosis	NOUN
iajs-3546	178	20	and	and	CCONJ
iajs-3546	178	21	risk	risk	NOUN
iajs-3546	178	22	of	of	ADP
iajs-3546	178	23	endothelial	endothelial	ADJ
iajs-3546	178	24	dysfunction	dysfunction	NOUN
iajs-3546	178	25	:	:	PUNCT
iajs-3546	178	26	role	role	NOUN
iajs-3546	178	27	of	of	ADP
iajs-3546	178	28	oxidative	oxidative	ADJ
iajs-3546	178	29	stress	stress	NOUN
iajs-3546	178	30	and	and	CCONJ
iajs-3546	178	31	pro	pro	ADJ
iajs-3546	178	32	-	-	ADJ
iajs-3546	178	33	inflammatory	inflammatory	ADJ
iajs-3546	178	34	mediators	mediator	NOUN
iajs-3546	178	35	.	.	PUNCT
iajs-3546	179	1	archves	archve	NOUN
iajs-3546	179	2	of	of	ADP
iajs-3546	179	3	clinical	clinical	ADJ
iajs-3546	179	4	infectious	infectious	ADJ
iajs-3546	179	5	diseases	disease	NOUN
iajs-3546	179	6	2019	2019	NUM
iajs-3546	179	7	,	,	PUNCT
iajs-3546	179	8	v.	v.	ADP
iajs-3546	179	9	14	14	NUM
iajs-3546	179	10	.	.	PUNCT
iajs-3546	180	1	no	no	INTJ
iajs-3546	180	2	.	.	NOUN
iajs-3546	181	1	6	6	NUM
iajs-3546	181	2	.	.	NOUN
iajs-3546	181	3	https://doi.org/10.5812/archcid.95563	https://doi.org/10.5812/archcid.95563	NOUN
iajs-3546	181	4	.	.	PUNCT
iajs-3546	182	1	31	31	NUM
iajs-3546	182	2	.	.	PUNCT
iajs-3546	183	1	mohamed	mohamed	PROPN
iajs-3546	183	2	k.	k.	PROPN
iajs-3546	183	3	;	;	PUNCT
iajs-3546	183	4	khadhum	khadhum	VERB
iajs-3546	183	5	m.	m.	NOUN
iajs-3546	183	6	;	;	PUNCT
iajs-3546	183	7	abu	abu	PROPN
iajs-3546	183	8	al	al	PROPN
iajs-3546	183	9	-	-	PUNCT
iajs-3546	183	10	ess	ess	PROPN
iajs-3546	183	11	m.	m.	NOUN
iajs-3546	183	12	;	;	PUNCT
iajs-3546	183	13	ali	ali	PROPN
iajs-3546	183	14	s.	s.	PROPN
iajs-3546	183	15	;	;	PUNCT
iajs-3546	183	16	alfukhar	alfukhar	PROPN
iajs-3546	183	17	s.	s.	PROPN
iajs-3546	183	18	;	;	PUNCT
iajs-3546	183	19	al	al	PROPN
iajs-3546	183	20	-	-	PUNCT
iajs-3546	183	21	wattar	wattar	PROPN
iajs-3546	183	22	w.	w.	PROPN
iajs-3546	183	23	;	;	PUNCT
iajs-3546	183	24	and	and	CCONJ
iajs-3546	183	25	mousa	mousa	PROPN
iajs-3546	183	26	j.	j.	PROPN
iajs-3546	183	27	impact	impact	PROPN
iajs-3546	183	28	of	of	ADP
iajs-3546	183	29	intenstiral	intenstiral	ADJ
iajs-3546	183	30	entamoeba	entamoeba	NOUN
iajs-3546	183	31	histolytica	histolytica	PROPN
iajs-3546	183	32	on	on	ADP
iajs-3546	183	33	sera	sera	NOUN
iajs-3546	183	34	of	of	ADP
iajs-3546	183	35	interleukin-5	interleukin-5	NUM
iajs-3546	183	36	histamine	histamine	NOUN
iajs-3546	183	37	,	,	PUNCT
iajs-3546	183	38	secretory	secretory	NOUN
iajs-3546	183	39	iga	iga	PROPN
iajs-3546	183	40	,	,	PUNCT
iajs-3546	183	41	and	and	CCONJ
iajs-3546	183	42	amylase	amylase	NOUN
iajs-3546	183	43	.	.	PUNCT
iajs-3546	184	1	current	current	ADJ
iajs-3546	184	2	research	research	NOUN
iajs-3546	184	3	in	in	ADP
iajs-3546	184	4	microbiology	microbiology	NOUN
iajs-3546	184	5	and	and	CCONJ
iajs-3546	184	6	biotechnology	biotechnology	NOUN
iajs-3546	184	7	2017	2017	NUM
iajs-3546	184	8	,	,	PUNCT
iajs-3546	184	9	v.	v.	ADP
iajs-3546	184	10	5no	5no	NOUN
iajs-3546	184	11	.	.	PUNCT
iajs-3546	185	1	5	5	NUM
iajs-3546	185	2	,	,	PUNCT
iajs-3546	185	3	v.	v.	ADP
iajs-3546	185	4	5	5	NUM
iajs-3546	185	5	no.5	no.5	PROPN
iajs-3546	185	6	p.p.1245	p.p.1245	NOUN
iajs-3546	185	7	-	-	PUNCT
iajs-3546	185	8	1249	1249	NUM
iajs-3546	185	9	.	.	PUNCT
iajs-3546	186	1	32	32	NUM
iajs-3546	186	2	.	.	PUNCT
iajs-3546	186	3	almuhammadi	almuhammadi	PROPN
iajs-3546	186	4	s.	s.	PROPN
iajs-3546	186	5	and	and	CCONJ
iajs-3546	186	6	alghamdi	alghamdi	PROPN
iajs-3546	186	7	s.	s.	PROPN
iajs-3546	186	8	the	the	DET
iajs-3546	186	9	future	future	NOUN
iajs-3546	186	10	of	of	ADP
iajs-3546	186	11	cryptocurrency	cryptocurrency	NOUN
iajs-3546	186	12	blockchains	blockchain	NOUN
iajs-3546	186	13	in	in	ADP
iajs-3546	186	14	the	the	DET
iajs-3546	186	15	quantum	quantum	ADJ
iajs-3546	186	16	era	era	NOUN
iajs-3546	186	17	in	in	ADP
iajs-3546	186	18	2021	2021	NUM
iajs-3546	186	19	.	.	PUNCT
iajs-3546	187	1	ieee	ieee	PROPN
iajs-3546	187	2	international	international	PROPN
iajs-3546	187	3	conference	conference	PROPN
iajs-3546	187	4	on	on	ADP
iajs-3546	187	5	blockchain	blockchain	PROPN
iajs-3546	187	6	2021	2021	NUM
iajs-3546	187	7	,	,	PUNCT
iajs-3546	187	8	(	(	PUNCT
iajs-3546	187	9	3	3	NUM
iajs-3546	187	10	):	):	PUNCT
iajs-3546	187	11	544–551	544–551	NUM
iajs-3546	187	12	.	.	PUNCT
iajs-3546	187	13	https://doi.org/10.1109/blockchain53845.2021.00082	https://doi.org/10.1109/blockchain53845.2021.00082	PROPN
iajs-3546	187	14	33	33	NUM
iajs-3546	187	15	.	.	PUNCT
iajs-3546	188	1	rashid	rashid	PROPN
iajs-3546	188	2	s.	s.	PROPN
iajs-3546	188	3	;	;	PUNCT
iajs-3546	188	4	kanwal	kanwal	PROPN
iajs-3546	188	5	b.	b.	PROPN
iajs-3546	188	6	;	;	PUNCT
iajs-3546	188	7	jarad	jarad	PROPN
iajs-3546	188	8	f.	f.	PROPN
iajs-3546	188	9	;	;	PUNCT
iajs-3546	188	10	elagan	elagan	PROPN
iajs-3546	188	11	s	s	PROPN
iajs-3546	188	12	.	.	PUNCT
iajs-3546	189	1	a	a	DET
iajs-3546	189	2	peculiar	peculiar	ADJ
iajs-3546	189	3	application	application	NOUN
iajs-3546	189	4	of	of	ADP
iajs-3546	189	5	the	the	DET
iajs-3546	189	6	fractal	fractal	ADJ
iajs-3546	189	7	–	–	PUNCT
iajs-3546	189	8	fractional	fractional	ADJ
iajs-3546	189	9	derivative	derivative	NOUN
iajs-3546	189	10	in	in	ADP
iajs-3546	189	11	the	the	DET
iajs-3546	189	12	dynamics	dynamic	NOUN
iajs-3546	189	13	of	of	ADP
iajs-3546	189	14	a	a	DET
iajs-3546	189	15	nonlinear	nonlinear	ADJ
iajs-3546	189	16	scabies	scabie	NOUN
iajs-3546	189	17	model	model	NOUN
iajs-3546	189	18	.	.	PUNCT
iajs-3546	190	1	results	result	NOUN
iajs-3546	190	2	in	in	ADP
iajs-3546	190	3	physics	physics	NOUN
iajs-3546	190	4	2022	2022	NUM
iajs-3546	190	5	,	,	PUNCT
iajs-3546	190	6	38	38	NUM
iajs-3546	190	7	:	:	SYM
iajs-3546	190	8	105634	105634	NUM
iajs-3546	190	9	.	.	PUNCT
iajs-3546	191	1	https://doi.org/10.1016/j.rinp.2022.105634	https://doi.org/10.1016/j.rinp.2022.105634	PROPN
iajs-3546	191	2	.	.	PUNCT
iajs-3546	192	1	https://doi.org/10.1111/j.1398-9995.2011.02570.x	https://doi.org/10.1111/j.1398-9995.2011.02570.x	PROPN
iajs-3546	192	2	https://doi.org/10.1111/j.1398-9995.2011.02570.x	https://doi.org/10.1111/j.1398-9995.2011.02570.x	PROPN
iajs-3546	192	3	https://doi.org/10.1016/j.ijpara.2004.04.002	https://doi.org/10.1016/j.ijpara.2004.04.002	PROPN
iajs-3546	192	4	https://doi.org/10.1177/0394632015627464	https://doi.org/10.1177/0394632015627464	PROPN
iajs-3546	192	5	https://doi.org/10.3390/antib8040057	https://doi.org/10.3390/antib8040057	ADJ
iajs-3546	192	6	https://doi.org/10.1016/s1369-7021(08)70088-9	https://doi.org/10.1016/s1369-7021(08)70088-9	NOUN
iajs-3546	192	7	.	.	PUNCT
iajs-3546	193	1	https://doi.org/10.1128/cvi.00195-10	https://doi.org/10.1128/cvi.00195-10	NOUN
iajs-3546	193	2	https://doi.org/10.32007/jfacmedbagdad.60145	https://doi.org/10.32007/jfacmedbagdad.60145	VERB
iajs-3546	193	3	https://doi.org/10.5812/archcid.95563	https://doi.org/10.5812/archcid.95563	NOUN
iajs-3546	193	4	https://doi.org/10.1109/blockchain53845.2021.00082	https://doi.org/10.1109/blockchain53845.2021.00082	PROPN
iajs-3546	193	5	https://doi.org/10.1016/j.rinp.2022.105634	https://doi.org/10.1016/j.rinp.2022.105634	NOUN
iajs-3546	193	6	.	.	PUNCT